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Abstract
The principal aim of this thesis was to investigate the role of nuclear factor-kappa B
(NFkB) in the developing nervous system. NFkB is a ubiquitously expressed
transcription factor that plays a key role in regulating the expression of genes
involved in a variety of cellular processes, including innate and adaptive immune
responses, stress responses, cell survival, proliferation and differentiation. In the
nervous system, NFkB plays a role in regulating neuronal survival and has been
implicated in learning and memory. As the elaboration and modification of neuronal
processes is thought to be an important anatomical change underlying learning and
memory, a major aim of the thesis was to investigate of the potential role of NFkB
signalling in the control of neuronal morphology. This was done by pharmacological
and genetic interference with NFkB signalling in populations of cultured peripheral
sensory and sympathetic neurons.
In sensory neurons of the nodose ganglion of newborn mice cultured with BDNF,
inhibiting NFkB activation with super-repressor IkB-oi, BAY 11-7082 (IkB-cx
phosphorylation inhibitor) or N-acetyl-Leu-Leu-norleucinal (proteosomal
degradation inhibitor) or inhibiting NFkB transcriptional activity with kB decoy
DNA substantially reduced neurite arbour size and complexity while having no effect
on survival. This novel role of NFkB signalling in regulating neurite growth and
morphology was found to be restricted to neurons cultured from mice between the
ages of E18 and PI, a stage of development immediately after the phase of naturally
occurring neuronal death when the processes and connections of the remaining
neurons are extensively modified and refined. Monitoring NFkB dependent
transcriptional activity with a GFP reporter revealed a basal level of activity that was
unaffected by BDNF. NFkB was also found to be involved in promoting neurite
growth from nodose neurons grown with CNTF, but not when these neurons were
grown with the related cytokine LIF.
Investigating the potential role of NFkB signalling in regulating the growth of
sympathetic neurites was complicated by the fact that NFkB signalling is involved in
in
mediating the survival-promoting effects of NGF, the neurotrophin that promotes the
survival of these neurons during development. To circumvent this problem, caspase
inhibitors were used to prevent the death of superior cervical ganglion neurons in
which NFkB activation was prevented using either the inhibitor peptide SN50 or
BAY 11-7082. These treatments resulted in significantly smaller neurite arbours seen
in the presence of NGF, suggesting that NFkB also plays a role in regulating the
growth and complexity of developing sympathetic neurons.
Reg-2 is a secreted signalling intermediate in CNTF-induced survival of motor
neurons that activates NFkB. The above demonstration that NFkB regulates the
growth, but not the survival, of newborn nodose neurons in response to CNTF raised
the question of whether Reg-2 plays a role in either process in these neurons. In the
final part of this thesis I began to look at the relationship between Reg-2 and CNTF
in these and other peripheral neurons. Reg-2 promoted the survival of nodose but not
trigeminal neurons, although its mRNA was expressed in both ganglia during a
restricted period of development. In vivo, this expression required the transcription
factor STAT-3, but not IKKa or p65, and in vitro CNTF or LIF, but not
neurotrophins, may be able to support neuronal expression of Reg-2. These results
suggest that while Reg-2 might be an intermediate for cytokine-induced neuronal
survival in some neuronal populations, this is not a universal requirement, and that its
expression in some neuronal populations may have another purpose.
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The vertebrate nervous system is the most complex biological system known. While
there are only a few basic cells types, the diversity within these types, particularly
neurons, is astounding. Each neuron interacts in a specific manner with many other
neurons, as well as a number of other cell types in the nervous system and in tissues
throughout the body. Study of the nervous system can be approached in many ways,
from examining individual cells to whole systems, in health and disease.
Alternatively insight can be gained into the function of this complex network of
interactions through studying its formation.
1.1. The Development of the Vertebrate Nervous System
During the earliest stages of vertebrate development systematic expression of the
genetic blueprint, in combination with environmental feedback, results in periods of
intensive cell division and transformation that take an organism from a single
fertilised egg to a fully formed organism. Development of the nervous system begins
with a series of coordinated events known as gastrulation. The monolayered blastula
becomes a more complex, three-layered structure, with different types of tissue
originating from each of these layers. The innermost layer, the endoderm, later forms
the epithelial structures of the respiratory and digestive systems and associated
organs, while the mesoderm gives rise to connective tissues, muscles and the
vascular and urogenital systems. The outer layer, the ectoderm, is the layer from
which the nervous system and epidermis are derived. A series of morphogenetic
movements described as neural induction first form a region called the dorsal
ectoderm, which thickens to become the neural plate. The lateral edges of this plate
then rise up as the neural fold. As the midline of the neural plate sinks, eventually
these edges come together and fuse in a rostro-caudal direction (Smith and
Sc'noenwolf, 1997). This forms a hollow structure called the neural tube. The cavity
of this tube gives rise to the ventricular system of the central nervous system, while
the neuroepithelial walls generate the central neurons and glia.
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The peripheral nervous system (PNS) forms a bridge between the central nervous
system (CNS) and the rest of the body, and consequently the organisms external
environment. It forms principally from a layer of ectodermal cells along the border
between the neural tube and the incipient epidermis called neural crest cells. Once
formed these cells break free from the ectoderm and migrate along well-defined
pathways through the mesoderm, where they develop into a range of cells types.
Neural crest cells form the majority of the peripheral nervous system, including the
autonomic, sympathetic and parasympathetic ganglia, most sensory ganglia,
Schwann cells and satellite cells, as well as giving rise to chromaffin cells in the
adrenal medulla, melanocytes and craniofacial connective tissues (Le Douarin et ah,
2004). The remaining neurons of the PNS, those of certain cranial sensory neurons,
are derived from another group of progenitor cells known as the neurogenic
placodes, epithelial thickenings that occur on the rostral ectoderm of the developing
embryo (D'Amico-Martel and Noden, 1983; Le Douarin, 1986; Webb and Noden,
1993). Although these two cell types have different origins, they have overlapping
patterns of gene expression that reflect the commonalities in their tasks, such as
delamination and migration, performed to give rise to mature, related, cell types
(Mccabe et ah, 2004).
1.1.1. Development of the Peripheral Nervous System
The peripheral nervous system is divided into the somatic and autonomic nervous
systems, each composed of different types of neurons innervating different target
fields. The neuron cell bodies are segregated into ganglia or are found in neural
plexuses. These ganglia and plexuses form after the precursor cells have migrated to
the appropriate locations.
1.1.1.1. Sensory Ganglia of the Peripheral Nervous System
The peripheral sensory ganglia consist of cranial sensory ganglia and the dorsal root
ganglia (DRG). The seven cranial sensory ganglia are found on five of the twelve
pairs of cranial nerves (Le Douarin, 1986; Weston, 1962). The trigeminal ganglion is
located on cranial nerve V and its neurons innervate the mechanoreceptors,
thermoreceptors and nociceptors in the face as well as providing sensory innervation
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to the teeth. The geniculate ganglion, on cranial nerve VII, innervates the taste buds
from the anterior two-thirds of the tongue and the vestibulo-cochlear ganglia (cranial
nerve VIII), the hair cells of the organs of hearing and balance. The petrosal ganglion
is located on cranial nerve IX and innervates the taste buds from the posterior third of
the tongue and the jugular and nodose ganglia, which are located on cranial nerve X,
innervate the pharynx, thorax and abdomen. The remaining ganglion is the superior
glossopharyngeal ganglion, located on cranial nerve IX. Additionally the trigeminal
mesencephalic nucleus, located in the midbrain but originating from neural crest
cells, contains the cell bodies of the proprioceptive neurons innervating the muscles
of mastication (Weston, 1962). The other ganglia of the sensory nervous system, the
dorsal root ganglia are located adjacent to the spinal cord, on the dorsal roots of the
spinal nerves. These neurons innervate the skin, muscles and joints of the limbs and
trunk.
1.1.1.2. Autonomic Ganglia of the Peripheral Nervous
System
The autonomic nervous system has three divisions, sympathetic, parasympathetic and
enteric. The sympathetic ganglia are divided into paravertebral and prevertebral
ganglia, with the paravertebral ganglia comprising a chain of ganglia lying on the
ventral aspect of the vertebral column and the prevertebral ganglia being found in
groups related to the major blood vessels in the abdomen. Principal paravertebral
sympathetic ganglia include the superior cervical ganglion (SCG), middle cervical
ganglion, stellate ganglion and sympathetic chain ganglia which innervate the
salivary, lacrimal and sweat glands, as well as the vessels and hair follicles of the
head and neck (SCG), heart and lungs (middle cervical and stellate ganglia) and
other thoracic viscera (sympathetic chain). Prevertebral sympathetic ganglia,
including the coeliac, aorticorenal and superior and inferior mesenteric ganglia,
innervate organs of the digestive and urogenital tracts. Parasympathetic ganglia are
found close to, or embedded in, their visceral targets and innervate the ciliary
muscle, lacrimal gland, pharyngeal gland, submandibular gland, parotid gland,
viscera of the thoracic and abdominal cavity and organs of the urogenital tract.
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The enteric nervous system is largely autonomous from the rest of the nervous
system, although its function is regulated by innervation from the sympathetic and
parasympathetic nervous systems. It is composed of networks of interconnected
sensory neurons, interneurons, motoneurons and astrocyte-like glia arranged in two
major groups, the submucosal and myenteric plexuses, embedded in the
gastrointestinal walls and provides innervation which controls the coordinated
muscle movements necessary for digestion, as well as innervating the vessels and
glands of the gastric mucosa.
1.1.1.3. The Origins of the Peripheral Nervous System
Sensory neurons arise from the proliferation and differentiation of progenitors
derived from either the neural crest or neurogenic placodes. Neural crest cells form
as a consequence of local interactions between the epidermis and neural plate and
segregate around the time that the neural tube closes (Selleck and Bronner-Fraser,
1995), while the neurogenic placodes are induced by mesoderm, neuroectoderm and
endoderm depending on the placode (Baker et al., 1999; Stark et al., 1997)reviewed
in (Baker and Bronner-Fraser, 2001). Detailed mapping experiments involving the
transplantation of neural crest- and placode-derived cells have determined the origins
of cranial sensory ganglia in avians. The ventrolateral part of the trigeminal ganglia
and the vestibulo-cochlear, geniculate, petrosal and nodose ganglia are derived from
neurogenic placodes, while the dorsomedial trigeminal ganglion, trigeminal
mesencephalic nucleus, jugular ganglion and dorsal root ganglion are derived from
cranial neural crest (D'Amico-Martel, 1982; D'Amico-Martel and Noden, 1983; Le
Douarin, 1986; Le Douarin et al., 2004; Noden, 1978; Webb and Noden, 1993). In
the autonomic nervous system, both neurons and glia of the parasympathetic ganglia
arise from mesencephalic neural crest cells, while the enteric nervous system is
formed from the vagal and lumbosacral neural crest (Epstein et al., 1994; Le Douarin
et al., 2004; Serbedzija et al., 1991). Sympathetic neurons are generated from the
entire length of the trunk neural crest (Le Douarin et al., 2004). Additionally, all
Schwann and satellite cells associated with all sensory and autonomic ganglia are
derived solely from the neural crest (D'Amico-Martel and Noden, 1983). Grafting
experiments have also revealed that both presumptive placodal ectoderm and pre-
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migratory neural crest cells are not specified to differentiate into particular sensory
neurons, but are multipotent, their phenotype being influenced by external factors
along their migratory path and at their destination site (Vogel and Davies, 1993; Le
Douarin et ah, 2004).
1.2. Regulation of cell survival and neuronal number in
the developing peripheral nervous system
1.2.1. The neurotrophic hypothesis...
During the development of the nervous system, neurons are produced in quantities
exceeding the total number of cells required to establish a functional nervous system.
Final cell number is determined during a subsequent phase of apoptotic cell death
when over half of the developing neurons die (Burek and Oppenheim, 1996). The
survival of each cell is determined by the limited availability of neurotrophic factors,
usually derived from the innervation target. This pattern of excess cell production
followed by cell death is thought to tailor the number of neurons to the size of the
target tissue and to eliminate any neurons whose cell bodies are wrongly located or
that have formed inappropriate connections. It has been termed the "neurotrophic
theory" (Davies, 1994b).
The neurotrophic hypothesis was formulated following the study of the classical
neurotrophic factor, nerve growth factor (NGF). Sensory and sympathetic neuronal
populations that are NGF-dependent in vitro were found to be eliminated in vivo
upon administration of anti-NGF or anti-NGF-receptor antibodies at the time of
target field innervation (Henderson et ah, 1994; Johnson, Jr. et ah, 1989; Johnson, Jr.
and Yip, 1985; Levi-Montalcini, 1987; Levi-Montalcini and Angeletti, 1968; Pearson
et ah, 1983; Yip et ah, 1984). Exogenous NGF administered at this time also rescued
additional neurons, resulting in an increased neuronal number in the relevant ganglia
(Henderson et ah, 1994; Yip et ah, 1984). More recently use of transgenic
technologies have confirmed these effects, with null mutations of the genes coding
for either NGF or its receptor tyrosine kinase, TrkA, resulting in the loss of the same
populations of peripheral neurons (Crowley et ah, 1994; Henderson et ah, 1994;
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Smeyne et al., 1994) and overexpression of neurotrophins, such as NGF, in the target
fields such as the skin resulting in increased numbers of sensory neurons surviving
(Albers et al., 1994; Davis et al., 1997). Additional support for this hypothesis has
been gained by studying the site, timing and level of expression of NGF. Initiation of
NGF synthesis in the relevant peripheral target fields occurs as target field
innervation begins (Davies et al., 1987; Korsching and Thoenen, 1988) and increased
cell death is seen when specific target fields are removed during development
(Caldero et al., 1998).
1.2.2. ...and beyond
Since the discovery of NGF several other neurotrophic factors have been described.
Studies of the effects of these proteins on neurons, both in vitro and in vivo, and of
the consequences of introducing null mutations in these proteins and their receptors,
have confirmed similar patterns to that of NGF (Baloh et al., 2000; Davies, 2003;
Huang and Reichardt, 2001; Turnley and Bartlett, 2000). Recent evidence has also
indicated, however, that the situation is more complex than initially described in the
neurotrophic hypothesis, and that different types of neurons require trophic support
from sources other than their target fields at points both before and after target field
innervation (Davies, 2003). As well as neurotrophic factors derived from target
fields, neurons may also need trophic support before target field innervation. This
can be derived from developing cells on the pathway through which the neurons are
extending processes, in an autocrine/paracrine manner from neighbouring neurons or
after target field innervation (Acheson et al., 1995; Caldero et al., 1998; Maina et al.,
1998; Riethmacher et al., 1997; Robinson et al., 1996b; Wright et al., 1992). It has
also become clear that most populations of neurons have trophic requirements that
change depending on their stage of development and which often overlap (Davies,
1994a; Davies, 1997; Ernfors et al., 1994b; Emfors et al., 1994a; Francis et al., 1999;
Hohn et al., 1990; Jones et al., 1994; Wyatt et al., 1997; Zhou and Rush, 1995).
Additionally, exposure of neurons to many trophic factors have consequences over
and above those of neuronal survival including influencing precursor proliferation
and differentiation, process outgrowth, neurotransmitter and neuropeptide phenotype,
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and synaptic form and function throughout life (Bibel and Barde, 2000; Davies,
2000a; Davies, 2000b; English, 2003; Maina et ah, 1998; Thoenen, 2000).
1.2.3. The effects of growth factors on the survival of the
developing sensory and sympathetic nervous systems
The studies in this thesis are performed on sensory neurons of the nodose and
trigeminal ganglia and sympathetic neurons of the superior cervical ganglion. In this
section I will therefore discuss what is known about the trophic requirements of these
ganglia. Where the responses of avian and mammalian neurons diverge I will
consider only the mammalian responses, as it is murine neurons that are used in my
studies.
1.2.3.1. The sensory ganglia
Neurons of the trigeminal ganglia have been shown to depend on a number of
different neurotrophic factors throughout their development. Neurons generated
during the earliest stages of trigeminal ganglia formation are initially dependent on
brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) for their
survival. By E12, however, very few trigeminal neurons are BDNF-dependent, with
NGF being their preferred survival factor (Buchman and Davies, 1993; Paul and
Davies, 1995). There are two reasons for this change in neurotrophic factor
dependence. Firstly, neurons generated in the trigeminal ganglia after E12 respond
immediately to NGF and never possess the ability of the earlier generated neurons to
respond to BDNF or NT-3 (Enokido et ah, 1999; Huang et ah, 1999). Additionally,
early neurons that respond to BDNF and NT-3 alter their trophic responses as they
develop (Enokido et ah, 1999). The change in responsiveness of trigeminal neurons
from BDNF and NT-3 to NGF is correlated with a change in receptor expression, as
well as in neurotrophin mRNA expression in the peripheral target fields (Arumae et
al., 1993; Buchman and Davies, 1993; Davies et al., 1987; Ninkina et al., 1996;
Wyatt and Davies, 1993). Analysis of the timing of excessive cell death in the
trigeminal ganglia of mice with null mutations of the receptor genes TrkA and TrkB
(NGF and BDNF receptors respectively) suggests that these changes are relevant in
vivo. Increased apoptosis in the trigeminal ganglia is seen at an earlier stage in trkB_/"
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or nt-3_/" embryos than in trkA_/" embryos (Pinon et al., 1996; Wilkinson et al., 1996).
BDNF and NT-3 are expressed in the tissues through which neuronal processes
extend suggesting that they provide intermediate trophic support before the neuronal
extension reaches the target fields (Buchman and Davies, 1993; Davies, 1997; Pinon
et al., 1996; Wilkinson et al., 1996).
The change in the trophic requirements of trigeminal neurons from BDNF and NT-3
to NGF before E12 is not the only change in trophic factor responsiveness that
occurs during development. Whilst in vitro NGF retains the ability to promote
neuronal survival past birth, its dose response curve shifts significantly so that 10-
fold higher concentrations of NGF are required to promote a maximal effect
(Buchman and Davies, 1993). During this same period of development, between E16
and El8, murine trigeminal neurons acquire the ability to respond to macrophage -
stimulating protein (MSP), which subsequently promotes in vitro survival at least as
well as NGF (Forgie et al., 2003). Around half of all trigeminal neurons acquire the
ability to respond to cytokines such as ciliary neurotrophic factor (CNTF) at the same
age. (Florton et al., 1998). Members of the glial-derived neurotrophic family (GDNF)
family of trophic factors are also involved in supporting trigeminal neuron survival
during development, as neurturin"'" mice show a significant loss of neurons in the
trigeminal ganglia (Fleuckeroth et al., 1999).
Nodose neurons survive in the absence of trophic support when they are first
generated. Dependence on neurotrophins for survival is acquired later in
development, at the same time as the expression of neurotrophin receptors (Robinson
et al., 1996a; Vogel and Davies, 1991). The in vitro survival of nodose neurons is
subsequently supported by the neurotrophins BDNF, NT-3 and NT-4 (Buj-Bello et
al., 1994; Davies et al., 1986; Davies et al., 1993; Lindsay et al., 1985; Vogel and
Davies, 1991). That these in vitro effects are relevant in vivo has been well
established, as increased neuronal death during embryonic development can be
caused by deletion of the genes coding for BDNF, NT-3 and NT4, or their receptors
TrkB and TrkC, and increased neuronal number is found in mice overexpressing
BDNF in the skin (Conover et al., 1995; ElShamy and Ernfors, 1997; Erickson et al.,
1996; Farinas et al., 1994; Klein et al., 1993; LeMaster et al., 1999; Liu et al., 1995).
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Recently a small population of early nodose neurons (E12-E13) were also found to
survive transiently in the presence of NGF in vitro and small decreases in neuronal
number have been detected in the NGF' mouse (Forgie et ah, 2000). As with the
trigeminal ganglia, nodose neurons also respond to a range of other neurotrophic
factors. Early in development, neurotrophic cytokines, including CNTF, leukaemia
inhibitory factor (FIF), oncostatin M (OsM) and cardiotrophin-1 (CT-1), support the
survival of a subpopulation of nodose neurons (Horton et al., 1998). As development
continues an increasing proportion of nodose neurons respond to these factors, so
that by birth most neurotrophic cytokines promote survival as effectively as BDNF
(Florton et ah, 1998). Neurons of the nodose ganglia also respond to neurturin during
development and decreases in neuronal number have been found in the nodose
ganglia in GDNF_/" mice (Kotzbauer et ah, 1996).
1.2.3.2. The sympathetic ganglia
Fike sensory neurons, neurons of the sympathetic ganglia show robust survival
responses to a range of trophic factors in vitro and the responses to these factors
change depending on the stage of neuronal development. New SCG neurons are
generated from a proliferating precursor population until E14/15. Artemin and
hepatocyte growth factor (FIGF) initially promote precursor proliferation and
survival respectively, while artemin alone promotes the survival of newly generated
neurons in mice and rats, a response that is lost by E16 (Andres et ah, 2001; Baloh et
ah, 1998; Maina et ah, 1998). MSP also promotes the survival of a subset of neurons
at E14, but by E17 has no trophic effect (Forgie et ah, 2003). Murine sympathetic
neurons start to respond to NGF at E14, so that by El8, shortly before birth, the
majority of these neurons depend on NGF for their survival (Wyatt and Davies,
1995). Additionally, between E16 and E18, a smaller proportion of sympathetic
neurons become NT-3 dependent in vivo (Birren et ah, 1993; Wyatt et ah, 1997).
Further changes in the trophic factor responses of SCG neurons occur after birth.
SCG neurons retain their ability to use NGF as a survival factor, however the
proportion of neurons that also survive in the presence of NT-3 increases so that
postnatal sympathetic neurons are both NGF and NT-3 dependent (Belliveau et ah,
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1997; Davies et al., 1995; Davies, 1997; Fagan et al., 1996; Francis et ah, 1999;
Levi-Montalcini, 1987; Wyatt et ah, 1997; Zhou and Rush, 1995). A phase of
neurotrophic response to artemin also occurs after birth, starting at P12 and
continuing into adulthood. This effect begins at the same time as over half of SCG
neurons are acquiring the ability to survive in the absence of trophic support.
Artemin, at this stage, promotes the survival of an additional 25% of neurons in vitro
(Andres et ah, 2001). During the postnatal period a significant loss of SCG neurons
is seen in mice lacking GFRa3, the ligand binding portion of the artemin receptor,
confirming the in vivo relevance of this change (Nishino et ah, 1999). Postnatal
sympathetic neurons of the SCG also acquire survival responses to CNTF, LIF
(Kotzbauer et ah, 1994) and HGF. HGF has been found to promote the survival of
late postnatal sympathetic neurons (P20), an effect that continues into adulthood
when these neurons have lost all NGF-responsiveness (Thompson et ah, 2004).
1.3. Regulation of axon and dendrite formation and the
establishment of innervation in the peripheral nervous
system
To establish a functional nervous system, neurons must not only develop in the
correct number and location, but they must also form functional connections with the
appropriate targets to allow participation in local and global neuronal circuitries. This
occurs through a number of mechanisms regulating the number, length, branching
and direction of growth of cell processes, as well as synaptogenesis. Intrinsic
developmental programs regulate some of the variations between neuronal types,
however a complex variety of extracellular signals are also essential to establishing
functional connections (Goldberg, 2004). These extracellular stimuli include soluble,
cell surface and extracellular matrix proteins, a large number of which are also
implicated in either cell proliferation, survival or migration (de Vellis and Carpenter,
1999). In line with the focus of the thesis, in this section I will introduce the basis of
neurite outgrowth and move on to discuss the roles that neurotrophic factors play in
this process. The effects of molecules such as guidance molecules and extracellular
matrix components will not be discussed in detail.
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The sequence of events occurring during neuritic growth has been well characterised
for neurons in culture. First, a number of neuritic processes are extended and
retracted by postmitotic neurons, with each process being both morphologically and
immunologically indistinguishable from any other process. All early processes
express both actin- and microtubule-associated proteins such as cofilin, tau and
MAP2 (Keith and Wilson, 2001). Initiation of process growth, however, is dependent
on the actin cytoskeleton, whereas the subsequent process elongation is microtubule-
dependent (Smith, 1994). In time, one neurite extends further than other processes
and develops axonal characteristics, becoming a non-tapering process that shows
increased expression of tau, but loses MAP2 expression. Subsequently, other
processes develop into dendrites, shorter tapering processes characterised by robust
expression of MAP2. Both tau and MAP2 appear essential to the specification of
neurite phenotype, and interfering with their expression is capable of blocking axonal
or dendritic specification respectively and causing retraction of previously developed
neurites (Heidemann, 1996; Mandell and Banker, 1995; Schoenfeld and Obar, 1994;
Tucker, 1990).
In vivo the selection of the neurite that will become the axon is thought to be a
stochastic process, with the direction of growth determined by local environmental
cues. Each developing neuritic process is specialised at the tip into a structure called
a growth cone, which differs from the shaft of an axon or dendrite in that its structure
is formed from a highly dynamic actin-based cytoskeleton. Within the growth cone
two different motile structures, filopodia and lamellipodia, interact with the
environment outside the cell, interpreting both pathfinding and outgrowth cues.
Lamellipodia contain branched networks of actin filaments that are principally
involved in elongation, whereas filopodia, mediating axonal guidance, are formed
from bundled actin filaments that interact with the microtubules from the shafts to
reinforce directional choices (Letourneau, 1996). Several different types of external
input can activate pathways that mediate outgrowth and pathfinding, from proteins
embedded in the structure of the extracellular matrix, to neurotrophic factors and
guidance molecules, neurotransmitters and electrical activation (Keith and Wilson,
2001; Tessier-Lavigne and Goodman, 1996; Wong and Ghosh, 2002). These inputs
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ultimately alter the size and shape of neurons by regulating the assembly,
stabilisation and disassembly of the neuronal cytoskeleton (Gallo and Letourneau,
2000; Miller and Kaplan, 2003). As with cell survival, factors influencing neurite
outgrowth can be found local to the cell body, throughout the route along which the
neurites are extending or in the target field (Miller and Kaplan, 2003).
1.3.1. The effects of growth factors on neurite outgrowth in the
developing peripheral nervous system
Many different proteins have been implicated in the promotion of differing types of
neurite outgrowth in the developing peripheral nervous system. The most studied
type of neurite outgrowth in the nervous system is axonal outgrowth (Keith and
Wilson, 2001). The majority of this section will therefore describe the role of
neurotrophic factors in promoting axonal growth, but wherever possible I have also
discussed how this compares to dendritic growth in the same, or related, neuronal
populations.
As with survival, the neurotrophins are one of the best studied families of proteins
with respect to neurite outgrowth. Abnormalities in axonal projections of the
vestibular and cochlear ganglia are found in mice lacking BDNF, NT-3, trkB and
trkC and in sympathetic axons of trkA_/" mice (Ernfors et ah, 1995; Fagan et ah,
1996; Postigo et ah, 2002; Schimmang et ah, 1995). The essential role of
neurotrophins in neuronal survival in many populations complicated the early study
of their role in neurite outgrowth (Davies et ah, 1987; Lumsden and Davies, 1983;
Scott and Davies, 1993). Recently these problems have been overcome by using new
compounds or transgenic mice to block apoptosis and allow neurons to survive both
in vivo or in vitro in the absence of trophic support (Deckwerth et ah, 1996; Lentz et
ah, 1999; Markus et ah, 2002b; Patel et ah, 2000; Werth et ah, 2000; White et ah,
1998). For example, Patel et al (2000) crossed TrkA or NGF null mice with mice
lacking the pro-apoptotic protein Bax, a manipulation that rescues peripheral sensory
neurons lost in the TrkA or NGF single knockout mice. In the DRG of these mice the
central axon projections extend normally into the dorsal roots and spinal cord, but the
peripheral axonal projections are absent. This may be a consequence of a genuine
role of NGF in regulating neurite outgrowth of DRG neurons or alternatively due to a
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role of NGF in the maintenance of the peripheral projection. Further evidence
supports the conclusion that NGF has a role to play in promoting neurite outgrowth
in these neurons. In vitro studies using E11-E13 Bax~~ DRG neurons find that in the
absence of additional trophic factors neurons extend a single short projection, but
become bipolar with robust neurite extension in the presence of NGF, NT-3 or
BDNF (Lentz et ah, 1999). In organotypic slice cultures the role of neurotrophins in
axonal growth and guidance has been further confirmed, as insertion of ectopically-
placed beads coated in NGF, BDNF, NT-3 or NT-4/5 caused changes in axon
targeting and injection of antibodies against NGF, BDNF or NT-3 caused dramatic
decreases in axonal extension in DRG neurons after E10.75 (Tucker et ah, 2001).
Despite the common role of NGF, BDNF and NT-3 in neurite outgrowth described
above, individual neurotrophins differ in their precise effect in shaping the neuronal
arbour. Fentz et al (1999) showed that Bax"/_ DRG neurons growth with NGF or NT-
3 elaborated neurites with very differently morphologies. In the presence of NGF
neurons extended long neurites with few branches until the terminal third of the
neurite, whereas neurons grown with NT-3 had much shorter neurites that showed
earlier and more extensive branching. BDNF initiated morphologies similar to those
with NT-3. Such a difference is confirmed by the changes in elongation and
branching that occur when wholemount explants of trigeminal ganglia connected to
their target fields are exposed to NGF or NT-3, or the changes in innervation that
occur in the trigeminal target when either NGF or NT-3 is overexpressed in the target
field in vivo (Davis et al., 1997; Rice et al., 1998; Ulupinar et al., 2000). Both NGF
and NT-3 also support neurite outgrowth by sympathetic neurons in vitro and again
their roles appear different (Campenot, 1982). While NGF_/" mice show relatively
normal axon elongation, but defects in final target innervation, NT-3"'" mice exhibit
decreased axonal extension long before the target field is reached (Glebova and
Ginty, 2004; Kuruvilla et al., 2004). This suggests that NT-3 is an intermediate
target-derived factor, promoting neurite extension of sympathetic neurons before
neurons are exposed to NGF. Adding further complexity to our understanding of
neurotrophin-mediated regulation of sympathetic neurite outgrowth, Belliveau et al
(1997) also found that NT-3, as well as NGF, promotes outgrowth via TrkA, rather
13
Chapter 1
than TrkC its preferred receptor. Activation of intracellular signalling pathways was,
however, temporally different. Additionally BDNF, acting via p75 in TrkB-negative
sympathetic and DRG neurons, appears to antagonise NGF-induced neurite
outgrowth (Kohn et al., 1999; Paves and Saarma, 1997).
Neurotrophins have also been implicated in dendritic formation, both in vitro and in
vivo. Injection of excess NGF in vivo causes increased dendritic growth in
sympathetic neurons (Ruit et ah, 1990; Ruit and Snider, 1991; Snider, 1988). This
effect only occurs in vitro in the presence of non-neuronal cells or with the co¬
operation of additional growth factors such as bone morphogenetic protein-7 (BMP-
7), a soluble protein that is found associated with the basement membrane
(Bruckenstein and Higgins, 1988; Lein et ah, 1995; Lein et ah, 1996; Tropea et ah,
1988). NGF can also enhance activity-dependent dendritic outgrowth in sympathetic
neurons (Vaillant et ah, 2002). Evidence of a role for BDNF and NT-3 in dendritic
growth comes principally from studies of specific populations of central, rather than
peripheral neurons. In most cases these neurotrophins promote dendritic outgrowth,
however in some cortical neurons it has been reported that the actions of BDNF and
NT-3 can be mutually antagonistic (Baker et ah, 1998; Gascon et ah, 2005; Horch et
ah, 1999; Horch and Katz, 2002; Jin et ah, 2003; Kohara et ah, 2003; Labelle and
Leclerc, 2000; McAllister et ah, 1995; McAllister et ah, 1996; McAllister et ah,
1997; Sang and Tan, 2003; Wirth et ah, 2003; Xu et ah, 2000).
Neurotrophins are not the only family of neurotrophic factors implicated in neurite
outgrowth and the establishment of innervation in the PNS. HGF can facilitate NGF-
induced neurite outgrowth in sensory neurons (Maina et ah, 1997). Outgrowth of
sympathetic neurites is significantly impaired in embryos lacking Ret, a common
receptor subunit for GDNF family ligands, while survival is unaffected (Enomoto et
ah, 2001). Vascular-derived artemin is also thought to promote axonal extension en
route to the target field, as it can promote outgrowth and attract neurites in vitro and
as defects similar to those in the Ret"'" embryos are seen in artemin and GFRa3
knockout mice (Enomoto et ah, 2001; Honma et ah, 2002). GDNF itself supports
axonal growth in the parasympathetic neurons of the ciliary ganglion both in vitro
and in vivo (Hashino et ah, 2001). Neurturin has also been found to be important in
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the establishment of innervation of certain types of sympathetic and parasympathetic
neurons (Hiltunen and Airaksinen, 2004; Laurikainen et al., 2000; Rossi et ah, 1999;
Rossi et ah, 2000; Rossi and Airaksinen, 2002).
Some evidence implicates neuropoietic cytokines in influencing neurite outgrowth,
although the majority of these studies are again in the CNS. Neurite outgrowth is
promoted by CNTF in retinal gangion cells and LIF in spinal cholinergic and
auditory neurons (Gillespie et al., 2001; Goldberg et al., 2002; Richards et al., 1992).
CNTF and LIF are also associated with plasticity-related changes, such as sprouting,
in primary sensory neurons and at the neuromuscular junction (English, 2003;
Gurney et al., 1992; Ramer et al., 1999; Tarabal et al., 1996; Thompson and Majithia,
1998). In contrast to this, however, both LIF and CNTF have been found to inhibit
dendritic outgrowth and cause dendritic retraction in sympathetic neurons where
growth is promoted by BMP-7 (Guo et al., 1997; Guo et al., 1999).
1.4. The biology of neurotrophic factors
There are many proteins that have been described as having the ability to promote
the survival of neurons, both in vitro and in vivo, and which can thus be described as
"neurotrophic factors". Some of these factors, such as NGF, were originally found in
this context (Levi-Montalcini and Angeletti, 1968), whereas others, such as the
neuropoietic cytokine LIF, were initially described in the context of different
systems, and subsequently found to be active in the nervous system. The principal
families of neurotrophic factors are: the neurotrophins (NGF, BDNF, NT-3 and NT-
4), the GDNF family (GDNF, neurturin, artemin and persephin), the neuropoietic
cytokines (CNTF, LIF, OSM, CT-1, IL-6, CLC and neuropoietin) and two related
factors FIGF and MSP. All of these factors have been found to promote neuronal
survival, however it is important to remember that none of these proteins act
exclusively in this manner. During development, neurotrophic factors have also been
found to promote the proliferation and differentiation of both neuronal and non-
neuronal precursors, to regulate neurite outgrowth and the establishment of
innervation, and to influence the eventual neurotransmitter and neuropeptide
phenotype of developing neurons (Airaksinen and Saarma, 2002; Davies, 2000a;
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Maina and Klein, 1999; Turnley and Bartlett, 2000). Neurotrophic factors have also
been found to be important throughout life, affecting neuronal outgrowth and
branching, synaptic plasticity and the stabilisation of synaptic contacts, as well as
being involved in regulating the consequences of injury and disease (Binder and
Scharfman, 2004; Boyd and Gordon, 2003; English, 2003; Kojima et al., 2002;
Mendell et al., 2001; Villoslada and Genain, 2004). In this section I wilt further
describe the families of neurotrophic factors that I use in my investigations, that is
the neurotrophin family and the neuropoietic cytokines of the IL-6 family, and their
roles in the development of the nervous system.
1.4.1. Neurotrophins and their receptors
The neurotrophin family of proteins has 4 members in reptiles, amphibians, birds and
mammals: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF)
neurotrophin-3 (NT-3), neurotrophin 4/5 (NT-4/5), and two additional members in
fish; neurotrophin 6 (NT-6) and neurotrophin-7 (NT-7). These proteins are both
structurally and functionally secreted proteins that signal through two classes of
receptor. These receptors are the high-affinity tyrosine kinase receptors of the Trk
family (TrkA, TrkB, and TrkC) and a common lower-affinity receptor, p75.
Generally neurotrophins are important regulators of neuronal survival, axonal growth
and synaptogenesis (Huang and Reichardt, 2001).
1.4.1.1. Nerve growth factor
Nerve growth factor was the first neurotrophin to be isolated, in 1959, when it was
purified from snake venom for its ability to promote neurite outgrowth and
subsequently found to be expressed in high levels in the submandibular salivary
gland of the adult mouse (Cohen, 1960; Cohen, 1959). The cloning of both the avian
and mammalian gene in several species has since shown that NGF is a highly
conserved protein (Ebendal et al., 1986; Meier et al., 1986; Ullrich et al., 1983). The
murine NGF gene produces a 307 amino acid precursor protein, which is cleaved to
give a 118aa mature protein containing a cysteine knot motif and two antiparallel p
strands (Berger and Shooter, 1977; Edwards et al., 1988; Scott et al., 1983) and
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which forms a forms a homodimer to produce a biologically active protein
(McDonald et al., 1991).
NGF is expressed in several regions of the CNS, including the hippocampus,
olfactory bulb and neocortex, regions associated with innervation from cholinergic
neurons of the basal forebrain, as well as in the septum, diagonal band of Broca and
the nucleus basalis of Meynert, where these neurons originate (Korsching et al.,
1985). Outside the central nervous system, NGF can also be detected in the target
tissues of neurons known to respond to NGF, including the heart, submandibular
gland, and the developing mouse whisker pads and the skin in general, where it is
principally produced by epithelial cells (Davies et al., 1987; Heumann et al., 1984;
Korsching et al., 1985; Korsching and Thoenen, 1983; Shelton and Reichardt, 1984).
In vitro and in vivo studies show that NGF is a survival factor for developing
sympathetic neurons, some sensory neurons and basal forebrain cholinergic neurons
(Chun and Patterson, 1977; Davies and Lindsay, 1985; Hamburger et al., 1981;
Hartikka and Hefti, 1988; Levi-Montalcini, 1987). Studies of the role of NGF in the
developing nervous system in vivo have been particularly advanced by the generation
of the NGF null mutant mouse, a mutation that is lethal soon after birth. NGF-/" mice
are born with almost no sympathetic neurons, and show losses of trigeminal neurons.
(Crowley et al., 1994). In the DRG, only a subpopulation of neurons, small diameter
neurons thought to mediate nociception, are affected (Crowley et al., 1994). No
obvious deficits on central neuronal populations have been found, suggesting that
NGF alone is not an essential survival factor in the developing central nervous
system. In terms of establishment of innervation, NGF has also been found be
involved in neurite outgrowth in trigeminal, sympathetic and DRG neurons (Davis et
al., 1997; Glebova and Ginty, 2004; Kohn et al., 1999; Kuruvilla et al., 2004; Lentz
et al., 1999; Patel et al., 2000; Paves and Saarma, 1997; Snider, 1988; Tucker et al.,
2001).
Recently a new aspect of neurotrophin signalling has been described. The precursor
protein for NGF, pro-NGF, has traditionally thought to be inactive, however Lee et al
(2001) found that pro-NGF can be released into the extracellular milieu. Here it can
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be cleaved by plasmin or matrix metalloproteinases, but additionally pro-NGF can
bind to the p75 receptor with high affinity, forming a receptor complex with sortilin
that activates pro-apoptotic signals (Lee et al., 2001; Nykjaer et al., 2004). ProNGF
has been shown to induce apoptosis after CNS-injury (Harrington et al., 2004).
1.4.1.2. Brain-derived neurotrophic factor
Brain-derived neurotrophic factor was first purified from adult porcine brain and was
found to be a survival factor for early embryonic chick dorsal root ganglion neurons
(Barde et al., 1982). It is a 12.3kDa basic protein that has subsequently been cloned
in several species including human, mouse and rat (Hofer et al., 1990; Jones and
Reichardt, 1990; Maisonpierre et al., 1991). Like NGF, BDNF is translated as a
precursor protein that is cleaved to produce an 119aa mature protein. BDNF shares
approximately 50% of its sequence with NGF, including the 6 cysteine residues
involved in forming the cysteine knot structure, and also forms a homodimer to
produce its biologically active species (Radziejewski et al., 1992).
Low levels of BDNF expression in the early embryonic CNS become higher and
more widespread as the CNS matures, with robust expression detected in the cortex,
hippocampus and cerebellum of adult mice, as well as lower levels detectable in the
striatum, olfactory bulb, midbrain, hindbrain and spinal cord (Hofer et al., 1990;
Leibrock et al., 1989). In the PNS, BDNF expression is found in neurons of the
dorsal root, jugular and trigeminal ganglia (Robinson et al., 1996a; Schecterson and
Bothwell, 1992). BDNF expression is also found in the target tissues of BDNF-
responsive neurons, including the heart, skin, muscle, and lung (Buchman and
Davies, 1993; Maisonpierre et al., 1990; Maisonpierre et al., 1991; Schecterson and
Bothwell, 1992).
During development of the PNS, BDNF promotes the survival of embryonic neural
crest-derived neurons of the trigeminal mesencephalic nucleus and the dorsal root
ganglia and the placode-derived neurons of the trigeminal ganglia, geniculate,
petrosal, vestibular and nodose ganglia (Barde et al., 1987; Davies et al., 1986; Hofer
and Barde, 1988; Lindsay et al., 1985). In the CNS, BDNF enhances the survival and
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differentiation of a range of neurons including basal forebrain cholinergic neurons,
mesencephalic dopaminergic neurons, motoneurons, hippocampal neurons,
cerebellar granule cells and retinal ganglion neurons (Alderson et al., 1990; Hyman
et ah, 1991; Johnson et ah, 1986; Knusel et ah, 1992; Lindholm et ah, 1993;
Oppenheim et ah, 1992). As with pro-NGF, pro-BDNF can activate apoptotic
signalling through p75 (Lee et ah, 2001). Mice with a homozygous null mutation of
the BDNF gene exhibit peripheral nervous system defects including substantial loss
of trigeminal, geniculate, vestibular, petrosal and nodose neurons, but no overt
defects of the central nervous system (Emfors et ah, 1994a; Jones et ah, 1994).
Defects are therefore principally of sensory neurons, with sympathetic, dopaminergic
or motoneurons being unaffected (Ernfors et ah, 1994a; Jones et ah, 1994). Like the
NGF null mutation, this mutation is lethal shortly after birth.
In the peripheral nervous system, BDNF is involved in neurite outgrowth in
vestibular, DRG, sympathetic and nodose neurons (Fritzsch et ah, 1997; Kohn et ah,
1999; Lentz et ah, 1999; Paves and Saarma, 1997; Postigo et ah, 2002; Schimmang
et ah, 1995; Tucker et ah, 2001). In the central nervous system, BDNF and TrkB
signalling are necessary for the growth and maintenance of hippocampal and cortical
dendrites (Horch et ah, 1999; Elorch and Katz, 2002; Jin et ah, 2003; Kohara et ah,
2003; Labelle and Leclerc, 2000; McAllister et ah, 1997; Sang and Tan, 2003; Wirth
et ah, 2003; Xu et ah, 2000) with local overexpression of BDNF in cortical neurons
causing only local increases in neurite outgrowth (Horch and Katz, 2002). The
source of the neurotrophin may change how it affects neurite outgrowth, as it has
been shown that distal BDNF can promote dendrite formation in venous retinal
ganglion cells, but that applied to the cell body it decreases dendritic branching (Lorn
et ah, 2002).
1.4.1.3. Neurotrophin-3
NT-3 is another member of the neurotrophin family important in the development of
the nervous system. It was discovered using oligonucleotide primers selected for the
conserved regions of the NGF and BDNF genes and its genomic sequence has been
cloned in several mammalian species including humans, mice and rats (Hohn et ah,
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1990; Jones and Reichardt, 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990).
Again, NT-3 is produced as a 258-aa precursor that is subsequently cleaved to
produce 119aa mature protein that shares 50-60% homology with NGF and BDNF
(Hohn et al., 1990).
In the peripheral nervous system NT-3 is expressed principally in the epithelium of
the whisker follicles, that is the trigeminal target field, with expression peaking early
in embryonic development and decreasing thereafter (Buchman and Davies, 1993;
Hallbook et al., 1993; Maisonpierre et al., 1990; Rosenthal et al., 1990). Some
expression is detected in adulthood, in a range of tissues including muscle, heart,
lung, liver, intestine and spleen, suggesting that NT-3 may act as a target derived
trophic factor for both sensory and sympathetic neurons (Henderson et al., 1993;
Hohn et al., 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990). In the central
nervous system, NT-3 is also highly expressed during development, with levels
falling dramatically as these regions mature (Maisonpierre et al., 1991). In adults,
expression can be detected principally in the hippocampus, cerebellum and medulla
oblongata (Hohn et al., 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990).
In vitro, subpopulations of neurons from the nodose, cochlear and dorsal root ganglia
as well as the proprioceptive neurons of the trigeminal mesencephalic nucleus
respond to NT-3 and a transient survival response of neural crest-derived sensory
neurons can also be detected (Ernfors et al., 1990; Hohn et al., 1990; Maisonpierre et
al., 1990; Rosenthal et al., 1990; Buchman and Davies, 1993; Buj-Belloet al., 1994;
Farinas et al., 1994; Farinas et al., 1996; Ockel et al., 1996; Wilkinson et al., 1996).
NT-3 also induces the survival, differentiation and proliferation of sensory neuronal
precursors (ElShamy et al., 1996; ElShamy and Ernfors, 1996; Kalcheim et al., 1992;
Memberg and Hall, 1995; Pinco et al., 1993). In the CNS, NT-3 is a survival factor
for cultured embryonic noradrenergic neurons and motoneurons (Friedman et al.,
1993; Henderson et al., 1993) and also promotes the proliferation and survival of
oligodendrocyte precursors in vitro and in vivo (Barres et al., 1994). Mice lacking the
NT-3 gene exhibit significant cell loss in all peripheral sympathetic and sensory
neuron populations including the SCG, DRG, trigeminal and nodose ganglia, thus
confirming the physiological relevance of the in vitro survival assays (ElShamy et
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al., 1996; ElShamy and Ernfors, 1996; Ernfors et al., 1994b; Farinas et al., 1994;
Farinas et al., 1996; Francis et al., 1999; Tessarollo et al., 1994; Wyatt et al., 1997).
In the peripheral nervous system, NT-3 also plays a role in the establishment of
innervation by vestibular, DRG, trigeminal and sympathetic neurons (Postigo et al.,
2002) (Belliveau et al., 1997; Kuruvilla et al., 2004; Lentz et al., 1999; Rice et al.,
1998; Schimmang et al., 1995; Tucker et al., 2001).
1.4.1.4. Other neurotrophins
Neurotrophin-4/5 was the fourth member of the neurotrophin family to be isolated.
It was originally cloned from Xenopus laevis and named neurotrophin-4 by Hallbook
et al. (1991). Later human and rat genes were cloned and designated NT-5
(Berkemeier et al., 1991; Ip et al., 1992) however it is now believed that the
Xenopus, rat and human genes are the same therefore they are referred to as NT-4/5.
Mature NT-4/5 is a 123aa protein bearing all 6 conserved cysteine residues and
having approximately 50% homology with NGF, BDNF and NT-3 (Ip et al., 1992).
NT-4/5 is expressed in the developing whisker pad and limb buds, thus indicating a
role in the development of trigeminal neurons and spinal motoneurons (Henderson et
al., 1993; Ibanez et al., 1993). NT-4/5 is also expressed in several other embryonic
and adult tissues, including heart, muscle, lung, kidney, thymus, ovary and testis
(Berkemeier et al., 1991). In the CNS, NT-4/5 is expressed in the cortex, olfactory
bulb, hippocampus, hypothalamus, cerebellum, pons and medulla (Timmusk et al.,
1993).
In the peripheral nervous system, NT-4/5 supports the survival of embryonic
trigeminal and jugular neurons in vitro, at ages when early target innervation is
occurring, and nodose neurons during the phase of naturally occurring cell death
(Davies et al., 1993). At high concentrations NT-4/5 can also support the survival of
sympathetic neurons (Berkemeier et al., 1991; Hallbook et al., 1991). Unlike BDNF,
NGF and NT-3, NT-4/5 does not appear to be well conserved between mammals and
birds, as the effects of NT-4/5 on chick neurons are very limited (Davies et al., 1993;
Ibanez et al., 1993). In the CNS, NT-4/5 promotes the survival of embryonic spinal
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motoneurons, cholinergic basal forebrain neurons and noradrenergic locus coeruleus
neurons (Friedman et al., 1993; Funakoshi et al., 1995). Mice lacking the NT-4/5
gene show losses of sensory neurons of the nodose, petrosal and geniculate ganglia,
while sympathetic SCG neurons, facial motoneurons and midbrain dopaminergic
neurons are unaffected (Conover et ah, 1995; Erickson et ah, 1996; Liu et ah, 1995).
NT-4/5 is also implicated in neurite outgrowth in adult nodose neurons (Wiklund and
Ekstrom, 2000).
Neurotrophin-6 was cloned from Xiphophorus maculatus and is a 146aa mature
protein containing the 6 cysteine residues characteristic of the neurotrophin family
(Gotz et ah, 1994). It differs from other family members by a 22aa insertion between
the second and third cysteine, containing a heparin domain. Additionally it does not
appear to be released into the culture medium of synthesising cells and is likely to be
found bound to proteoglycans of the cell surface or extracellular matrix (Gotz et ah,
1994). NT-6 is expressed in the developing and adult fish brain, as well as the adult
gill, liver and eye. Weak expression is also found in the skin spleen, heart and
skeletal muscle. Like NGF, NT-6 supports the survival of embryonic chick DRG and
sympathetic neurons, although it is less potent than NGF (Gotz et ah, 1994).
Neurotrophin-7 is the last member of the neurotrophin family to be identified (Lai
et ah, 1998; Nilsson et ah, 1998). It possesses the 6 conserved cysteine residues as
well as a 15aa acid insertion in the same location as that of NT-6. NT-7 is expressed
at high levels in adult skin, heart and intestine and low levels in brain and testis (Lai
et ah, 1998). NT-7 promotes the survival and neurite outgrowth of chick DRG
neurons (Lai et ah, 1998).
1.4.1.5. The Trk family of receptors
Neurotrophins are capable of binding two types of receptor, the tyrosine kinase
receptors of the Trk family and the unrelated p75 receptor. The Trk receptor was
originally identified as a part of a proto-oncogene resulting from a DNA
rearrangement fusing a truncated tropomyosin with a protein tyrosine kinase
sequence (Martin-Zanca et ah, 1986; Martin-Zanca et ah, 1989). Now referred to as
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trkA this gene encodes a 140kDa transmembrane glycoprotein containing a
cytoplasmic tyrosine kinase domain capable of activating intracellular signalling
pathways (Martin-Zanca et al., 1989). Two related genes have since been cloned and
designated trkB and trkC, both encoding 145kDa proteins with 65-70% homology to
the TrkA protein (Klein et al., 1989; Lamballe et al., 1991). The different trk
receptors generally mediate the effects of different neurotrophins, NGF, BDNF and
NT-3 preferentially binding and stimulating trkA, trkB and trkC respectively (Kaplan
et al., 1991a; Kaplan et al., 1991b; Klein et al., 1991a; Klein et al., 1991b; Lamballe
et al., 1991; Soppet et al., 1991; Squinto et al., 1991). Some cross-activation can
occur with NT-3 also being able to bind trkA and trkB and NT-4/5 trkA and trkB
(Berkemeier et al., 1991; Klein et al., 1991b; Klein et al., 1992; Soppet et al., 1991;
Squinto et al., 1991), although higher levels of protein are usually required for these
interactions. NT-7 has so far been reported to bind trkA with lower affinity, but the
receptor for NT-6 has yet to be defined (Lai et al., 1998).
Trk receptors are activated through ligand-mediated dimerisation followed by
autophosphorylation of the activation loop of the tyrosine kinase domain
(Cunningham and Greene, 1998; Kaplan and Stephens, 1994). This
autophosphorylation leads to increased activation of the catalytic portion of the
receptors as well as revealing recruitment sites for protein substrates (Figure 1.1). A
range of proteins, mediating signalling through a number of intracellular signalling
pathways, are activated by Trk receptors, including She, PLC-yl, SNT and SHP-1
(Belia et al., 1991; Borrello et al., 1994; Kaplan and Stephens, 1994; Obermeieret
al., 1993; Ohmichi et al., 1991; Rabin et al., 1993; Vambutas et al., 1995; Dikic et
al., 1995; Bibel and Barde, 2000). She activates PI3K and Ras/MEK/ERK, to
promote neuronal differentiation and survival, while activation of PLC-yl activates
PKC and increases intracellular free calcium. These increases in calcium levels
particularly are associated with survival, injury and activity-dependent plasticity
(Jiang and Guroff, 1997). SNT is implicated in cell cycle progression and SHP-1 is a
protein phosphatase that regulates trophic factor receptor activation (Barbacid, 1994;
Bartoe and Nathanson, 2000; Greene and Kaplan, 1995; Gunn-Moore and Tavare,
1998; Kaplan and Miller, 1997; Marsh et al., 2003).
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Figure 1.1 Trk-activcitecl signalling pathways
This figure illustrates the principal pathways that are activated following neurotrophin-induced trk
receptor dimerisation. This can result in the activation of the Ras/MEK/ERK, PI3 kinase and CAM
kinase pathways. These pathways promote growth, survival and activity-dependant plasticity
respectively, although, as can be see here, there is overlap between the pathways.
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While cell bodies can be exposed to neurotrophins through autorcrine and paracrine
mechanisms, as I described earlier a large part of neuronal exposure to neurotrophins
is target derived. How then is a signal propgated from the distant nerve terminal to
the cell body in order to effect changes in gene transcription? The current model
describes retrograde transport of internalised, activated Trk receptors form the nerve
terminal, through the axon, to the cell body by the transport of receptor containing
vesicles. The Trk receptors carried by these vesicles are capable of activating signal
transduction pathways along the entire length of the axon and in the cell body
(Bhattacharyya et al., 1997; Ehlers et al., 1995; Kuruvilla et al., 2004; Riccio et al.
1997). The signalling pathways activated by retrogradely transported Trk receptors
differ in some respects to those activated at the site of neurotrophin exposure, for
example retrograde signalling from NGF activated Erk5, rather than Erkl/2, on
reaching the soma (Watson et al, 2001).
Trk receptor expression is detected throughout the central and peripheral nervous
systems. In the CNS, trkA expression is limited to cholinergic neurons of the basal
forebrain and striatum (Holtzman et al., 1992; Merlio et al., 1992; Steininger et al.,
1993; Vazquez and Ebendal, 1991), while the vast majority of central neurons
express either trkB or trkC or both (Klein et al., 1989; Klein et al., 1990; Lamballe et
al., 1994; Merlio et al., 1992; Tessarollo et al., 1993). In the periphery, trk receptors
are detected on all neurons except parasympathetic ciliary neurons (Carroll et al.,
1992; Klein et al., 1989; Lamballe et al., 1994; Martin-Zanca et al., 1990; Ninkina et
al., 1996; Tessarollo et al., 1993) and in other non-neuronal neural crest-derived cell
types (Schropel et al., 1995; Tessarollo et al., 1993). Outside the nervous system
trkA expression also occurs in the immune system, trkB in lung muscle and ovary
and trkC in facial structures as well as various tissues in the body cavity (Ehrhard et
al., 1993; Lamballe et al., 1994; Tessarollo et al., 1993).
Mice carrying mutations in the trkA, B and C genes have been used to further
elucidate the roles of neurotrophins during development. In general these mice have
similar phenotypes to those of their dominant ligand null mutant (Crowley et al.,
1994; Ernfors et al., 1994b; Ernfors et al., 1994a; Jones et al., 1994; Klein et al.,
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1993; Klein et al., 1994; Smeyne et al., 1994). The principal difference is that mice
lacking trkC have less severe defects that those of the NT-3 knockout mice,
highlighting the more promiscuous binding of NT-3 to the Trk receptors and
suggesting that its in vitro ability to signal through the other receptors is
physiologically relevant. Mice lacking trkA display insensitivity to pain and have
decreased neuronal populations in the trigeminal, dorsal root and sympathetic ganglia
(Smeyne et al., 1994). TrkB-deficient mice lose a substantial proportion of
trigeminal, nodose and DRG neurons (Klein et al., 1993), while trkC knockout mice
have decreased numbers of myelinated axons emerging from the dorsal root and
posterior columns of the spinal cord, as well as loss of a subpopulation of DRG
neurons (Klein et al., 1994).
1.4.1.6. The p75 receptor
The p75 receptor is a second receptor for members of the neurotrophin family.
Generally, it binds neurotrophins with a lower affinity that the Trk receptors,
although high-affinity binding with NT-3 can also occur (Dechant et al., 1997). It has
been identified in a range of species including human, rat and chicken (Chao et al.,
1986; Large et al., 1989; Radeke et al., 1987). p75 is a 75kDa transmembrane
glycoprotein containing a long extracellular domain with four cysteine repeats
responsible for ligand binding (Welcher et al., 1991; Yan and Chao, 1991). These
cysteine repeats are common to a range of cell surface receptors, such as Fas antigen
and tumour necrosis factor (TNF) receptors I and II (Nagala and Golstien, 1995).
Expression of p75 is detected in the developing and adult CNS (Ernfors et al., 1988;
Yan and Johnson, Jr., 1989), as well as in developing sensory and sympathetic
neurons, where it is upregulated once neurons have established target contact
(Hallbook et al., 1990; Heuer et al., 1990; Wyatt et al., 1990).
The consequences of p75 activation vary considerably between cell types, and are
affected by the presence or absence of trk receptors. p75 modifies the function of the
high-affinity trk receptors (Barker and Shooter, 1994; Hempstead et al., 1991; Verdi
et al., 1994) and can affect ligand discrimination by these receptors, particularly
decreasing the ability of NT-3 to signal via TrkA (Benedetti et al., 1993; Bibel et al.,
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1999; Brennan et al., 1999; Clary and Reichardt, 1994; Lee et al., 1994). p75 may
also be able to activate its own intracellular signalling pathways, such as NFkB, to
enhance neuronal survival in some sensory neurons (Hamanoue et al., 1999).
Activation of NFkB by p75 is thought to be through interactions with the TRAF
family of protein adaptors (Khursigara et al., 1999). This NFkB signalling appears to
be activated by solely NGF, but not BDNF or NT-3, binding to p75 (Carter et al.,
1996b; Hamanoue et al., 1999; Maggirwar et al., 1998). In contrast, p75 has also
been found to promote apoptosis, both in the presence or absence of neurotrophins
(Barrett and Bartlett, 1994; Frade and Barde, 1998; Rabizadeh et al., 1993). Evidence
supporting the pro-apoptotic role of p75 can be found in BDNF knockout mice,
where increased numbers of sympathetic neurons are found during development,
despite BDNF not activating Trk receptors in these neurons (Bamji et al., 1998), and
in mice overexpressing p75 where significant reductions in neuronal number in
sympathetic, sensory and neocortical neurons are found, as well as increased cell
death following axotomy (Majdan et al., 1997). Additionally, activation of p75 by
NGF in TrkA-negative neurons promotes a cell death, which is abrogated by BDNF-
activated TrkB signalling, suggests competitive actions of trk and p75 signalling
pathways in cell survival (Davey and Davies, 1998).
Several adaptor proteins are recruited to the p75 receptor upon ligand binding and
have been implicated in the pro-apoptotic effects of p75. Of these proteins NRIF
(neurotrophin receptor interacting factor) appears particularly important in mediating
cell death. Neuronal death in mice lacking the NRIF gene is decreased in a similar
pattern to that of p75 and NGF knockout mice and may directly link p75 activation to
transcription, as receptor activation leads to its nuclear translocation (Bibel and
Barde, 2000; Casademunt et al., 1999). Other adaptor proteins that may be involved
in p75-mediated apoptosis are NRAGE homolog (neurotrophin receptor interacting
MAGE) and NADE (p75 NTR-associated cell death executor) (Mukai et al., 2000;
Salehi et al., 2000) as well as p53 and the related protein p73 (Pozniak et al., 2000).
Activation of p75 in the absence of Trk signalling may also act by increasing
intracellular ceramide levels (Carter et al., 1996a; Casaccia-Bonnefil et al., 1996;
Dobrowsky et al., 1994; Dobrowsky et al., 1995; Hamanoue et al., 1999). Ceramide
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and JNK accumulation correlates with apoptotic signals in some cell types and
inhibition of JNK activity can block apoptosis caused by activation of p75 (Brugg et
al., 1996; Hartfield et al., 1998; Wiesner and Dawson, 1996; Yoon et al., 1998). p75
is also implicated in regulating neurite outgrowth through RhoA where p75
constitutively activated RhoA, with neurotrophin binding blocking this effect
(Davies, 2000b; Yamashita et ah, 1999; Yamashita and Tohyama, 2003). In contrast
with the reported role of increased intracellular ceramide in mediating apoptosis,
NGF-induced neurite outgrowth in hippocampal neurons has been shown to be
through increased ceramide levels (Brann et ah, 1999). Signalling of BDNF through
p75 has also been reported to inhibit neurite outgrowth in postnatal sympathetic
neurons, suggesting that there is much still to be learnt about neurotrophin signalling
in neurite outgrowth.
1.4.2. Neuropoietic cytokines and their receptors
Within the nervous system, cytokines influence many processes including
proliferation and survival, differentiation, myelination, plasticity and regeneration
(English, 2003; Heller et ah, 1996; Horton et ah, 1996; Horton et ah, 1998; Jonakait,
1997; Murphy et ah, 1997; Profyris et ah, 2004; Turnley and Bartlett, 2000). The
neuropoietic cytokine family consists of nine proteins that are capable of signalling
through the receptor protein, gpl30. These are ciliary neurotrophic factor (CNTF),
leukaemia inhibitory factor (LIF), oncostatin-M (OSM), cardiotrophin-1 (CT-1),
interleukin-6 (IL-6) and interleukin-11 (IL-11), growth promoting activity (GPA),
neuropoeitin (NP) and cardiotrophin-like cytokine (CLC, also known as novel
neurotrophin-l/B-cell stimulating factor 3 or NNT-l/BSF-3). Sequence homology
between these proteins is low, however all members carry a similar gene organisation
and adopt similar tertiary structure, suggesting that they may have had a common
ancestral gene (Bazan, 1991; Bruce et ah, 1992).
1.4.2.1. Ciliary neurotrophic factor
CNTF is a 200-residue, highly acidic protein with a molecular mass of 20-24kDa
(Masiakowski et ah, 1991). It is the best characterised neuropoietic cytokine, and,
unlike other family members such as LIF, is expressed exclusively in the nervous
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system (Dobrea et al., 1992; Stockli et al., 1989; Stockli et al., 1991; Turnley and
Bartlett, 2000). It was first identified as a protein capable of promoting the survival
of parasympathetic neurons of the chicken ciliary ganglion in vitro (Adler et ah,
1979) and has since been cloned in a number of mammalian systems including
rabbit, rat, human and mouse (Kaupmann et ah, 1991; Lam et ah, 1991; Lin et ah,
1989; Masiakowski et ah, 1991; Stockli et ah, 1989). In addition to ciliary neurons, a
wide variety of peripheral and central neurons respond to CNTF in vitro, including
neurons of the nodose, trigeminal, dorsal root and sympathetic ganglia, spinal
motoneurons, hippocampal neurons and Purkinje cells (Arakawa et ah, 1990; Barbin
et ah, 1984; Ernsberger et ah, 1989; Horton et ah, 1998; Ip et ah, 1991; Larkfors et
ah, 1994). In vivo, CNTF is able to protect motoneurons and dopaminergic neurons,
but not ciliary, sympathetic or sensory neurons, from naturally-occuring or axotomy-
induced cell death (Curtis et ah, 1993; Hagg and Varon, 1993; Oppenheim et ah,
1991; Sendtner et ah, 1990; Vejsada et ah, 1995). Decreases in CNTF expression
have also been associated with some familial amyotrophic lateral sclerosis and early
onset of multiple sclerosis (Giess et ah, 2002b; Giess et ah, 2002a).
As well as its pro-survival effects, CNTF inhibits proliferation and induces
cholinergic differentiation in developing sympathetic neurons and can influence
neurotransmitter phenotype and receptor expression in a range of central and
peripheral neurons (Burnham et ah, 1994; Ernsberger et ah, 1989; Louis et ah,
1993a; Magal et ah, 1991; Patterson and Nawa, 1993; Saadat et ah, 1989; Wong et
ah, 1993; Zurn and Werren, 1994). CNTF also promotes neurite outgrowth in retinal
ganglion cells and induces sprouting at the neuromuscular junction, but can inhibit
dendritic outgrowth and cause dendritic retraction in sympathetic neurons where
growth is promoted by BMP-7 (English, 2003; Goldberg et ah, 2002; Guo et ah,
1997; Guo et ah, 1999; Gurney et ah, 1992; Siegel et ah, 2000; Tarabal et ah, 1996).
CNTF also acts on non-neuronal cells in the nervous system, promoting the
differentiation of astrocyte progenitor cells and microglia in vitro (Bonni et ah, 1997;
Hughes et ah, 1988; Rajan and McKay, 1998; Yoshida et ah, 1993) as well as the
maturation and survival of oligodendrocytes, depending on the culture conditions
(Louis et ah, 1993b; Mayer et ah, 1994). Despite a number of roles for CNTF being
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defined in vitro, its role in vivo is less well defined. The expression of CNTF mRNA
is only detected postnatally (Ip et al., 1993; Sendtner et al., 1994; Stockli et al., 1991)
and it appears only to be released from damaged cells, consequently CNTF null
mutant display no overt phenotype at birth (Masu et al., 1993). It does, however,
evidence a slow degeneration of a subset of adult motoneurons during the subsequent
postnatal period, and in LIF/CNTF double knockout mice this degeneration is more
severe than in either single knockout, suggesting redundancy in the system (Sendtner
et al., 1996).
1.4.2.2. Leukaemia inhibitory factor
Unlike CNTF, LIF is widely expressed throughout the mammalian organism from
the early stages of development, and has a large range of effects, particularly with
respect to growth and differentiation (Turnley and Bartlett, 2000). At the earliest
stages of development, LIF can suppress the differentiation of embryonic stem cells
(Williams et al., 1988) and act as a survival factor for primordial germ cells (De
Felici and Dolci, 1991; Matsui et al., 1992). LIF also plays many roles in
haematopoiesis, inhibiting leukaemic cell production and stimulating the production
of megakaryocytes and platelets (Metcalf et al., 1991; Metcalf et al., 1992). It also
regulates bone resorption through osteoclasts (Martin et al., 1992).
In the peripheral nervous system, LIF can stimulate neural crest precursor cells to
differentiate into sensory neurons and subsequently act as a survival factor for these
neurons (Murphy et al., 1993; Murphy et al., 1994). In fact, a number of populations
of embryonic and postnatal neurons survive when exposed to LIF in vitro including
sensory neurons, parasympathetic ciliary neurons and neurons of the spiral ganglion
(Adler et al., 1979; Horton et al., 1996; Horton et al., 1998; Marzella et al., 1997).
LIF also regulates neurotransmitter phenotype and neuropeptide expression in
motoneurons, neurons of the sympathetic ganglia and trigeminal sensory neurons
(Fan and Katz, 1993; Michikawa et al., 1992; Nawa et al., 1991; Zurn and Werren,
1994). In the CNS, LIF can stimulate or inhibit differentiation of central neurons
depending on the population and circumstances (Turnley and Bartlett, 2000). LIF
promotes neurite outgrowth in spinal choliergic neurons and auditory neurons
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(Gillespie et al., 2001; Richards et al., 1992), although it also inhibits dendritic
growth of sympathetic neurons where neurite outgrowth is promoted by BMP-7 or
NGF (Guo et al., 1997; Guo et al., 1999), and is associated with plasticity-related
synaptic changes in primary sensory neurons and at the neuromuscular junction
(English, 2003; Ramer et al., 1999; Thompson and Majithia, 1998). LIF is also
important in promoting the generation, maturation and survival of oligodendrocytes
and astrocytes in vitro (Chang et al., 2004; Kahn and De Vellis, 1994; Mayer et al.,
1994; Nakagaito et al., 1995; Pitman et al., 2004; Richards et al., 1996; Yoshida et
al., 1993). There are decreased numbers of GFAP-immunoreactive astrocytes in the
hippocampus and dentate gyrus of LIF knockout mice (Koblar et al., 1998).
Like CNTF, LIF can maintain both motoneurons and peripheral sensory neurons
neurons in vivo after nerve injury (Cheema et al., 1994b; Cheema et al., 1994a;
Curtis et al., 1994). LIF also stimulates regeneration of olfactory neurons after injury
and regenerative axonal growth in peripheral sensory neurons (Bauer et al., 2003;
Cafferty et al., 2001; Moon et al., 2002).
1.4.2.3. Other neuropoietic cytokines
Oncostatin M (OsM) was originally described as inhibiting tumour cell proliferation
(Zarling et al., 1986), however in the nervous system it supports the survival of
peripheral sensory neurons in vitro (Horton et al., 1996) and promotes
oligodendrocyte survival and differentiation (Vos et al., 1996). A subset of DRG
neurons, those expressing both the vanilloid receptor-1 (VR-1) and P2X3, also
express the OsM receptor, and these neurons are lost in OsM_/ mice (Morikawa et
al., 2004; Tamura et al., 2003a). OsM is also implicated in regulating the expression
of choline-acetyl transferase and vasoactive intestinal peptide expression in cultured
sympathetic neurons (Rao et al., 1992). In the central nervous system the OsM
receptor is expressed in the hypoglossal nucleus, as well as in olfactory bulb
astrocytes (Tamura et al., 2003b).
Cardiotrophin-1 (CT-1) was characterised as a factor that mediates cardiac
hypertrophy (Pennica et al., 1995a). Within the nervous system, it is a survival factor
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for cultured sensory and parasympathetic neurons, hindbrain dopaminergic neurons
and motoneurons (Arce et al., 1998; Horton et ah, 1998; Pennica et ah, 1995b;
Pennica et ah, 1996a).
IL-6 promotes the survival of cultured embryonic and postnatal midbrain
catecholaminergic neurons and basal forebrain cholinergic neurons, as well as
stimulating astrocyte proliferation (Fattori et ah, 1995; Flama et ah, 1989; Kushima
et ah, 1992; Kushima and Hatanaka, 1992a; Kushima and Hatanaka, 1992b).
Additionally, IL-6 is a survival factor for peripheral sensory neurons in culture
(Horton et ah, 1996).
Cardiotrophin-like cytokine (CLC) was identified in 1999 as a novel ligand for the
CNTFRa/LIFR(3/gpl30 receptor complex (Senaldi et ah, 1999; Shi et ah, 1999).
CLC is expressed mainly in secondary lymphoid organs, but has also been detected
in a number of other systems, including kidney, heart, lung and pancreas (Senaldi et
ah, 1999; Shi et ah, 1999). It appears to be released from cells only in a complex
with a protein called cytokine-like factor 1 (CLF-1), a soluble protein that has a high
level of homology with gpl30 (Elson et ah, 1998; Elson et ah, 2000), or with a
soluble form of the CNTFRa (Plun-Favreau et ah, 2001). In the nervous system
CLC supports the survival of embryonic motor and sympathetic neurons (Elson et
ah, 2000; Plun-Favreau et ah, 2001; Senaldi et ah, 1999) and can induce astrocyte
differentiation (Uemura et ah, 2002).
Neuropoietin is a recently identified cytokine that acts through the
CNTFRa/LIFRp/gpl30 complex to activate STAT3 signalling (Derouet et ah, 2004).
Neuropoietin is highly expressed during embryonic development, a stage at which
the alternate CNTFRa ligands CNTF and CLC are not present. It is expressed in
embryonic neuroepithelial cells, the retina, and skeletal muscle and in vitro promotes
the survival of embryonic motoneurons, as well as promoting the proliferation of
neural precursors in association with epidermal growth factor (EGF) and fibroblast
growth factor (FGF) 2.
32
Chapter 1
1.4.2.4. The neuropoietic cytokine receptor complex.
Neuropoietic cytokines signal through a multicomponent receptor complex. This
consists of a common subunit, a glycoprotein called gpl30, which interacts with
different adaptor proteins depending on the ligand involved (Heinrich et al., 2003;
Hibi et al., 1990; Sato and Miyajima, 1994). LIF binds directly to a receptor subunit
called LIF receptor P (LIFRP), which induces dimerisation with the gpl30 subunit,
while CNTF, neuropoietin and CLC require an additional protein, CNTFRa, to
induce the formation of a complex with first gpl30 then LIFRP (Davis et al., 1991;
Davis et al., 1993; Gearing et al., 1991; Gearing et al., 1992; Ip et al., 1993; Stahl and
Yancopoulos, 1994) (Elson et al., 2000; Plun-Favreau et al., 2001). CT-1 also
appears to require an adaptor protein to interact with gpl30 and LIFRa, but this
protein is yet to be identified (Pennica et al., 1995a; Pennica et al., 1996b; Robledo et
al., 1997). IL-6 and IL-11 have their own supplementary subunits, IL6Ra and
IL1 IRa (Barton et al., 2000; Murakami et al., 1993), and ligand binding induces
gpl30 homodimerisation as part of a hexameric complex while OSM induces the
heterodimerisation of gpl30 and the OSM receptor subunit (OSMR) (Heinrich et al.,
2003; Ichihara et al., 1997; Lindberg et al., 1998).
Neither gpl30 nor LIFRa themselves possess intrinsic enzymatic activity, thus
ligand binding induces a conformational change in the receptor complex that results
in the phosphorylation and activation of receptor tyrosine kinases that are associated
with LIFRP and gpl30 even in the inactive state (Stahl and Yancopoulos, 1994). The
receptor tyrosine kinases typically associated with the gpl30 receptor complexes are
of the janus kinase, or JAK, family, particularly JAK1 (Vlotides et al., 2004).
Activated JAKs then phosphorylate several tyrosine residues in the cytoplasmic tails
of gpl30 and LIFRp, revealing docking sites for proteins containing SH2-domains
including SHP-2, She and Grb, which link cytokine signalling to the MAPK
pathway, PLCy, PI3K, and Raf-1 (Boulton et al., 1994; Chen et al., 1999; Giordano
et al., 1997; Lelievre et al., 2001; Oh et al., 1998; Stahl et al., 1994; Stahl et al.,
1995; Stahl and Yancopoulos, 1994). The activation of PI3K and Akt by cytokines
has been implicated in pro-survival responses to cytokines in both central (motor)
and peripheral (nodose) neurons (Alonzi et al., 2001; Nishimune et al., 2000). Ligand
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binding also results in the activation of the STAT family of SH2-bearing proteins,
particularly STAT-3, which appears to be the principal pathway for cytokine
signalling (Segal and Greenberg, 1996; Stahl and Yancopoulos, 1994; Turnley and
Bartlett, 2000; Zhong et al., 1994). Activated STAT proteins dimerise and translocate
to the nucleus where they activate the transcription of a number of genes (Chen et al.,
1999; Heinrich et al., 2003; Hirano et al., 2000). These genes include a number of
anti-apoptotic proteins such as Bcl-2 and Bcl-xL (Catlett-Falcone et al., 1999; Chen
et al., 1999; de Koning et al., 2000; Fukada et al., 1996; Kami et al., 1999) as well as
the neurotrophic factor Reg-2 (Nishimune et al., 2000).
As each receptor subunit is used in receptor complexes formed by a number of
ligands, the phenotypes of mice lacking each receptor subunit are more severe than
those of mice with null mutations for any of the ligand genes. CNTFRa knockout
mice display the mildest phenotype, surviving to birth, however these mice die
shortly after birth, failing to initiate the feeding process, and showing a dramatic loss
of motoneurons (DeChiara et al., 1995). This phenotype is more severe than that of
the CNTF ligand knockout mice and, as the CNTFRa is expressed strongly long
before expression of CNTF is detected (Ip et al., 1993; Sendtner et al., 1994), this led
to the proposal that another ligand "CNTF2" must signal through CNTFRa. Recent
candidates for "CNTF2" have recently been found to be neuropoeitin and CLC
(Derouet et al., 2004; Elson et al., 2000; Plun-Favreau et al., 2001; Senaldi et al.,
1999; Shi et al., 1999). LIFRp knockout mice also die within hours of birth, with
significant reductions in the number of facial, trigeminal hypoglossal and spinal
motoneurons and a loss of astrocytes in the brainstem and spinal cord (Li et al., 1995;
Ware et al., 1995). In gpl30"/_ knockout mice there is loss of DRG neurons and
specific populations of motoneurons, that occurs between E14.5 and E18.5,
suggesting that cytokines are principally involved in regulating neuronal survival
during the period of naturally occurring cell death, rather than in the early generation




1.4.3. The reg family of proteins
The Reg family of proteins is a large family of secretory proteins, so named because
the first Reg gene was identified as a gene upregulated in regenerating pancreatic [3-
cells (Terazono et ah, 1988). Since then five further Reg family members have been
identified in mice, separated into 3 different groups based on their structural
homology (Abe et ah, 2000; Narushima et ah, 1997; Unno et ah, 1993). Over the
same period of time several Reg-family proteins have also been isolated from other
mammalian cells types. Some of these proteins are homologues of the murine reg
genes and fit into the three murine groups, while the identification of an additional
Table 1: The Reg family of proteins
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human protein has led to a fourth group being established (Hartupee et al., 2001).
The converging identifications of different Reg-family proteins in different species
have led to a complicated nomenclature (see Table 1). For the purposes of this thesis
the murine nomenclature will generally be used, with regIII(3/Reg-2 being referred to
as Reg-2 throughout.
Each reg family gene covers approximately 3kbp, arranged into 6 exons and 5
introns with identical intron/exon boundaries, an organisation which is conserved
across different species (Abe et al., 2000; Hartupee et al., 2001; Narushima et al.,
1997; Unno et al., 1993). With the exception of the Reg-IV in humans, these genes
are clustered in the same chromosome loci, 2pl2 in humans or 6C in mice, and are
consequently considered to have arisen through gene duplication (Okamoto, 1999).
Reg-family proteins are expressed in varying ranges of tissues and play multiple
roles, functioning particularly as anti-apoptotic, growth factors or mitogens for
pancreatic p cells, neural cells or gastrointestinal epithelial cells (Zhang et al., 2003).
Group III is the only group whose members have been found to be active in the
nervous system (Livesey et al., 1997; Nishimune et al., 2000; Schweizer et al., 2002;
Tarn et al., 2002). Of the four murine group III genes, both PAP/Reg-IIip/Reg-2 and
INGAP/Reg-III5 are known to function in the nervous system. Livesey et al (1997)
first reported a role for Reg-2 in the nervous system when they detected its
expression in developing or regenerating motor neurons or sensory neurons of the
DRG. They found Reg-2 to be a potent Schwann cell mitogen, and that blocking
Reg-2 signalling significantly delayed axonal regeneration, which is itself dependent
on Schwann cell proliferation. Reg-2 expression during development is dependent on
contact with peripheral target tissues, with the IL-6 type cytokines probably
mediating this effect, as Reg-2 expression is abolished in mice lacking the LIF
receptor gene. The expression of Reg-2 in regenerating DRG neurons at different
time points varies depending on the subtype of neurons, with small-diameter
nociceptive neurons expressing Reg-2 24h after transection, while after 5 days Reg-2
expression is predominantly in large diameter non-nociceptive neurons (Averill et
al., 2002). The induction of Reg-2 expression in axotomised motor neurons is
dependent on functional STAT-3 signalling (Schweizer et al., 2002). STAT-3 is a
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major downstream mediator of IL-6-type cytokine signalling therefore this suggests
another link between cytokines and Reg-2 expression in neurons. In developing
motor neurons in vitro, Reg-2 is an indispensable intermediate for CNTF-induced
neuronal survival. Reg-2 promotes the survival of these neurons via a PI3K- and
NFicB-dependent pathway (Nishimune et al., 2000). In motoneurons in vivo, Reg-2
expression occurs after innervation of the target muscle.
Group III reg proteins have also been implicated in neurite outgrowth in the
peripheral nervous system. In adult DRG explants, a model of nerve axotomy, the 15
amino acid active sequence of INGAP/Reg-III5 enhances neurite outgrowth in a
dose-dependent manner (Tarn et ah, 2002). This effect was, however, blocked by a
preincubation of the explant with anti-NGF antibodies, a treatment which itself does
not independently alter neurite outgrowth, suggesting that INGAP peptide may
stimulate NGF production within the ganglion. INGAP peptide stimulated [H]J
thymidine incorporation into these explants, suggesting that it was acting on a
population of proliferating non-neuronal cells in the ganglia.
In contrast to the growth-promoting role described above, Reg-2 has been implicated
in the aetiology of Alzheimer's Disease (AD). Reg proteins are highly susceptible to
proteolysis, producing a C-terminal polypeptide that forms insoluble fibrils at
physiological pFI (Cerini et ah, 1999) reminiscent of A[3 and Tau in senile plaques
and neurofibrillary tangles in AD. Reg-I and Reg-2 are found in such protein
deposits in AD (Duplan et ah, 2001). The levels of both proteins are also elevated in
the cerebrospinal fluid in AD patients. Interestingly, cytokines such as TNF-a and
IL-6, which are capable of regulating Reg-family protein expression, have also been
implicated in AD (Fillit et ah, 1991; Ringheim et ah, 1998; Singh and Guthikonda,
1997) with this synthesis of TNF-a by microglia being stimulated by Ap peptides.
Duplan et ah (2001) have speculated that the production of Reg proteins and their
subsequent precipitation contribute to a cycle that worsens precipitate formation in
AD plaques and tangles.
Reg family gene expression is constitutive in some tissues, such as the pancreas and
the developing pituitary gland, through the presence of DNA binding motifs for
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tissue-specific transcriptional regulators such as Pan-1 and Pit-1 in their promoter
sequences (Abe et al., 2000; Narushima et al., 1997; Vierra and Nelson, 1995). Reg
family genes are also induced in response to cytokine exposure, with the promoter
region of each gene containing a variety of IL-6 response elements (IRE) (Abe et al.,
2000; Dusetti et al., 1995; Narushima et al., 1997; Okamoto, 1999). Expression of
Reg-I in pancreatic islet (3 cells can be induced by IL-6, growth-hormone releasing
hormone, TNF-a and interferon-y (Chakraborty et al., 1995; Dusetti et al., 1996;
Okamoto, 1999). Reg-2 mediates effects of TNF-a in pancreatic acinar cells, and its
expression is induced by IL-6 in combination with dexamethasone, TNF-a or IFN-y
in these cells (Dusetti et al., 1995). Reg-2 has also been reported to be induced by
growth-hormone releasing hormone in the small intestine and pituitary and oestradiol
in the uterus (Chakraborty et al., 1995; Katsumata et al., 1995).
Reg-I is the only member of the reg family of proteins for which a receptor has been
described. Isolated by probing a rat islet cDNA expression library with [I]'^"labelled
Reg I, the 919 amino acid sequence predicts a type II transmembrane protein with a
long extracellular domain (868 a.a.) and a short intracellular N-terminal (28 a.a.)
(Kobayashi et al., 2000). The amino acid sequence has 97% homology to the human
Ext-like gene 3 (Extl3) sequence, suggesting that Extl3 is the rat homologue of this
protein. Expression of this protein in COS-7 cells confers Reg-1 binding and
overexpression of this putative receptor in pancreatic islet cells increased
proliferation in response to Reg-I.
1.5. Intracellular Signalling
Intracellular signalling is a diverse and rapidly expanding field of study. One simple
way of classifying signalling cascades types is into those that use non-protein
intermediates or second messengers (such as calcium ions, cyclic nucleotides or
phosphoinositides) to exert their physiological actions and those that do not, such as
G-protein based systems or those based on using phosphorylation of specific residues
in subsequent proteins to modify to their functions. These are not, however, discrete
systems since signalling pathways using second messengers will usually use G-
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proteins and protein kinases in their signalling cascades, and there is extensive
potential for crosstalk between different signalling cascades.
Individual signalling cascades are usually identified by significant proteins that occur
at some point in the cascade. These names can vary from second-messenger activated
proteins, to a particular transcription factor. The signalling pathway that is the major
focus of investigation in this thesis is that centred on the NFkB family of
transcription factors. Several other pathways are also considered, as they are
activated by the growth factors used, or commonly associated with signalling for
either neuronal survival or outgrowth. These pathways are the JAK/STAT signalling
pathway, commonly implicated in mediating the intracellular effects of cytokines,
and the PI3 kinase/Akt and MAP kinase pathways, common pathways mediating
neurotrophin signalling. In this section of the introduction I will describe the
structure of the NFtcB signalling pathway. I will then discuss the roles of these
signalling pathways neuronal survival and outgrowth.
1.5.1. The nuclear factor kB family of transcription factors
Nuclear factor kB (NFkB) was first described almost 20 years ago by (Sen and
Baltimore, 1986) as a protein that binds an immunoglobulin k enhancer sequence.
Since then NFtcB family proteins have been found to be important in signal
transduction in a wide variety of situations, particularly in the immune response and
other times of cell stress, often by helping support cell survival (Li and Stark, 2002).
NFkB family proteins are highly conserved, from Drosophila to humans, with each
member containing a characteristic Rel homology (RH) domain. Structurally, NFkB
family proteins are divided into two groups, the first group containing the
mammalian proteins, p65 (Rel A), Rel (c-Rel) and Rel B as well as the drosophila
proteins Dorsal and Dif, while the second group contains plOO, pl05 and Relish
(Siebenlist et al., 1994). All these proteins contain the RH domain, with additional
regions varying between the two groups and determining their functions. Proteins
from the group containing p65 possess c-terminal transcriptional activation domains.
Members of the second group possess 5-7 ankyrin repeats in long c-terminal domains
that act to inhibit nuclear translocation. Before signalling can occur plOO and p!05
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undergo partial degradation, plOO to a protein called p52 and pl05 to p50, releasing
proteins that are able to participate in the activation of transcription.
Transcriptionally active NFkB family proteins form homo- or hetero-dimers, the
most common of which is the p65-p50 dimer, often referred to simply as NFkB, its
original name (Li and Stark, 2002). In the inactive state, NFkB dimers are bound by
a protein complex called IkB or consist of a dimer containing the p52/p50 precursor
proteins plOO or pl05 (Baeuerle and Baltimore, 1988). The IkB complex is formed
from combinations of 5 subunits, hcBa, IkB[3, MBy, IkBs and Bcl-3, with hcBa and
IkBP being the principal proteins (Ghosh et al., 1998; Ghosh and Karin, 2002;
Silverman and Maniatis, 2001). IkB proteins are characterised by the presence of C-
terminal ankyrin repeats that mediate their interaction with NFkB. IkBci also contains
a nuclear export sequence (NES) and is involved in removing NFkB from the
nucleus (Tarn et ah, 2000). The IkB complex conceals several important regions of
the NFkB subunits, including the nuclear localisation sequence of p65, as well as
regions important for DNA binding and phosphorylation sites necessary for maximal
activation of gene transcription (Hayden and Ghosh, 2004). For a long time it was
thought that the IkB complex limited NFkB to the cytosol, however it has recently
been discovered that while NFkB is held inactive by the IkB complex, the p50
nuclear localisation signal is still exposed and IkB/NFkB complexes are constantly
being transported into the nucleus. The nuclear export sequence of IkBci, however,
causes the removal of inactive dimers, resulting in a situation where inactive
NFkB/IkB complexes are constantly being shuttled into and out of the nucleus, but
where the balance of this shuttling leaves the majority of NFkB dimers in the
cytoplasm at any one time (Huang et al., 2000b; Huxford et al., 1998; Johnson et al.,
1999; Malek et al., 2001; Malek et al., 2003). In order for the NFkB become
transcriptionally active the principal event that must occur is for the NFkB dimer to
be released from the IkB complex. This removes the contribution of the NES of FcBa
to the equilibrium, leading to an accumulation of NFkB dimers in the nucleus, and
exposes the p65 nuclear localisation signal, DNA binding and phosphorylation sites
(Huang et al., 2000b; Huxford et al., 1998; Johnson et al., 1999; Malek et al., 2001;
Malek et al., 2003).
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There are several ways in which dissociation of NFkB from the IkB complex can be
initiated (figure 1.2). The principal method is serine phosphorylation of an IkB
protein, on serines 32 and 36 for hcBa or Ser 19 and Ser 26 in IkB(3. This allows the
IkB protein to be recognised by the (3TrCP subunit of the SCF ubiquitin ligase
complex, targeting it for proteosomal degradation, and is the classical pathway of
NFkB activation (Karin and Ben Neriah, 2000). More recently, additional events
leading to the release of active NFkB dimers have been described. Phosphorylation
of IkB at tyrosine residues has been described as a mechanism initiating the release
of NFkB dimers from the IkB complex. This mechanism appears to be used
particularly in response to oxidative stress (Fan et al., 2003; Mahabeleshwar and
Kundu, 2003; Natarajan et al., 2002; Takada et al., 2003). Phosphorylation of this
residue leads of dissociation of NFkB from the IkB complex, but appears to be
independent of IkB degradation (Canty et al., 1999; Natarajan et al., 2002; Takada et
al., 2003). This mechanism has been found to be activated in response to NGF
exposure in neuronal cell lines, as well as primary hippocampal neurons (Bui et al.,
2001). A third pathway leading to the release of functioning NFkB dimers occurs
when the RelB protein is associated with the inactive plOO. Phosphorylation of the
plOO protein on at least 5 serine residues (serines 99, 108, 115, 123, and 872) targets
it for partial degradation releasing a p52/RelB dimer (Dejardin et al., 2002; Xiao et
al., 2001; Xiao et al., 2004).
A number of different kinases are capable of phosphorylating IkB proteins, thus
releasing NFkB for signal transduction. The protein kinases that perform this service
as part of the classical activation cascade are those of the IkB kinase (IKK) complex.
There are three members of this class of protein, IKKa, IKKP and IKKy (also called
NEMO; NFkB Essential Modifier). IKKa and IKKP both possess catalytic ability
while the third member, IKKy, which is catalytically inactive, regulates the
formation of the IKK complex and mediates many of the upstream signals that result
in IKK activation (May et al., 2000; May et al., 2002; Rudolph et al., 2000; Yamaoka
et al., 1998). The IKK complex is formed from either IKKa or IKKp homodimers, or
IKKa/p heterodimers, regulated by IKKy. The IKKa/p heterodimer has the highest













Figure 1.2 Intracellular pathways leading to NFkB activation.
This figure illustrates the principal pathways leading to NFkB activation. Phosphorylation activates
the IKK complex, leading to IkB phosphorylation on serine residues and its subsequent degradation,
releasing p50-p65 dimers for nuclear translocation and transcriptional activation. Tyrosine
phosphorylation of IkB does not result in its degradation, but nevertheless releases p50-p65 dimers
and is one alternative pathway. A second alternative pathway invloves activation of IKKa, leading to
the phosphorylation and partial degradation ofplOO and releasing p52-RelB dimers. Serine
phosphorylayion of p50-p65 dimers can also increase its transcriptional activity and its ability to
associate with its coactivator CBP.
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identical functions. IKK(3 is the protein kinase that necessary for serine
phosphorylation of IkBoc and IkB(3, leading to activation of NFkB through the
classical pathway and cannot be replaced by IKKa (Hayden and Ghosh, 2004).
Whether IKKa is involved in the classical pathway is still unknown, although recent
evidence suggests that IKKa, but not IKK(3 or IKKy, has a nuclear role,
phosphorylating histone H3, a process that is important for NFicB-dependent gene
transcription (Anest et ah, 2003; Birbach et ah, 2002; Yamamoto et ah, 2003). IKKa
is also the kinase involved in the non-canonical pathway, where phosphorylation of
plOO leads to its partial degradation, leaving RelB-p52 dimers (Solan et ah, 2002;
Xiao et ah, 2001; Xiao et ah, 2004; Yilmaz et ah, 2003). Additionally, IKKa appears
to have some NFkB independent actions, particularly involved in the formation of
the epidermis (Cao et ah, 2001; Hu et ah, 1999; Hu et ah, 2001; Li et ah, 1999a;
Takeda et ah, 1999). The differences in the roles of the IKKa and p proteins are
reflected in mice lacking these genes. The phenotype of the IKKp7" mice resembles
that of p657" and both mutations are lethal by E15 (Beg et ah, 1995; Li et ah, 1999b;
Li et ah, 1999c; Tanaka et ah, 1999). In contrast, IKKa7" embryos survive until birth,
but have significant epidermal and skeletal defects that result in death soon after
birth, and which are not dependent on NFkB activation (Cao et ah, 2001; Hu et ah,
1999; Hu et ah, 2001; Li et ah, 1999a; Sil et ah, 2004; Takeda et ah, 1999). Like
IKKp and p65-deficient mice, IKKy7" mice die from liver apoptosis around E13
(Rudolph et ah, 2000).
Several models have been proposed for activation of the IKK complex. In one case
IKK activity occurs through serine phosphorylation by MAP kinase kinase kinases
(MAP3K), while in another the IKK complex is recruited to cell surface receptors,
where autophosphorylation occurs. Several MAP3Ks have been found to associate
with the IKK complex and in vitro can activate the IKK complex. These include
nfkb-inducing kinase (NIK), mitogen-activated protein/Erk kinase kinase (MEKK)
1, MEKK 3, TGFP activating kinase 1 (TAK1) and NFkB activating kinase (NAK)
(Lee et ah, 1998; Ninomiya-Tsuji et ah, 1999; Tojima et ah, 2000; Woronicz et ah,
1997; Yang et ah, 2001). The physiological significance of several of these
interactions, particularly those of NIK and MEKK1 in the classical activation of
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NFkB have proved hard to substantiate, particularly using gene knockouts. This
effect could be a consequence of redundancy among MAP3 kinases (Yamamoto and
Gaynor, 2004; Yin et ah, 2001; Yujiri et ah, 2000) or alternatively because some of
these proteins are being found alternative roles as adaptor proteins (Hayden and
Ghosh, 2004). One MAP3K, NIK, does play a role in activating NFkB dimers,
through the non-canonical NFkB pathway, where it activates IKKa, leading to partial
degradation of plOO and release of RelB-p52 dimers (Claudio et ah, 2002; Coope et
ah, 2002; Dejardin et ah, 2002; Lin et ah, 1998b; Ling et ah, 1998; Muller and
Siebenlist, 2003; Regnier et ah, 1997; Senftleben et ah, 2001; Uhlik et ah, 1998;
Xiao et ah, 2001; Yilmaz et ah, 2003). NIK activation in the non-canonical pathway
is caused by factors such as B cell activating factor and CD40 ligand (Claudio et ah,
2002; Coope et ah, 2002) Polyubiquitination of IKKy through a TRAF6/TAK
interaction also seems to positively regulate NFkB signalling (Deng et ah, 2000;
Tang et ah, 2003; Wang et ah, 2001). Less is known about the induction of tyrosine
phosphorylation of IkB proteins than about serine phosphorylation. It has been
suggested that PI3K may be involved in neurotrophin-activated tyrosine
phosphorylation, and the Syk tyrosine kinase in hydrogen peroxide-induced NFkB
activation (Beraud et ah, 1999; Bui et ah, 2001; Takada et ah, 2003).
As well as release from the IkB complex, several modifications to the NFkB proteins
regulate their transcriptional activity. Such modifications alter the ability of NFkB to
associate with other elements, including DNA and co-activator proteins. NFkB
subunits p65 and c-Rel can be phosphorylated on serine 276 by PKA, which
enhances DNA binding and exposes an site for interaction with CBP/p300, a
transcriptional co-activator (Naumann and Scheidereit, 1994; Neumann et ah, 1995;
Zhong et ah, 1997; Zhong et ah, 1998; Zhong et ah, 2002). Other protein kinases also
perform this function, including MSK1 and 2 (Vermeulen et ah, 2003). Serine
phosphorylation on other residues also affects transcriptional activation. Both IKKa
and IKKP have been shown to phosphorylate p65 at ser 536 (O'Mahony et ah, 2004;
Sizemore et ah, 2002; Yang et ah, 2003) while PKCi^ phosphorylates p65 at Ser 311
(Anrather et ah, 1999; Leitges et ah, 2001). GSK3 and TBK1 are also implicated in
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NFkB signalling, although whether they directly modify NFkB proteins is as yet
unknown (Bonnard et al., 2000; Hoeflich et al., 2000; Schwabe and Brenner, 2002).
The different NFkB proteins are not interchangeable. The release of different active
dimers has varying biological effects, with particular dimers being implicated in the
signalling of specific factors in different cell types. The most basic indication of the
roles of each of the NFkB proteins can be gained from transgenic mice. Mutants
lacking the p65 gene reveal the essential role of NFkB in preventing apoptosis during
development, as p65v~ embryos dies from liver degeneration at E15-16 (Beg et al.,
1995). Rescue of this defect by crossing with the mice deficient in TNFa then reveals
increased susceptibility to infection and apoptosis in some neuronal populations
(Alcamo et al., 2001; Middleton et al., 2000). Mice lacking the p50 gene show a very
different phenotype. While there are no major developmental defects, there are major
defects in immune system function (Sha et al., 1995). Defects in the immune system
also occur in p52, c-Rel and RelB knockout mice (Caamano et al., 1998; Franzoso et
al., 1998; Paxian et al., 2002). The differences in the roles of NFkB dimers are partly
related to differences in the ability of different dimers to bind to each other and the
IkB proteins. IkBcc associates mainly with p65/p50, IkBs with p65 homodimers and
c-Rel/p65 dimers, and Bcl-3 with p50 or p52 homodimers, while RelB can interact
only with plOO (Bours et al., 1993; Dobrzanski et al., 1994; Fujita et al., 1993;
Hatada et al., 1992; Hayden and Ghosh, 2004; Li and Nabel, 1997; Ryseck et al.,
1992; Simeonidis et al., 1997; Solan et al., 2002; Whiteside et al., 1997). Not all
possible combinations of NFkB hetero- and homo- dimers occur in vivo. RelB, for
example, only interacts with p50 and p52, while homodimers of p50 and p52 bind to
NFkB sequences but, having no inherent transcriptional domain, usually have an
inhibitory effect on gene transcription (Ishikawa et al., 1998; Li and Verma, 2002;
Zhong et al., 2002). Different combinations of NFkB subunits activate transcription
of different sets of genes depending on the dimer, with some genes being present in
the activation sets of more than one dimer (Dejardin et al., 2002; Saccani et al.,
2003). This specificity is partly embedded in the different kB binding sequences, as
different sequences bind NFkB dimers with varying efficiencies. Binding efficiency,
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however, does not necessarily correlate with transcriptional activity and is also
modified by other elements in the promoter sequences (Saccani et al., 2003).
Genes transcribed as a consequence of NFkB activation include cytokines, such as
TNFa, IL-6 and GM-CSF, chemokines, adhesion molecules, such as ICAM-1 and
inducible enzymes, such as iNOS and COX-2 (Yamamoto and Gaynor, 2004). NFkB
also regulates the expression of receptors involved in immune recognition,
proliferation and cell survival. Proteins involved in regulating cell survival include
cellular inhibitors of apoptosis (c-IAP 1 and 2), TNF-receptor associated factors
(TRAF 1 and 2) and Bcl-2 family genes (Karin and Lin, 2002; Yamamoto and
Gaynor, 2004).
1.5.2. Intracellular signalling and the regulation of neuronal
survival in the developing nervous system
The survival of any cell depends on a "decision" at the intracellular level as to
whether the intrinsic apoptotic program will be executed. Thus, proteins that promote
cell survival activate intracellular signalling pathways that alter the balance of the
pro- and anti-apoptotic cellular machinery to support survival. A number of
intracellular signalling pathways have been implicated in this effect in a variety of
systems, the principal of which is the PI3K/Akt pathway. PI3K and Akt (also called
protein kinase B) are two proteins that together form part of a major pathway that
regulates neuronal survival using both transcription-dependent and independent
mechanisms (Brunet et al., 2001; Datta et al., 1999). Neurotrophic factors, such as
neurotrophins and cytokines, on activating their receptors, recruit PI3K to the plasma
membrane, where it catalyses the production of phosphoinositide phosphates PIP2
and PIP3 (Alonzi et al., 2001; Crowder and Freeman, 1998; Hetman et al., 1999;
Kuruvilla et al., 2000; Nishimune et al., 2000). This results in the recruitment and
activation of a number of serine/threonine kinases, including Akt. In neurons, the
role of Akt in survival is well established (Crowder and Freeman, 1998; Dudek et al.,
1997; Eves et al., 1998; Philpott et al., 1997), however that of PI3K is more
controversial. There have been several reports that inactivation of PI3K interferes
with NGF-induced neuronal survival, particularly in sympathetic neurons (Crowder
and Freeman, 1998; Hetman et al., 1999; Kuruvilla et al., 2000; Mazzoni et al., 1999;
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Vaillant et al., 1999; Yao and Cooper, 1995). However, other studies suggest that
PI3K has only a modest role in survival (Philpott et al., 1997; Tsui-Pierchala et al.,
2000; Virdee et al., 1999). One possible explanation for these ambiguous results is
that the approach most commonly taken in such studies is the use of dominant
negative constructs. This approach, unfortunately, also runs the risk of interfering
with the function of other proteins downstream of the PI3K, several of which may
themselves be implicated in regulating cell survival (Brunet et al., 2001).
Alternatively, certain neuronal populations may require cooperation with other
intracellular signalling pathways to promote the full survival effect of a particular
neurotrophic factor (Datta et al., 2000; Lizcano et al., 2000; Pierchala et al., 2004;
Shaywitz and Greenberg, 1999; Virdee et al., 2000)
The consequences of Akt phosphorylation are varied. Akt is capable of regulating
transcription factors of several classes, for example members of the Forkhead family,
NFkB and cAMP-responsive element binding protein (CREB) (Biggs, III et al.,
1999; Brunet et al., 1999; Du and Montminy, 1998; Gustin et al., 2004; Kane et al.,
1999; Kane et al., 2002; Kops et al., 1999; Kops and Burgering, 1999; Ozes et al.,
1999; Romashkova and Makarov, 1999). The forkhead family of transcription factors
regulates the expression of pro-apoptotic proteins, such as FasL, and phosphorylation
of these factors by Akt inhibits their function (Biggs, III et al., 1999; Brunet et al.,
1999; Kops and Burgering, 1999). In contrast, NFkB and CREB are activated
through Akt phosphorylation and can cause the transcription of anti-apoptotic
proteins such as Bcl-xL and Bcl-2 (Chen et al., 2000; Riccio et al., 1999) as well as
additional neurotrophin expression (Tao et al., 1998). Akt can also directly
manipulate the apoptotic machinery, for example by phosphorylating Bad, thus
preventing it from inactivating both Bcl2 and Bcl-xL (Datta et al., 1997; Del Peso et
al., 1997; Zha et al., 1996) and may act to indirectly promote cell survival by
regulating cellular metabolism (Brunet et al., 2001).
Cytokines commonly activate members of the signal transducer and activator of
transcription (STAT) family of transcription factors to promote cell survival (Hirano
et al., 2000). In the nervous system, STAT-3 has been reported to mediate CNTF-
induced survival in nodose neurons (Alonzi et al., 2001). Indeed Nishimune et al
47
Chapter 1
(2000) proposed the STAT-3 and PI3K/Akt signalling were inextricably linked in
promoting CNTF-induced motoneuron survival, where STAT-3 induction by
cytokines led to the production of Reg-2. In these neurons, Reg-2 subsequently acts
as an obligatory autocrine or paracrine trophic factor via PI3K and Akt. Akt
activation by cytokines is also dependent on functional STAT-3 in nodose neurons
(Alonzi et ah, 2001). In this case Akt appears to promote survival through the
activation of NFkB as interference with NFkB signalling also prevents CNTF-
induced neuronal survival (Middleton et ah, 2000; Nishimune et ah, 2000). STAT-3
may also function by directly manipulating the apoptotic machinery as it is capable
of inducing anti-apoptotic proteins BAX and Bcl-xL in lymphocyte and myeloid and
fibroblast cell lines respectively (Catlett-Falcone et ah, 1999; Fukada et ah, 1996;
Kami et ah, 1999), thus mediating survival induced by granulocyte colony
stimulating factor (G-CSF) in the myeloid cell line (de Koning et ah, 2000)and by
interleukin-6 (IL-6) in lymphocyte and hepatoma cell lines (Chen et ah, 1999;
Fukada et ah, 1996).
Three MAPK cascades, converging on extracellular-regulated kinase (ERK), c-Jun
N-terminal kinase (JNK) and p38 MAPK, have been implicated in regulating cell
survival in the nervous system. The ERK cascade is generally associated with cell
survival promoted by neurotrophic factors, while the JNK and p38 cascades are
mainly activated in situations involving external stresses such as radiation or pro¬
inflammatory cytokines (Tibbies and Woodgett, 1999). Activation of the ERK
cascade is anti-apoptotic, while JNK and p38 are pro-apoptotic, with mice lacking
JNK genes showing reduced neuronal apoptosis to noxious stimuli and during
development (Cheung and Slack, 2004; Harper and LoGrasso, 2001; Kuan et ah,
1999). The classical ERK cascade begins with the recruitment of the low molecular
weight G-protein Ras to receptors such as Trks. This results in the sequential
activation of Raf, MEK1/2, ERK1/2 and RSK (ribosomal S6 kinase). RSK can then
perform a number of functions, including inhibiting the pro-apoptotic protein BAD
or activating CREB (Bonni et ah, 1999; Finkbeiner, 2000; Shimamura et ah, 2000).
MEK/ERK, in some case though CREB, can regulate the transcription of a number
of anti-apoptotic genes including Bcl-2, Bcl-xL, Mcl-1 and those of survival factors
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such as BDNF itself (Ballif and Blenis, 2001; Boucher et ah, 2000; Huang et ah,
2000a; Jost et ah, 2001; Leu et ah, 2000; Pugazhenthi et ah, 1999; Riccio et ah,
1999; Tao et ah, 1998). NGF-dependent survival of sympathetic neurons has been
shown to be partially dependent on CREB (Riccio et ah, 1999). In the peripheral
nervous system, the importance of ERK signalling in neurotrophic factor-induced
neuronal survival varies. Neuronal survival through TrkB has been found to be
partially dependent on MEK (Atwal et ah, 2000), however NGF-induced neuronal
survival in sympathetic and DRG neurons is independent of ERK1/2 (Creedon et ah,
1996; Klesse and Parada, 1998; Virdee and Tolkovsky, 1996). Several points of
crosstalk between PI3K and ERK signalling cascades have been identified. PI3K can
both negatively and positively regulating the activities of Ras, Raf and MEK,
depending on the signalling context and 3'-phosphoinositide-dependent protein
kinase (PDK), and Akt, kinases downstream of PI3K can activate RSK and CREB
respectively (Finkbeiner, 2000; Guan et ah, 2000; King et ah, 1997; Rommel et ah,
1999; Wennstrom and Downward, 1999; York et ah, 2000; Zimmermann and
Moelling, 1999) and in DRG neurons, York et ah (2000) showed that ERK activation
by NGF requires PDK.
1.5.3. Intracellular signalling and regulation of neurite outgrowth
by neurotrophic factors in the developing peripheral nervous
system
Several different intracellular signalling pathways and second messenger systems
have been implicated in regulating axonal growth and the establishment of
innervation in the nervous system. As axonal outgrowth is typically regulated by
neurotrophic factors, electrical activity and extracellular matrix proteins, the
pathways studied with respect to neurite outgrowth are pathways typical of those
activated by such stimuli. These pathways include calcium- and cyclic nucleotide-
based pathways, as well as those using protein kinases and phosphatases (Keith and
Wilson, 2001). Again, in this section I will discuss only the signalling pathways
relevant to neurotrophic factor-induced neurite outgrowth.
One of the most widely studied pathways implicated in neurotrophic factor-induced
neurite outgrowth is the Ras-activated Raf-Mek-Erk cascade. NGF, BDNF and NT-4
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can activate the ERK pathway in a range of embryonic and adult neurons and in
some cases this activation is localised to the axonal compartment, and not the cell
body (Becker et ah, 1998; Cowley et ah, 1994; Howe et ah, 2001; Minichiello et ah,
1998; Sjogreen et ah, 2000; Susen et ah, 1999; Svensson and Ekstrom, 1998). In the
peripheral nervous system, sympathetic neurons have been shown to require
functional ERK signalling, as well as PI3K or calcium signalling pathways in order
to elicit normal neurite outgrowth in response to BDNF or NGF respectively (Atwal
et ah, 2000; Svensson and Ekstrom, 1998; Vaillant et ah, 2002) and sensory neurons
of the DRG require Ras, Raf and Mek, as well as PI3K for NGF-induced axonal
growth (Liu and Snider, 2001; Markus et ah, 2002a; Markus et ah, 2002b; Sjogreen
et ah, 2000) Outgrowth in adult nodose neurons, induced by NT-4/5, is also
dependent on MEK activation, as well as PKA (Wiklund and Ekstrom, 2000).
Activation of this MAP kinase pathway alone may be sufficient to support axonal
growth in some neurons. Gain of function studies in PC12 cells, as well as in bax
null DRG neurons, show that transfection with activated forms of Ras, C-Raf or Erk2
in the absence of trophic support is capable of inducing robust neurite extension
equivalent to that of NGF (Markus et ah, 2002b; Robinson et ah, 1998). Targets of
Erkl and Erk2 that may mediate effects on neurite outgrowth include MAP2 and tau,
which have also been shown to be downstream targets of neurotrophins (Vaillant et
ah, 2002). Phosphorylation ofMAP2 induces increased association with, and
consequently stabilisation of, microtubules (Brugg and Matus, 1991; Jameson and
Caplow, 1981; Sanchez et ah, 2000a; Vaillant et ah, 2002).
PI3K has also been implicated in neurite outgrowth in neurons stimulated by
neurotrophins (Liu and Snider, 2001). One mechanism through which PI3K could
affect neurite outgrowth is by regulating the activation of Erk via Ras and Rapl
(York et ah, 2000). The downstream target of PI3K, Akt, has also been implicated in
regulating axon calibre and branching in NGF-stimulated DRG neurons (Markus et
ah, 2002b). Indeed in adult DRG neurons, NGF and insulin-like growth factor-1
(IGF-1) act in a synergistic manner to promote neurite outgrowth through PI3K, Akt
and GSK-3, a pathway that was found to be more important in regulating neurite
outgrowth than MAP kinase signalling (Jones et ah, 2003). GSK-3 can phosphorylate
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MAP2C and consequently regulate the stability of microtubules (Sanchez et ah,
2000b). PI3K could also activate Racl. Rac proteins have a number of targets that
can modulate the cytoskeleton (Lundquist, 2003; Miller and Kaplan, 2003; Yasui et
al., 2001). Pakl stimulates LIM kinase activity, which can then inhibit cofilin, an
actin-depolymerising protein to modulate dendritic growth (Lundquist, 2003).
Another downstream target of Racl, JNK1 has also been shown to be important in
maintaining dendritic microtubules (Chang et ah, 2003).
Calcium-dependent signalling pathways are predominantly involved in mediating
activity-induced neurite outgrowth (Lohmann et ah, 2002; Miller and Kaplan, 2003;
Redmond et ah, 2002; Vaillant et ah, 2002). Calcium-activated proteins such as
calcium/calmodulin dependent kinase (CAMKII) phosphorylate MAP2 thus causing
stabilisation of dendritic microtubules (Sanchez et ah, 2000b; Sanchez et ah, 2000a;
Vaillant et ah, 2002; Wu and Cline, 1998). Interestingly, CAMKII has also been
reported to limit axonal and dendritic arbour elaboration during the maturation
process (Zou and Cline, 1999). Most recently Fink et ah (2003) reported that it is the
CaMKII(3 isoform that can regulate dendritic morphology in hippocampal neurons
and Gaudilliere et ah (2004) reported that CaMKII regulates activity-dependent
changes in dendritic morphology in cerebellar granule cells through the transcription
factor NeuroD. Activity-dependent changes in calcium levels can also act to promote
neurite outgrowth through the CaMKIV-CREB pathway (Redmond et ah, 2002).
Activity-dependent outgrowth also requires the Ras-MEK-Erk pathway, and it has
been proposed that neurotrophin- and activity-dependent signalling of dendritic
outgrowth converge on both the Ras-MEK-ERK- and calcium-dependent signalling
pathways (Vaillant et ah, 2002). Neurotrophins activate both CaMKII and CaMKIV
through PLCy activation, which stimulates calcium ion release from intracellular
stores and are implicated in neurotrophin-induced neurite outgrowth in some
circumstances (He et ah, 2000; Kaplan and Miller, 2000; Minichiello et ah, 2002;
Vaillant et ah, 2002). Neurotrophins can also directly initiate membrane




Several additional proteins have been implicated in regulating neurite outgrowth in
certain circumstances. Neurite outgrowth in adult nodose neurons stimulated by NT-
4/5 can also be inhibited by blocking PKA or PKC signalling (Wiklund and Ekstrom,
2000) and PKC has also been implicated in axonal growth and neurite initiation in
hippocampal neurons (Cabell and Audesirk, 1993), although NGF-stimulated
outgrowth in embryonic DRG neurons is not affected by inhibition of PKC (Liu and
Snider, 2001).
Novel interactions between neurotrophin receptors and other intracellular
components that regulate neurite outgrowth are being discovered. Recently the p75
neurotrophin receptor has been found to interact directly with the RhoA protein
(Yamashita et ah, 1999). RhoA is a member of the Ras family of GTP-binding
proteins that is known to regulate the organisation of the actin cytoskeleton in a
range of cell types (Mackay and Hall, 1998). The actions of Rho are thought to
oppose the actions of Rac, mentioned earlier in the context of PI3K, and cdc42, two
proteins that positively regulate actin-dependent growth(Etienne-Manneville and
Hall, 2002). p75 constitutively activates RhoA by acting as a displacement factor,
releasing RhoA from a complex with Rho-GDP dissociation inhibitor (Rho-GDI)
(Yamashita and Tohyama, 2003). Inactivating RhoA, by overexpressing a RhoA
inactivating protein C3 transferase or a dominant negative construct enhanced neurite
outgrowth whereas overexpression of a constitutively active RhoA blocks
neurotrophin-induced neurite growth in trigeminal or ciliary neurons (Davies, 2000b;
Ozdinler and Erzurumlu, 2001; Yamashita et al., 1999). Neurotrophin binding to p75
blocks constitutive RhoA activation (Yamashita et al., 1999). RhoA mediation of
neuritic growth depends on Rho-associated kinase (ROK), as ROK inhibition blocks
the actions of constitutively active RhoA in hippocampal neurons and activated ROK
also limits dendritic length (Nakayama et al., 2000). ROK is thought to act by
controlling the phosphorylation of myosin light chains and actomyosin contractility
(Hirose et al., 1998; Kimura et al., 1996; Winter et al., 2001). RhoA and ROK also
mediate the effects of electrical activity withdrawal on neurite outgrowth (Nakayama
et al., 2000; Sin et al., 2002). In that situation, ROK has been reported to act through
lim kinase (LIMK) which can activate cofilin, an actin depolymerisation factor
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(Etienne-Manneville and Hall, 2002; Meng et al., 2002; Meyer and Feldman, 2002).
As RhoA has been implicated in dendritic, rather than axonal, development in a
number of neuronal types this might prove to be a mechanism through which
neurotrophins influence dendritic rather than axonal morphology (Lee et ah, 2000; Li
et ah, 2000; Nakayama et ah, 2000; Ruchhoeft et ah, 1999; Wong et ah, 2000).
So far I have principally described the ways in which trophic factor stimulation,
particularly using neurotrophins, can influence cytoskeletal dynamics to alter normal
axonal and dendritic growth in a transcription independent manner. Changes in gene
transcription through specific transcription factor activation have also been
implicated in affecting neurite outgrowth. CREB is one such factor. CREB can be
activated through Ras/ERK signalling and in sympathetic and sensory neurons is
phosphorylated in response to NGF exposure (Lonze and Ginty, 2002; Xing et ah,
1996). Although sensory neurons undergo apoptosis by E17.5 in CREB 7 mice, at
E13.5 a normal number complement of neurons are present and early axonal defects
are seen. Similar axonal defects are seen at a later age in the CREB 7 /Bax 7 mutant,
in which neuronal survival is rescued (Lonze et ah, 2002). In vitro, dominant-
negative CREB constructs also inhibit neurite outgrowth of cortical neurons
(Redmond et ah, 2002). Axon targeting in DRG neurons in response to NT-3 has also
been shown to be transcription dependent. Expression of transcription factor ER81 in
these neurons is dependent on NT-3 and its expression abolished if the target field is
removed from the developing embryo (Lin et ah, 1998a). In mice lacking Er81, the
central projection of DRG neurons does not extend further than the intermediate zone
(Arber et ah, 2000). Finally, as mentioned earlier, CaMKII activates NeuroD to





NFkB signalling regulates neurite outgrowth in peripheral
sensory neurons
2.1. Introduction
Nuclear factor kB (NFkB) is a ubiquitously expressed transcription factor that
regulates the expression of many different proteins involved in a variety of cellular
processes, including innate and adaptive immune responses, stress responses, cell
survival, proliferation and differentiation (Baldwin, Jr., 1996; Karin and Lin, 2002;
Li and Stark, 2002). It consists of homo- and heterodimers of any of p65 (Rel A),
RelB, c-Rel, p50 or p52 proteins, although it is the p50/p65 heterodimer that is
predominant in most cells types, and which is commonly referred to simply as NFkB
(Karin and Lin, 2002; Li and Verma, 2002). Active NFkB dimers are detected
principally in the nucleus, while, in the majority of cell types, the basal condition is
for these dimers to be held inactive in the cytosol through their interaction with
inhibitory proteins of the IkB family. This family consists of 7 family members:
IkBci, IkB(3, IkBs, IkBy, Bcl-3, as well as plOO and pl05, the precursor proteins for
p52 and p50 respectively (Hayden and Ghosh, 2004; Yamamoto and Gaynor, 2004).
It is the degradation of these inhibitory proteins by the proteosome, induced by their
phosphorylation and subsequent ubiquitination and usually occurring as a
consequence of the binding of an extracellular signalling molecule, that reveals the
NFkB nuclear localisation sequence and allows its translocation to the nucleus. The
degradation of these inhibitory proteins also reveals phosphorylation sites whose
state can influence the transcriptional activation ability of NFkB (Li and Stark, 2002;
Sizemore et ah, 1999; Wang et ah, 2000; Zhong et ah, 1997; Zhong et ah, 1998).
Once located in the nucleus, NFkB binds to the promoter and enhancer regions of
genes containing kB consensus sequences, thus influencing gene transcription
(Baldwin, Jr., 1996; Karin, 1999).
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NFkB expression is found throughout the central and peripheral nervous systems, in
both neuronal and non-neuronal cells (Bhakar et ah, 2002; Maggirwar et ah, 1998;
Nickols et ah, 2003; O'Neill and Kaltschmidt, 1997). The ways in which NFkB
influences cells in the nervous system are still being defined, with NFkB being
implicated in the signalling pathways of a growing number of extracellular signals,
including neurotrophic factors, cytokines and neurotransmitters (Carteret ah, 1996a;
Digicaylioglu and Lipton, 2001; Guerrini et ah, 1995; Hamanoue et ah, 1999;
Kaltschmidt et ah, 1995; Nishimune et ah, 2000; Yalcin et ah, 2003). NFkB has been
found to promote the neuronal survival both during development (Bhakar et ah,
2002; Hamanoue et ah, 1999; Maggirwar et ah, 1998) and after a wide range of toxic
insults (Bargeret ah, 1995; Daily et ah, 2001; Digicaylioglu and Lipton, 2001;
Fridmacher et ah, 2003; Lipsky et ah, 2001; Mattson et ah, 2000; Piccioli et ah,
2001; Tamatani et ah, 2000; Yu et ah, 2000). In some circumstances, however, it has
also been implicated in promoting neuronal death (Pizzi et ah, 2002; Post et ah,
1998; Schneider et ah, 1999; Shou et ah, 2002; Uberti et ah, 2000). In cerebellar
granule cells and hippocampal neurons, at least, this difference has been attributed to
activation of different NFkB subunits, and manipulation of the expression of these
subunits has been sufficient to convert positive effects on survival into negative ones
(Pizzi et ah, 2002). NFkB is also involved in the adaptations that occur in response to
inflammatory conditions and neurodegenerative disease (Bhakar et ah, 2002;
Blondeau et ah, 2001; Clemens et ah, 1997; Fridmacher et ah, 2003; Gabriel et ah,
1999; Gentry et ah, 2000; Grilli and Memo, 1999; Mattson el ah, 2000) and in non-
neuronal cells NFkB also participates in peripheral nerve myelination (Nickols et ah.
2003).
An additional role for NFkB in processes related to learning and memory has
recently emerged. N-methyl-d-aspartate receptor activation by glutamate, in
hippocampal neurons and cerebellar granule cells stimulates nuclear translocation of
NFkB (Guerrini et ah, 1995; Scholzke et ah, 2003), and interruption of NFkB-
induced transcriptional activation, using kB decoy DNA, interferes with both long-
term potentiation and long-term depression in hippocampal slice cultures (Albensi
and Mattson, 2000). That these changes are physiologically relevant is indicated by
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interference with NFkB, either pharmacologically or through transgenic technology,
preventing memory formation in the crab, interfering with spatial learning in mice
and inhibiting fear conditioning in rats (Meffert et al., 2003; Merlo et al., 2002; Yeh
et al., 2002). One important physiological alteration that is associated with the
adaptive changes involved in learning and memory is synaptic remodelling, where
certain terminal branches extend and retract as a consequence of inputs to the
neurons from a combination of synaptic activity and retrograde signalling by either
neurotransmitters or neurotrophic factors (Balderas et al., 2004; Tyler et al., 2002;
Vicario-Abejon et al., 2002). This process is thought to be mediated by events that,
to a certain extent, reiterate the processes that determine neuronal morphology during
development (Arendt, 2003; Keith and Wilson, 2001; Lang et al., 2004; Reuss and
Halbach, 2003; Zhou et al., 2004b). This prompted us to question whether NFkB
could also be involved in neuronal process growth, elaboration and modification
during development.
In order to investigate the role of NFkB in neurite outgrowth during development 1
studied neurite outgrowth from neurons of the nodose ganglion. The nodose ganglion
is a well-defined population of peripheral neurons that have been well characterised
both in vitro and in vivo, and cultures of these neurons can be easily established and
maintained in vitro in the presence of BDNF (Davies et al., 1993). Unlike other
populations of peripheral neurons, such as those of the SCG or trigeminal ganglion,
no link has been described between NFkB signalling and survival in these neurons
(Hamanoue et al., 1999; Maggirwar et al., 1998), a dissociation confirmed by the
experiments shown in this chapter, making them ideal for studying outgrowth
without the confounding effects of changes in neuronal survival. These studies show
that preventing NFkB activation by interfering with IkBci degradation or inhibiting
the transcriptional activity of NFkB reduces both the overall length and the
complexity of nodose neurons. This effect is limited to a distinct developmental
window between E18 and PI.
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2.2. Materials and Methods
2.2.1. Neuronal culture
Dissociated cultures of nodose ganglion neurons were set up from embryos and early
postnatal mice obtained from overnight matings of CD1 mice. The dissected ganglia
were trypsinized and dissociated by trituration and the neurons plated in defined
serum-free medium, on a polyomithine/laminin substratum, in 35mm tissue culture
dishes (Davies et al., 1993).
The murine nodose ganglia are situated just below the base of the skull, close to the
jugular foramen (see fig 2.1). Embryonic mice were removed, following cervical
dislocation of the pregnant mother, decapitated and the heads collected in Leibowitz-
15 medium (L-15) without sodium bicarbonate. Postnatal mice were killed by carbon
dioxide asphyxiation, followed by decapitation. The top of the skull and the forebrain
were removed and the head was bisected in the sagittal plane. The jugular foramen
was then exposed by removal of the hindbrain and opened as shown in figure 2.1,
revealing the nodose and superior cervical sympathetic (SCG) ganglia underneath.
The nodose ganglion is a distinctive spherical structure with a prominent vagus nerve
coming from is distal aspect. The SCG is elongated and lies lower down, attached to
the thinner sympathetic chain. The nodose ganglion was removed from the head by
grasping the base of the vagus nerve, and then cleaned of all nerve and connective
tissue using tungsten needles. All dissections were performed in a laminar flow hood,
using a stereomicroscope and a fibre-optic light source to prevent overheating of the
tissue. Dissection instruments were sterilised by flaming in alcohol. Tungsten
needles were produced by electrolytically sharpening tungsten wire (0.5mm
diameter) in 1M KOH. The needles were held in chuck-grip platinum wire holders
(Davies, 1988).
Dissected ganglia were trypsinized by incubation in 0.1% trypsin in calcium and
magnesium free Hanks balanced salt solution (CMF-HBSS; GibcoBRL) for between
15 and 25 minutes at 37°C, washed in Ham's F12 medium (GibcoBRF)
supplemented with 10% heat-inactivated horse serum (HIHS; GibcoBRL) so as to
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Figure 2.1 Dissection of the nodose ganglia
This diagram shows the medial aspect of half of the head of an E14 mouse embryo at two stages of
dissection. The shaded area represents the bisected midline structures. A) An incision is made from
the jugular foramen (J) to the midline is made (dotted line) and the occipital bone reflected in the
direction of the arrow to open the jugular foramen. B) the nodose (N) and superior cervical ganglion
(S) are revealed underneath. (T- tongue, ACF-anterior cranial fossa, IE-inner ear, R-root of the
trigeminal nerve) From Davies, 1995.
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stop trypsin activity. The ganglia were transferred into defined, serum-free medium
(F-14 medium supplemented with 2mM L-glutamine and SATO supplement
(composition in appendix) and dissociated by trituration using a fire-polished
siliconized Pasteur pipette. The neurons were plated on 35mm tissue culture dishes
prepared by overnight incubation with polyomithine (0.5mg/ml poly-DL-omithine
hydrobromide, Sigma in 0.15M borate buffer, pH 8.4) at room temperature, the
dishes were washed, dried and then incubated for 3 hours with laminin (20pg/ml in
CMF-HBSS, Sigma) at 37°C.
Different density cultures were required for different experiments. Ballistic
transfection requires an initially high neuronal density in order to achieve
transfection of sufficient numbers of neurons, whereas the cultures established from
transgenic mice or for use with pharmacological inhibitors need to be low density so
that the neuritic arbour of individual neurons can be distinguished.
If the culture was destined for ballistic transfection, the substratum was prepared by
placing 50pl of laminin in a droplet in the centre of the dish. Neurons were then
plated by replacing the laminin with a 50pl droplet of the cell suspension in
supplemented F14 (as described earlier) containing 1000-3000 neurons. For cultures
that were to be treated with pharmacological inhibitors, 80pil of laminin was added to
the centre of the dish and spread over a circular area covering three quarters of the
35mm dish. 1ml of cell suspension was then plated directly into 1ml of supplemented
F-14 medium to give a final density of 500-1000 neurons per dish. In both cases, the
dishes were incubated at 37.5°C in a humidified 3.5% CCF incubator for 3-4 hours to
allow the cells to attach. Neurotrophic factor (BDNF, R and D, lOng/ml) was added
after either ballistic transfection or an initial cell count followed by a pre-incubation
of 45 minutes with the relevant pharmacological inhibitor.
2.2.2. Genotyping transgenic mice
IKK-a knockout embryos were generated by mating mice heterozygous for null
mutations in the IKK-a gene (Hu et ah, 1999; Takeda et ah, 1999). Pregnant females
were killed at embryonic day 18 just before the age at which embryos were found to
die in utero, and tissue samples for genotyping collected from each embryo
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immediately prior to dissection of the ganglia of interest. DNA was extracted using
the FastDNA kit (Qbiogene, UK) following the manufacturers instructions. Briefly,
the tissue was homogenised and the cells were lysed in the supplied lysing matrix
and buffer. The supernatant was removed and incubated with DNA binding matrix,
which was then washed using an ethanol-based solution and the DNA eluted using
ultra-pure water. Polymerase chain reaction (PCR) was used to ascertain the
genotype of each embryo. For IKKa null, heterozygous and wildtype mice, four
primers were used in the amplification, giving a 400bp product for the wildtype
allele (5'-ACA ATA CAT AAA ATA ATT GAT-3' and 5'-TGA AAT GTT TCC
ACT ACC ATT-3') and a 600bp product for the null allele (5'-CAA CAT TAA ATC
TCA GCG AG-3' and 5'-GGA ACA TTG CAG TAT TTG G-3'), which were
separated on a 2% agarose gel and visualised using ethidium bromide.
The PCR reaction was prepared using a reaction master mix of a volume appropriate
to the number of embryos (see appendix for composition). For each embryo the PCR
reaction was carried out in duplicate and positive (known heterozygote DNA) and
negative (DNA-free) control used. Each reaction was performed in a 20pl reaction
volume, in a 500pl microfuge tube and layered with mineral oil to prevent
evaporation during cycling. An initial denaturation step of 15mins at 95°C was
followed by 35 cycles consisting of a 40 second denaturation at 95°C, primer
annealing at 55°C for lmin and extension at 72°C for lmin. An additional final
extension phase of lOmins at 72°C was used.
2.2.3. Ballistic transfection
Particle mediated gene transfer, or ballistic transfection, has been shown to be an
effective way of transferring genes into neurons (Gutierrez et al., 2004; Sole et al.,
2004). Compared to other methods of gene transfer, such as viral vectors, chemical
methods, such as lipofection, or microinjection, it is quick, non-toxic and causes no
interference with global gene expression. The process of ballistic transfection
consists of three steps (Figure 2.2A). First the DNA is coated onto inert
microcarriers, and then these particles transferred onto a macrocarrier, such as Teflon
tubing, for loading into the gene gun. The final step is to inject the target cells with
60
Chapter 2
the microcarriers using a motive force such as high-pressure helium. In the
experiments reported in this thesis, a hand-held gene gun (Helios Gene-Gun, Byroad,
Hercules, CA USA) was used in conjunction with a gold microcarrier as described in
(Gutierrez et al., 2004).
2.2.3.1. Preparation of gold particle cartridges
Gold particles were prepared using the manufacturers protocol. 20mg of 1.6pm gold
particles were suspended in lOOpl of spermidine (50mM) plus 20pg of pYFP
(Clontech) and either the plasmid of interest, such as pSR-lKB-a, or a pCDNA
control plasmid for 15 minutes. The DNA-coated gold particles were precipitated
with lOOpl of 2M CaCl?, washed with 100% ethanol (3 washes) and resuspended in
1.2 ml of 100% ethanol plus 0.01 mg/ml polyvinylpirrolidone. The interior wall of
Teflon tubing was coated with this mixture. The tubing was dried using nitrogen gas
and cut into cartridges.
kB decoy DNA was prepared by annealing complimentary single-stranded
oligonucleotides (5'-GAGGGGACTTTCCCT-3' and 5'-AGGGAAAGTCCCCTC-
3') containing a k-B DNA binding sequence previously been described as effectively
knocking down NFkB dependent gene expression in neurons (Yeh et al., 2002).
Control DNA with a scrambled sequence was also prepared by annealing
oligonucleotides of the following sequence: 5'-GATGCGTCTGTCGCA-3' and 5'-
TGCGACAGACGCACT-3'. Double stranded DNA solutions were prepared at
50mM, and were ethanol precipitated onto the gold particles in addition to the pYFP
marker plasmid.
'
Figure 2.2 Ballistic transfection
A) Schematic diagram showing the process of ballistic transfection. Plasmid DNA is coated onto inert
microcarriers (1.6pm gold particles; a) that are subsequently loaded onto a macrocarrier (teflon
tubing; b) for insertion into the gene gun (c). Culture medium is then removed from the previously
prepared culture of nodose neurons (d) and the DNA-coated microcarriers transferred into the cells
using high pressure helium as a motive force (e). Culture medium is the replaced, this time containing
the required trophic factors (f). B) Photomicrographs showing neonatal neurons expressing pYFP as a
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2.2.3.2. Neuronal transfection using the gene-gun
Neurons were transfected using the gene-gun three hours after plating, by which time
the cells were securely attached to the dish. Immediately prior to transfection the
culture medium was removed from the dish and the gold particles were shot into the
cultured neurons with the gun pressurized at 140psi. The gun was held approximately
3cm above the dish, and a 70pm nylon mesh screen placed between the gun and the
culture to prevent the cells being damaged by the shock wave. After transfection 2ml
of supplemented F14 with or without lOng/ml BDNF were added to each dish.
Figure 2.2B shows a culture transfected with a YFP reporter plasmid (pYFP,
Clontech), visualised using both bright field and filtered light. Neuron cell bodies
and gold particles (small black dots) can be seen by bright field optics (top left). The
top right panel shows the same field at lower intensity bright field, superimposed
with the YFP fluorescent image. Another pair of cells is shown in the bottom left
panel. The bottom right panel shows a single YFP positive neuron under filtered light
alone, where the neuritic arbour can be seen in addition to the cell body.
In addition to the YFP (pYFP, Clontech) and RFP (pDSred2, Clontech) reporter
plasmid the following plasmids were used: Super-repressor IkBoi expression plasmid
(pCDNAIII, S32A/S36A mutation, Rodriguez et cil., 1996), p65 expression plasmid
(pCDNAIII, human wild-type p65, Rodriguez et cil., 1996), NIK wildtype
(pCDNAIII, human, gifted by R.T.IIay, St. Andrews University) and mutant
expression plasmids (pCDNAIII, K429A/K430A mutation, gifted by R.T.Hay, St.
Andrews University), and an p50-p65 promoter-controlled GFP expression plasmid
(Gifted by J. Cornelia, University of Llieda).
2.2.4. Quantification of fluorescence
Quantification of neuronal fluorescence was performed to estimate the relative level
of NFkB activation in neurons transfected with a plasmid expressing GFP under the
control of an NFkB promoter. Neurons were transfected with this plasmid along with
pRFP, to allow the identification of transfected cells, incubated for 24h with or
without BDNF (20ng/ml) and subsequently imaged with a Zeiss Axioplan laser
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scanning confocal microscope. The mean intensity of fluorescence of each cell body
was obtained using the LSM510 software and the standard 255 intensity scale after
subtraction of the background intensity. In each experimental condition all imaging
and quantification was performed blind. 40-60 neurons were assessed per condition
and statistical comparisons were performed using ANOVA followed by Fishers'
post-hoc test. The results shown are from a single experiment that is representative of
the results seen in three separate experiments. In all experiments reporter gene
expression was also analysed ratiometrically, that is by expressing the level of GFP
fluorescence of each cell relative to the level of RFP fluoresence. In all cases this
analysis showed the same changes as those seen with GFP fluorescence alone, and is
therefore not presented.
2.2.5. Estimating neuronal survival
Estimates of neuronal survival in cultures treated with pharmacological inhibitors
were obtained by counting the number of neurons surviving after 24 hours in culture
using phase-contrast microscopy, as compared to an initial count just prior to
addition of the relevant inhibitor. Two hours after plating the number of neurons
present in a 12 x 12mm grid in the centre of the dish was counted. Immediately after
this count, the pharmacological inhibitor or control compound was added to the
culture medium, followed, after 45 min, by the addition of BDNF (10 ng/ml) to half
the dishes in each condition. A second count was performed 24h after the addition of
inhibitor, directly before the cells were fixed for immunocytochemistry. The number
of neurons surviving at 24h is expressed as a percentage of the initial number of
neurons.
Estimates of neuronal survival in cultures transfected using the gene gun were
performed differently. These were obtained by counting the number of YFP-labelled
neurons surviving 48 hours after transfection. This count was then expressed as a
percentage of the number of labelled neurons counted 12 hours after transfection, the
earliest time point at which all the cells expressing YFP can be reliably seen. Each
cell was also examined using phase-contrast conditions to corroborate cell survival.
The area counted was defined by the area of each culture dish in which gold particles
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were seen to be embedded. Despite the initial neuronal count in this method being
earned at 12 hours after transfection, this method of quantifying neuronal survival is
unlikely to miss the death of significant numbers of nodose neurons, as this particular
population of neurons, unlike neurons of the superior cervical ganglia, have a slow
rate of death even in the absence of trophic factors (26% death at 12h, compared to
97% death at 12h in SCG). In all cultures, this has been confirmed by examining the
absolute counts of transfected neurons after 12 and 48 hours, and none of which
reveal significant differences in absolute cell numbers in BDNF-treated transfected
and untransfected neurons.
For the survival data presented in figure 2.7, the percentage survival for each dish is
then expressed as a percentage of the mean survival of the BDNF-treated control-
transfected group, and statistical comparisons performed using ANOVA followed by
Fishers' post-hoc test. Triplicate cultures were set up for all conditions and the data
shown is compiled from 2-4 separate experiments for each age.
2.2.6. Analysis of neurite outgrowth
Analysis of neurite outgrowth was performed on images acquired digitally using an
Axioplan Zeiss laser-scanning confocal microscope. Images of transfected, YFP-
labelled neurons were of live neurons that could be visualized directly, while cultures
treated with pharmacological inhibitors were first fixed and fluorescently labelled for
the neuronal-specific marker |3-III tubulin. For this cells were washed twice with PBS
and fixed for 10 min in 4% paraformaldehyde in PBS at 37°C. Immunocytochemistry
was performed by first permeabilising the cells with 0.1% Triton X-100 in PBS for
30 min (room temperature), followed by a lhour block using 5% bovine serum
albumin in PBS. The cells were incubated with anti-pill tubulin antibodies (1:1000,
Promega) overnight at 4°C, washed three times in PBS and incubated with FITC-
labelled rabbit anti-mouse IgG secondary antibody (Molecular Probes Inc, Eugene,
OR, USA) for 2h30 at room temperature.
The neuritic arbours of 60 to 90 neurons were imaged and neurite morphology
assessed using three different analyses. Total neurite length was assessed by counting
the number of coloured pixels per neuron, using skeletonised neurons, and adjusted
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by the number of pixels in a bar of known length, while the total number of branch
points were counted manually. In addition to these basic analyses, the Sholl analysis
was also used to gain a more detailed quantification of neuronal morphology (Sholl,
1953). For this analysis, computer-generated concentric rings 30 pm apart were
superimposed on the image, centred on the cell soma (figure 2.3A). The number of
neurites intersecting each ring was then counted. An example of the additional
information that can be gained by such an analysis can be seen in figure 2.3B. The
two theoretical arbors are of the same total neurite length and have the same number
of branch points, but have very different morphologies. These differences are visible
in the Sholl analysis. In each experimental condition all imaging and quantification
was performed blind. The data shown for each analysis is from a single experiment
that is representative of the results obtained in three separate experiments. Statistical
analysis was performed using ANOVA followed by Fishers' post-hoc test.
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Figure 2.3 Sholl analysis
A) Photomicrograph of a pYFP transfected neonatal nodose neurons cultured for 24h in the presence
ofBDNF and overlaid with the concentric circles used to perform the Sholl analysis. B) Two
theoretical neurons, of the same length and with the same number of branch points, but with two




2.3.1. Phosphorylation and degradation of IkB-cx is essential for
neurite outgrowth and NFicB-activated gene transcription
during a restricted window of development
2.3.1.1. Preventing NFicB-induced gene transcription by
transfection of super-repressor IkB-o reduces the
neurite growth of nodose neurons.
The investigation into the role of NFkB in the regulation of neuronal morphology
began with a study of the effect of transfecting neonatal nodose neurons with a
plasmid expressing a super-repressor form of the IkB-cx protein. This plasmid
produces an IkB-ci protein capable of binding NFkB dimers, but which carries serine
to alanine mutations at positions 32 and 36 that prevent the signal-induced
phosphorylation required to target it for ubiquitination and proteosomal degradation.
Production of this protein therefore blocks the release the NFkB dimers for nuclear
translocation and consequently prevents NFkB induced gene transcription
(Rodriguez et al., 1996: Roff et al., 1996).
NFkB is known to be involved in the survival of many types of neurons, therefore
the first experiment assessed whether the transfection of neonatal nodose neurons
with super-repressor IkB-cx altered neuronal survival. Dissociated cultures of nodose
neurons were established and, after three hours incubation in the absence of trophic
support, transfected with either the super-repressor IkB-cc or a control plasmid, in
combination with a plasmid expressing YFP to allow visualisation of transfected
neurons. FTalf the culture dishes were then supplemented with BDNF. Neurons were
transfected by ballistic transfection, using plasmid-coated inert gold microcarriers.
Twelve hours later, once all transfected neurons were clearly identifiable by their
expression of YFP, an initial count of the number of transfected neurons was
performed. A second count of living, YFP-positive neurons, performed 48 hours
after transfection, was used to assess survival. The number of surviving YFP-positive
neurons at 48 hours was expressed as a percentage of the initial number of
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transfected neurons in each dish. Figure 2.4A shows that after 48 hours in culture in
the presence of BDNF 80% of control-transfected neurons survived, and that
transfection with the IkB-cx super-repressor plasmid had no apparent effect on
neuronal survival. At the same time, only 40% of neurons cultured in the absence of
BDNF were surviving, and transfection with the IkB-cx super-repressor had no
additional effect on their survival (data not shown). These results suggest that in the
case of neonatal nodose neurons surviving with BDNF there is no effect on survival
as a consequence of blocking NFkB signalling through transfection of super-
repressor IkB-cl
As super-repressor IkB-cx transfection has no effect on the survival of nodose
neurons, its role in neurite outgrowth can be easily assessed, as any effect seen
cannot be attributed to differences in the survival of any subpopulations of neurons
present. Cultures were established in the same manner as the survival cultures
described earlier. Twenty-four hours after transfection 40-70 YFP-positive neurons
per condition were digitally imaged using confocal microscopy and their neurite
arbours reconstructed. Examples of reconstructed neurons grown in the presence of
BDNF can be seen in figure 2.5. The images in the left column show the range of
neurite arbours of control-transfected neurons, while the images in the right-hand
column show the range of those transfected with super-repressor IkB-cx. The neurons
Figure 2.4 Super-repressor IkB-u reduces net/rite growth from neonatal nodose neurons but does
not affect survival
PI nodose neurons were transfected with a YFP expression plasmid together with either a super-
repressor IkB-cx plasmid or an empty control plasmid and incubated in medium containing lOng/ml
BDNF. Control transfected neurons were also grown without BDNF. A) Percent survival 48 hours
after transfection. B) Sholl analysis of neurite arbour morphology 24 hours after transfection. C)
Total neurite length 24 hours after transfection. D) Number of branch points in neurite arbours 24
hours after transfection. E) Photomicrographs of a typical control and super-repressor IkB-cx
transfected neurons grown for 24 hours with BDNF (Scale bar = 50 pm). The means and standard
errors of data obtained from 40-70 neurons in each experimental condition are shown. Statistical
comparisons shown are with respect to the control transfected neurons, * p<0.05, ** p<0.001.
Figure 2.5 Representative sample of reconstructed newborn nodose neurons
The illustrated neurons represent the range of morphologies observed in P0 control transfected
cultures (left) and super-repressor IkB-u transfected cultures (right) after 24 hours incubation with 10
ng/ml BDNF. The neurons shown correspond to percentiles 25, 50, 75 and 100 of the sampled
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shown represent percentiles 25, 50 75 and 100 of the sampled populations in terms of
total neurite length, and it can be seen that the neurite arbours of neurons transfected
with super-repressor IkB-ci appear smaller and less intricate than those transfected
with the control plasmid.
Sholl analysis and assessment of total neurite length and number of branch points
were performed on the reconstructed neurons. Figure 2.4B shows the Sholl analysis
of PI nodose neurons cultured for 24 hours in the presence of BDNF and transfected
with either super-repressor IkB-o. or a control plasmid. The number of neurites
intersecting each ring of a series of digitally generated concentric circles, 30 pm
apart and centred on the cell body, was counted, providing a quantification of the
complexity of the neurite arbour at a range of distances from the cell body. Control
transfected neurons cultured in the presence of BDNF show that, on average, the
total number of intersections at each distance increases from a mean of 4.2
intersections at the first ring, 30pm from the cell body, to a maximum number of
12.4 intersections at 150pm, after which the number of intersection decreases so that
by 450pm from the cell body less that 2 intersections can be found. In neurons
transfected with the super-repressor IkB-cx the number of intersections at each ring is
decreased as compared to control neurons, with this effect reaching statistical
significance at distances of between 120 and 300pm from the cell soma. Figure 2.4B
also shows the outgrowth seen in control-transfected neurons cultured in the absence
of trophic support, where a mean of 2 intersections per neurons can be seen at the
initial ring 30pm from the cell body, and in which there is no subsequent peak, only
a gradual decrease in the number of intersections detected per ring.
The effect of IkB-cx on neurite outgrowth can also be seen when the total neurite
length and number of branch points are calculated. These calculations were
performed on the same set of neurons and the results can be seen in figures 2.4C and
2.4D (total neurite length and number of branch points, respectively). The total
neurite length of PI control neurons grown in the presence of BDNF was found to
average 4100 pm, while the average length of neurons cultured in the absence of
trophic support was found to be 750 pm. Neurons cultured in the presence of BDNF,
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but transfected with super-repressor IkB-cx, showed a 30.1% decrease in total neurite
length as compared to those transfected with the control plasmid (p < 0.05, Student's
t-test). Similarly control neurons cultured in the presence of trophic support
possessed an average of 50 branch points per neuron, while those grown in the
absence of trophic support possessed an average of only 8. Neurons cultured in the
presence of BDNF, but transfected with the super-repressor IkB-cx construct showed
a 28.4% reduction in the average number of branch points compared to the control
transfected neurons (p < 0.001, Student's t-test). Figure 2.4E shows examples of
typical control and super-repressor ItcB-a neurons grown in the presence of BDNF.
To exclude the possibility that transfection with IkBcx reduced overall cellular
metabolism, and consequently decreased neurite outgrowth, the size of the cell soma
was measured in super-repressor IkBcx- and control-transfected cells grown in the
presence of BDNF for 24h. The somal cross sectional area was quantified using
confocal microscopy, revealing that there was no significant difference between the
somal size of the super-repressor IicBa-transfected neurons (680±113pm2, n=50) and
control-transfected neurons (715±34pm2, n=51). Taken together these results show
that blocking NFicB-induced gene transcription by transfection with super-repressor
IkB-o decreases the overall size and complexity of the neurite arbours of neonatal
nodose neurons without affecting cell survival or causing a global reduction in cell
metabolism affecting cell growth.
2.3.1.2. Basal NFkB dependent gene expression is not
affected by BDNF
The next group of experiments addressed the question of whether BDNF is able to
influence basal NFkB expression. To do this the levels of NFicB-dependent
transcriptional activity in neonatal nodose neurons were measured under different
experimental conditions by transfecting these neurons with a plasmid expressing
GFP under the control of an NFkB promoter sequence. Three hours after plating, the
neurons were transfected with this plasmid in combination with a plasmid expressing
RFP (to allow identification of transfected neurons even in the absence of NFkB-
dependent GFP transcription) and either the superrepressor IkB-o. plasmid or the
corresponding empty control vector. These neurons were then incubated in the
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presence or absence of BDNF for 18 hours. Representative fields of neurons cultured
in the presence of BDNF, and transfected with either the ItcB-a super-repressor or
control plasmid can be seen in Figure 2.6A. The upper panels show neurons
identified through the RFP signal, superimposed with the NFKB-dependent GFP
image, while the lower panels show the GFP signal alone. Neurons transfected with
the control plasmid exhibit a clear GFP signal (left panels) while in the neurons
transfected with super-repressor IkB-gi only a weak expression of GFP can be seen.
Note also that the decrease in neurite length and complexity found in the previous
experiments can also been seen in the RFP image in this study. Quantification of the
levels of fluorescence in these neurons revealed an 80% decrease in the levels of
GFP fluorescence in neurons cultured in the presence of BDNF and transfected with
super-repressor IicB-a as compared to control transfected neurons (Figure 2.6B).
Also of interest is that there was no significant difference in the level of fluorescence
in control-transfected neurons grown with or without BDNF and that super-repressor
iKB-a-transfected neurons grown in the absence of trophic support showed a similar
decrease in GFP fluorescence as those grown in the presence of trophic support.
Figure 2.6 NFKB-dependent gene expression in newborn nodose neurons is not affected by BDNF.
P0 nodose neurons were co-transfected with the GFP NF-kB reporter plasmid, RFP plasmid and either
the super-repressor IicB-a plasmid or corresponding control plasmid. They were then cultured with or
without 20ng/ml BDNF for 24h. A) Photomicrographs of representative fields of neurons cultured
with BDNF for 24h. The left panels show neurons transfected with IxB-a and the right panels show
those transfected with a control plasmid. Transfected neurons, with their dendritic arbours are outlined
by RFP in the upper panels. The effect of super-repressor IkB-cx on neuronal morphology, seen in the
previous figures, is also evident in these images. NFKB-dependent GFP fluorescence in the same
fields (lower panels) shows the marked reduction caused by super-repressor IkB-o (Scale bar = 50
pm). B) Quantification of the level of NF-xB-driven GFP fluorescence in super-repressor IkB-o-
transfected and control-transfected neurons after 24 hours incubation with and without 20 ng/ml
BDNF. Fluorescence measurements were made from 40 to 60 neurons in each experimental
condition, and the data are expressed as a percentage of the mean fluorescence of the No
factor/Control vector-transfected group (mean and standard error are shown). Statistical comparisons
shown are with respect to the control transfected neurons, ** p<0.001. C) Time course of NF-kB-
driven GFP fluorescence after BDNF stimulation. Neurons were transfected with the GFP NFkB
reporter plasmid and pRFP and cultured overnight in the absence of trophic support. Neurons were
then imaged immediately prior to and at 0.5, 1, 2 and 3 hours after the addition of BDNF to the
medium (20ng/ml). An untreated group of neurons (No Factor) was imaged at the same time. The
fluorescence of each neuron was quantified and expressed as a percentage of the initial (Oh time point)







































To investigate further whether BDNF treatment is capable of activating NFkB-
dependent gene transcription in this experimental situation, neurons were plated in
defined medium, transfected with both pRFP and the plasmid expressing GFP under
the control of the NFkB promoter and cultured overnight in the absence of trophic
support. Identifiable fields in these cultures were then imaged both before and at 0.5,
1, 2 and 3 hours after treatment with BDNF, as were similar fields from untreated
parallel cultures. Figure 2.6C shows that at no time point did BDNF treatment appear
to increase NFicB-induced GFP expression above those of untreated neurons. These
results therefore suggest that BDNF does not affect NFKB-induced gene transcription
in this experimental paradigm.
2.3.1.3. The super-repressor IkB-cj decreases the neurite
outgrowth of nodose neurons in a developmentally
dependent manner.
The response of nodose neurons to trophic factors is known to change significantly
throughout development, particularly during the embryonic and early postnatal
stages, during which neurons are establishing their patterns of innervation and
neurotransmitter phenotypes (see Chapter 1). The next step was therefore to
investigate whether the role of NFkB in promoting neurite outgrowth is similar
throughout development. To this end, cultures of nodose neurons were established
from the earliest age at which these neurons can be successfully transfected using the
gene-gun (El6), up to P3. Neurons were then transfected with cither a control
plasmid or super-repressor IkB-cx, along with pYFP, and half the dishes were
supplemented with BDNF, as in the previous set of experiments. Again, neurons
were imaged at 24 hours using a confocal microscope and their survival assessed by
counting at 48 hours. Throughout the range of ages studied the survival of control-
transfected neurons grown in the presence of trophic support was between 60 to
80%. In this case figure 2.7A shows the proportion of transfected neurons surviving
to 48 hours for each dish expressed as a percentage of the mean value for the positive
control group to allow comparison between different ages, each with differing
inherent potential to survive in the presence of BDNF. It can be seen that there was




Figure 2.7 Super-repressor IxB-a reduces neurite growth from nodose neurons in a
developmentally dependent manner
El6, El8, PO, PI and P3 nodose neurons were transfected with a YFP expression plasmid together
with either a super-repressor IkB-ci plasmid or an empty control plasmid and were incubated in
medium containing 10 ng/ml BDNF. A) Neuronal survival 48 hours after transfection, expressed as
a percentage of the BDNF, control-transfected group at each age. In addition to showing survival
data for super-repressor IkB-u transfected and control transfected neurons grown with BDNF,
survival data for control-transfected neurons grown without BDNF are also shown at each age. B)
Total neurite length 24 hours after transfection. C) Number of branch points in neurite arbors 24
hours after transfection. D-H) Sholl analysis of neurite arbour morphology 24 hours after
transfection at El 6, El 8, PO, PI and P3, respectively. The means and standard errors of data
obtained from 60 neurons in each experimental condition are shown. Statistical comparisons shown
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control plasmid or superrepressor IkB-<x, when grown in the presence of BDNF.
Interestingly, anl increase in the survival of control transfected neurons cultured in
the absence of BDNF can be seen until P3, when the neurons of the nodose ganglia
appear to be capable of surviving in the absence of additional trophic support.
Analysis of the total neurite length and branching showed that transfection of
neurons at E16 and P3 with super-repressor IkB-cc did not have any effect on the
outgrowth of these neurons (Fig 2.7B and 2.7C respectively). However, during the
perinatal period, between El8 and PI, an important effect of suppressing NFkB-
induced gene transcription was revealed. This effect peaked in cultures established
from pups on the day of birth, where a 43% decrease in neurite length and 48%
decrease in neurite branching was seen (p < 0.001, Student's t-test). These results
were also reflected in the Sholl analyses (Fig 2.7 D-H) where significant decreases in
the complexity of the neurite arbour were seen in neurons cultured at El8, P0 and PI.
Together, these results suggest that NFicB-induced gene transcription plays a role in
neurite outgrowth in a developmentally restricted manner, having an effect only
during late embryonic and early postnatal stages.
2.3.1.4. BA Y 11-7082 reduces neurite outgrowth from
nodose neurons
To confirm the role of NFkB in the growth of neuritic arbours a variety of methods
were employed, all of which were targeted at disrupting NFkB signalling. The
second method used was disrupting IkB-o. phosphorylation with BAY 11-7082, a
commonly used, selective and irreversible inhibitor of IkB-ci phosphorylation
(Chiarugi, 2002; Pierce et al., 1997). These experiments were performed using P0
nodose neurons, as the earlier study indicated that this was the age at which the effect
of blocking NFKB-activated gene transcription was maximal. The use of a chemical
inhibitor also allowed us to examine the role of NFkB in neurite outgrowth in low
density cultures, where there is no contact between neurons, as opposed to the earlier
transfected cultures where close contact between YFP-positive neurons and adjacent
untransfected neurons may alter neuronal morphology. To investigate whether this
dose of BAY 11-7082 affected neurite outgrowth or neuronal survival, neurons were
plated and after three hours subjected to a 43 minute pre-incubation with BAY 11-
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7082 or a similar volume of vehicle, before the addition of BDNF to half of the
dishes. Figure 2.8A shows that there was no significant difference in the survival of
neurons grown in BDNF-supported cultures and treated with either vehicle or lOpM
BAY 11-7082, at 24 hours after plating. Immediately after the second survival count,
at 24h, neurons were fixed and stained for (3111-tubulin expression, combined with a
fluorescent secondary antibody, to allow imaging using confocal microscopy. These
images were analysed and the results can be seen in Figures 2.8B-E. The Sholl
analysis (figure 2.8B) shows that treatment of P0 nodose neurons with BAY 11-7082
causes a decrease in the number of intersections at each ring, which reaches
significance between 180 and 420pm from the cell body. This finding is reflected in
the analyses of total neurite length and number of branch points where treatment with
BAY 11-7082 resulted in a 19.6% reduction in total neurite length and a 28.2%
decrease in the number of branch points, both of which reached statistical
significance (p < 0.001, Fig 2.8C and D respectively). It should also to be noted that
neurons cultured at this low density appear to present a different pattern of outgrowth
and branching as compared to the higher density cultures used for ballistic
transfection. Whereas the high density cultures show a peak number of intersections
between 90 and 150pm from the cell body at this age, neurons cultured at a lower
density appears to have a less abrupt peak that occurs further from the cell body, here
at 240pm, with the maximum number of intersections being lower, at around 7
intersections at the peak, whereas up to 14 intersections at the peak distance can be
observed in the higher density cultures. This suggests that in low density culture
neurites extend further before branching and that the distances between branches
may also be longer, but that they also branch less than neurons in high density
Figure 2.8. BAY 11-7082 reduces neurite outgrowth from nodose neurons
P0 nodose neurons were incubated in medium containing lOng/ml BDNF and either the IkB-cc
phosphorylation inhibitor BAY 11-7082 at a concentration of lOpM or vehicle control. Vehicle
treated neurons were also grown without BDNF. A) Percent survival after 48h in culture. B) Sholl
analysis of neurite arbor morphology after 24h in culture. C) Total neurite length after 24h in culture.
D) Number of branch points in neurite arbors after 24h in culture E) Photomicrographs of typical (3III
tubulin stained, vehicle or BAY 11-7082 treated neurons grown for 24 hours with BDNF (Scale bar =
50 pm). The means and standard errors of data obtained from at least 40 neurons in each experimental
condition shown. Statistical comparisons shown are with respect to the control transfected neurons
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cultures. The images in figure 2.8E show typical neurons grown in the presence of
trophic support, with and without BAY 11-7082. These results provide additional
evidence supporting the conclusion that inhibition of NFkB signalling by interfering
with the phosphorylation and degradation of IkB-ci decreases neurite outgrowth from
nodose neurons grown in both high and low density culture.
2.3.1.5. Proteosome inhibition reduces neurite outgrowth
from nodose neurons
After phosphorylation by the IKK complex, IkB-cc is ubiquitinated, targeting it for
degradation by the proteosome. Therefore in order to provide additional support for
the role of blocking NFkB signalling, at the level of the IkB, in causing a reduction
in neurite outgrowth, the effects of the widely used proteosomal degradation
inhibitor N-acetyl-leucinyl-leucinyl-norleucinal (AFFN) were studied (Chiarugi,
2002; Maggirwar et al., 1998). Cultures were established and analysed in the same
fashion as those used to study the BAY 11-7082 compound and figure 2.9A shows
that at a dose of lOpM AFFN has no effect on the survival of P0 nodose neurons.
Analysis of individual neurons treated with the same dose of AFLN, however,
revealed that there was a highly significant decrease in the number of intersections at
all distances between 120 and 390pm from the cell body, with ALLN completely
eliminating the increase in the number of intersections per ring that would normally
occur up to approximately 210pm from the centre (figure 2.9B). This effect can also
be seen in the analyses of total neurite length and branching (fig 2.9C and D), where
treatment with ALLN reduces total neurite length by nearly 60% and branching by
65% (p < 0.001, Students t-test).
Figure 2.9 Proteosome inhibition reduces neurite growth from nodose neurons
P0 nodose neurons were incubated in medium containing lOng/ml BDNF and either the proteosomal
degradation inhibitor ALLN at a concentration of lOpM or vehicle control. Vehicle treated neurons
were also grown without BDNF. A) Percent survival after 48h in culture. B) Sholl analysis of neurite
arbor morphology after 24h in culture. C) Total neurite length after 24h in culture. D) Number of
branch points in neurite arbors after 24h in culture. E) Photomicrographs of typical pill tubulin
stained, vehicle or ALLN treated neurons grown for 24 hours with BDNF (Scale bar = 50 urn).
Statistical comparisons shown are with respect to the control transfected neurons cultured in the
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2.3.2. Disrupting nfkb-induced gene transcription using kB
decoy DNA reduces neurite outgrowth in postnatal nodose
neurons
As well as establishing that disrupting key steps in the activation of NFkB results in
decreased neurite outgrowth from perinatal nodose neurons, the effect of directly
blocking NFkB transcriptional activity in these neurons was also examined. This was
done using kB decoy DNA. This is a double stranded oligonucleotide designed to
contain a kB consensus binding sequence found in the promoters of NFkB target
genes, and which has been previously described as preventing NFkB transcriptional
activity both in vitro and in vivo (Yeh et ah, 2002). This oligonucleotide, or a
scrambled control oligo, were precipitated onto gold microcarriers, in combination
with a YFP reporter to allow identification and visualisation of transfected neurons,
and cultures of P0 neurons established and transfected in the same manner as that
described for super-repressor IkB-ci transfected cultures. Again, the survival of these
cultures was assessed to rule out any detrimental effects on neuronal survival biasing
the results. The transfection of kB decoy oligonucleotides was found to have no
effect on the neuronal survival, as compared to the scrambled oligo control (Fig
2.10A), with the overall survival of both groups of neurons being excellent. Figure
2.1 OB shows the Sholl analysis of the neurons from these cultures, where the
transfection of neurons with kB decoy DNA significantly reduced the number of
neurites intersecting each ring from 120 to 360pm from the cell body (p<0.05 for
120pm, p<0.001 at all other distances) as compared to the scrambled oligo control.
This difference is also reflected in a 27% decrease in total neurite length and a 36%
decrease in the number of branch points. Typical neurons grown transfected with
Figure 2.10 kB decoy DNA reduces neurite growth from nodose neurons
P0 nodose neurons were transfected with a YFP expression plasmid together with either a kB decoy
DNA or a scrambled control variant and were incubated in medium containing 10 ng/ml BDNF.
Control transfected neurons were also grown without BDNF. A) Percent survival 48 hours after
transfection. B) Total neurite length 24 hours after transfection. C) Number of branch points in
neurite arbours 24 hours after transfection. D) Sholl analysis of neurite arbour morphology 24 hours
after transfection. E) Photomicrographs of typical neuron transfected with the scrambled control or
kB decoy oligonucleotides and grown for 24 hours with BDNF. Scale bar = 50 pm. Statistical
comparisons shown are with respect to the control transfected neurons cultured in the presence of
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either kB decoy DNA or the scrambled oligonucleotide and cultured in the presence
of trophic support can be seen in Figure 2.10E. These results demonstrate that NFkB
transcriptional activity also plays a role in controlling neurite outgrowth in PO nodose
neurons.
2.3.3. NFkB gain-of-function promotes neuronal survival, but has
no effect on neurite outgrowth
To investigate whether increases in NFkB activity could promote additional neurite
outgrowth in neonatal nodose neurons, PO nodose neurons were established in
culture and transfected with a p65 expression plasmid that has previously been
shown to activate NFKB-induced gene transcription in other neurons (Flamanoue et
al., 1999). Firstly we confirmed that expression of the p65 plasmid resulted in
increased NFKB-induced gene transcription in our system. This was done by using
the gene gun to simultaneously transfect neurons with the p65, or an empty control
plasmid, in combination with the GFP/NFkB reporter plasmid used in section
2.3.1.2. This revealed that transfection of neonatal nodose neurons with the p65
expression plasmid caused a two-fold increase in NFKB-dependent gene transcription
after 18 hours in culture (Fig 2.11A). Despite this, no changes in the growth and
complexity of the neurite arbours were seen in p65 transfected neurons, either in the
presence or absence of BDNF, in any of our analyses (Fig 2.11 C, D and E).
Interestingly, one effect of increasing NFkB activity in these neurons was seen.
While overexpression of p65 had no effect on neuronal survival when neurons were
cultured in the presence of BDNF, in the absence of BDNF the two-fold increase in
NFKB-dependent gene transcription was sufficient to cause neurons to survive to the
Figure 2.11 Overexpression ofp65 increases NFkB activation ancl promotes neuronal survival but
does not enhance neurite outgrowth
A) Quantification of the level of NFtcB-driven GFP fluorescence in neurons transfected with either a
p65 overexpressing plasmid or the corresponding empty control, after being cultured in the presence
of BDNF for 24 hours. B-E) PO neurons transfected with either the p65-overexpressing or the empty
control plasmid were cultured in the presence or absence of BDNF. B) Percent survival after 48h in
culture. C) Sholl analysis of neurite arbour morphology after 24h in culture. D) Total neurite length
after 24h in culture. E) Number of branch points in neurite arbours after 24h. Statistical comparisons








































30 90 150 210 270 330 390 450













same extent as they do in the presence of BDNF (Fig 2.1 IB). These results suggest
that the basal level of NFkB expression in nodose neurons is maximal for neurite
growth, but suboptimal for survival. They also suggest that a BDNF-activated
signalling pathway must cooperate with NFkB to promote neuronal survival in
perinatal nodose neurons, as neurite extension is not seen in the neurons that survive
in the absence of trophic support after transfection with p65.
2.3.4. Upstream of IkB-o, the outgrowth of early postnatal nodose
neurons is independent of IKKa and NIK.
After demonstrating that NFkB activation involved in the growth and elaboration of
neuronal processes in perinatal nodose neurons, two of the proteins that have been
reported to be upstream of IkB-ci phosphorylation and degradation were investigated.
The first protein investigated was IKKa, a protein involved in the kinase complex
that phosphorylates iKBa thus targeting it for degradation in the classical NFkB
activation pathway. IKKa may also phosphorylate histone H3 to allow NFkB-
dependent gene transcription (Anest et al., 2003; Birbach et ah, 2002; Hayden and
Ghosh, 2004; Yamamoto et ah, 2003), as well as activating the non-canonical NFkB
signalling pathway that releases p52-RelB dimers through the partial degradation of
plOO (Solan et ah, 2002; Xiao et ah, 2001; Yilmaz et ah, 2003). We used IKKa
knockout mice to investigate the role of this protein in neurite outgrowth in nodose
neurons. IKKa7 embryos survive until just before birth. Neurite outgrowth from
neurons derived from E18 embryos homozygous for a null mutation of the IKKa
gene was quantified, and the results compared to wild-type littermates. Embryos
were removed from the dam and following genotyping, the dissected homozygous
mutant and wild-type ganglia grouped separately and plated in low density cultures.
Survival was assessed from two counts of living neurons, at 3 and 24h, with half of
the dishes of each genotype being supplemented with BDNF immediately after the
three hours count, the remaining dishes being left without trophic support. At 24
hours the survival was assessed, immediately prior to fixing and staining for pill-
tubulin to allow images of the neurite arbours to be obtained using confocal
microscopy. No significant difference was found between the survival of IKK-a
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Figure 2.12 Neurite outgrowth from IKK-anodose neurons is normal
Nodose neurons from E18 IKK-a knockout mice were cultured for 24h in the presence ofBDNF
(lOng/ml) and their survival and outgrowth compared to wildtype littermates. A) Percent survival
48h after transfection. B) Sholl analysis of neurite arbour morphology 24h after transfection. C)
Total neurite length 24h after transfection. D) Number of branch points in neurite arbors 24h after
transfection. The means and standard errors of data obtained from 60-90 neurons in each
experimental condition are shown.
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was also no detected difference between the neurite outgrowth of IKK-a deficient
and wild-type neurons in any of the analyses performed (Sholl analysis, total neurite
length and number of branch points, figures 2.12B, C and D respectively). This
suggests that IKK-a is not involved in activating NFkB in the regulation of neurite
outgrowth. Unfortunately it was not possible to investigate whether the related
protein IKKp is involved in promoting neurite outgrowth in nodose neurons using
the IKKP knockout mice as these embryos die in utero at E14, an age at which no
effect of NFkB on neurite outgrowth can be detected.
NFKB-inducing kinase (NIK) is another protein kinase that has been shown to play a
role in activating NFkB signalling in cortical neurons (Bhakar et al., 2002) and may
be involved in transducing the classical NFkB signalling pathway. NIK also activates
IKKa in the non-canonical NFkB signalling pathway. The possibility of NIK being
involved in activating the NFkB signalling responsible for neurite outgrowth in our
culture system was investigated by transfecting P0 nodose neurons with either a
construct expressing a dominant-negative form of NIK or a control plasmid in
combination with pYFP in the same manner as described for super-repressor hcB-a
earlier, and the survival and neurite outgrowth quantified. Transfection with
dominant-negative NIK had no effect on neuronal survival in these cultures (figure
2.13A). No effect of dominant-negative NIK transfection on neurite outgrowth could
be detected using either Sholl analysis or measurement of total neurite length or
branching (figures 2.13B, C and D respectively). I also investigated whether the
overexpression of wild-type NIK alters neurite outgrowth in these cultures. Using the
same techniques, P0 nodose neurons were transfected with either wild-type NIK or a
control plasmid and assessed for survival and neurite outgrowth. Figure 2.14A shows
that transfection with wild-type NIK neither increased nor decreased neuronal
survival, either in the presence or absence of BDNF. The outgrowth and complexity
of NIK-overexpressing neurons grown in the presence of BDNF was identical to the
outgrowth and complexity of control-transfected neurons, as can be seen in figures
2.I4B, C and D (Sholl analysis, total neurite length and number of branch points
respectively). These results suggest that NIK is not involved in activating NFkB in
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Figure 2.13 Dominant-negative NIK does not affect neurite growth or survival in neonatal nodose
neurons
P0 nodose neurons were transfected with a YFP expression plasmid together with either a dominant-
negative NIK plasmid or an empty control plasmid and incubated in medium containing 10 ng/ml
BDNF. Control transfected neurons were also grown without BDNF. A) Percent survival 48 hours
after transfection. B) Sholl analysis of neurite arbor morphology 24 hours after transfection. C)
Total neurite length 24 hours after transfection. D) Number of branch points in neurite arbors 24
hours after transfection. The means and standard errors of data obtained from 60-90 neurons in each
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Figure 2.14 Overexpression ofwildtype NIK does not affect neurite growth or survival in neonatal
nodose neurons
P0 nodose neurons were transfected with a YFP expression plasmid together with either a wild-type
NIK expressing plasmid or an empty control plasmid and were incubated in medium containing 10
ng/ml BDNF. Control transfected neurons were also grown without BDNF. A) Percent survival 48
hours after transfection. B) Sholl analysis of neurite arbor morphology 24 hours after transfection.
C) Total neurite length 24 hours after transfection. D) Number ofbranch points in neurite arbors 24
hours after transfection. The means and standard errors of data obtained from 40-70 neurons in each




This study investigated whether the transcription factor NFkB plays a developmental
role in regulating neurite outgrowth from peripheral sensory neurons of the nodose
ganglia. Using several complementary methods it was found that inhibiting NFkB
activation or NFid3-dependent transcriptional activity in neonatal nodose neurons
significantly reduced the size and complexity of the neuronal arbours. Inhibition of
IicBa phosphorylation, using either super-repressor IkBci or the pharmacological
inhibitor BAY 11-7082, or its subsequent degradation, through the use of the
proteosomal inhibitor N-acetyl-Leu-Leu-norleucinal, significantly reduced the total
neurite length, total branch number and branching with distance from the cell body
(Sholl analysis). Similar, significant, decreases in these parameters were also seen
when NFKB-dependent gene transcription was blocked using kB decoy DNA. These
effects are not a consequence of reduced neuronal viability, as in each study we
confirmed that there was no effect of treatment on the survival of neurons cultured in
the presence of BDNF. Additional studies in our laboratory have also indicated that
NFkB is not limited to regulating neurite outgrowth in the peripheral nervous system,
but also regulates dendritic growth and morphology in layer 2-3 pyramidal neurons
in the postnatal mouse somatosensory cortex. Flere, both super-repressor IkBgc and
kB decoy DNA cause significant decreases in overall dendritic length, total number
of branch points and branching with distance from the cell body in slice cultures
established from P3-P4 mice (Gutierrez et al., 2005). NFkB has also been linked with
neurite outgrowth in PC 12 cells, where inhibition of NFkB decreases the proportion
of cells possessing neurites following Trk A activation (Foehr et ah, 2000), although
this effect could have represented a downstream consequence of affecting TrkA-
induced differentiation, rather than a direct effect on neurite outgrowth.
Initial investigation of upstream activators of NFkB suggested that neither IKKa nor
NIK are involved in activating NFkB in cultured nodose neurons. IKKa traditionally
forms a complex with IKKp and NEMO that phosphorylates MBa and targets it for
degradation. Whether IKKa actually plays a role in the activation of NFkB through
its classical activation pathway is not certain, as IKKp has been shown to be
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sufficient and essential in such activation (Hayden and Ghosh, 2004). Any
involvement of IKKa in the classical NFkB pathway appears to be nuclear where it
phosphorylates histone H3 to facilitate NFkB dependent gene transcription (Anest et
al., 2003; Birbach et ah, 2002; Yamamoto et ah, 2003). IKKa, activated by NIK, also
targets plOO for degradation, releasing active p52-RelB dimers (Solan et ah, 2002;
Xiao et ah, 2001; Yilmaz et ah, 2003). My results therefore suggest that the NFkB
activation involved in neurite outgrowth is unlikely to be through the non-canonical
pathway. Further investigation of the classical proteins activating IkB degradation
and NFkB release would therefore be of interest. Neurite outgrowth cannot be
investigated in IKKP"/_ mice as, like p65 knockout mice, they die in utero around E15
(Li et ah, 1999b; Tanaka et ah, 1999). In future experiments I intend to investigate
the effects of overexpressing both wild-type and mutant forms of both IKKa and
IKKp.
Analysis of the role of NFkB throughout the period during which nodose neurons
extend and elaborate their neuronal processes showed that inhibition of NFkB
signalling, using super-repressor IkBo or p65 knockout mice, only altered neuronal
morphology during a restricted period of development, starting after E16 and ending
before P3. We do not know the cause of this developmental restriction, but it is worth
noting that other developmentally restricted changes occur in nodose neurons over
this time period, including the expression of Reg-2 mRNA between El8 and PI
described in chapter 4. In terms of neurite outgrowth, this timing coincides not with
the period when neurons are extending neurites for the first time, but with the latter
end of the period of naturally occurring apoptosis when the remaining neurons are
establishing and refining their terminal arborisations (Davies and Lumsden, 1984b).
This suggests that NFkB modulates neurite outgrowth during the later stages of
target field innervation and process refinement and branching, rather than promoting
of de novo neurite extension. Similarly, the inhibition of neurite outgrowth in cortical
neurons that occurs on blocking NFkB signalling was detected during a period when
these neurons are growing rapidly and establishing and refining their functional
connections (Gutierrez et al., 2005). Learning and memory in adults is thought to be
dependent on long-term synaptic plasticity, that, alongside other changes, includes
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remodelling of axon terminal branches and dendritic morphology. Synaptic
complexity increases with both development and environmental input in mature
animals (Briones et al., 2004b; Briones et ah, 2004a; Buonomano and Merzenich,
1998; Camel et ah, 1986; Greenough et ah, 1986; Jones et ah, 1997; Katz and
Davies, 1984; Turner and Greenough, 1985) and some of the changes that occur in
plasticity in adulthood may recapitulate events that occur during development. As
NFkB is already implicated in learning and memory (Albensi and Mattson, 2000;
Meffert et ah, 2003; Merlo et ah, 2002; Yeh et ah, 2002) it is possible that its
influence on these processes result from its modulatory role in refining neuronal
morphology.
In addition to examining neurite outgrowth, I also examined NFkB activation in our
culture system, through transfecting neurons with a plasmid expressing GFP under
the control of an NFkB promoter. Unexpectedly, I found robust levels of NFkB
activation in neurons grown for 24 hours in the absence of trophic support, and that
the levels of NFkB activation were unaffected by the presence of BDNF in the
culture medium, either in the short- or long-term. I also confirmed that transfection
of neurons with super-repressor IkBo. significantly reduced NFKB-induced GFP
expression. These results suggest that the treatments we used did not interfere
directly with the BDNF-activated signalling pathways that promote neurite
outgrowth in developing cultured nodose neurons, but that constitutive NFkB
activation co-operates with BDNF to promote neurite outgrowth in late embryonic
and early postnatal nodose neurons.
The events driving the basal expression of NFkB seen in cultured nodose neurons are
unclear. It may be that NFkB is constitutively active in these neurons, or that its
activation is secondary to activation of neuronal receptors by molecules other than
BDNF in our culture system. Constitutive activation of NFkB in neurons has been
described both in vivo and in vitro. In vivo, constitutive activation is detected in both
developing and adult neurons throughout the central nervous system (Acarin et al.,
2000; Bhakar et al., 2002; Fridmacher et al., 2003; Kaltschmidt et al., 1994; Schmidt-
Ullrich et al., 1996; Gabriel et al., 1999), although in vivo each neuron will be
receiving a variety of inputs that may be activating NFkB, including, neurotrophic
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factors, glutamate, and nitric oxide (Burr and Morris, 2002; Guerrini et al., 1995;
Meffert et al., 2003; Simpson and Morris, 1999). Constitutive NFkB activation has
also been found in vitro (Burr and Morris, 2002; Camandola and Mattson, 2000;
Glazner et al., 2001; Piccioli et al., 2001) although in some of these cultures NFkB
activity may have been induced by the method of maintaining the cells in culture,
such as mild depolarisation (Piccioli et al., 2001). In other studies, constitutive NFkB
activity has been attributed to spontaneous calcium ion release from IP3 sensitive
intracellular stores although, again, such release could also be stimulated by growth
factors or neuropeptides (Glazner et al., 2001). In the culture system used in the
studies reported in this thesis, exogenous factors as a source of NFkB activation can
be excluded as the cultures were established in defined medium. However, the
cultured neurons may themselves release neurotrophic factors or other proteins into
the medium, as may contaminating non-neuronal cells (although there are relatively
few non-neuronal cells at the age at which the cultures were established). Such
proteins could then act in an autocrine or paracrine manner to promote NFkB
activity, particularly in the cultures established at high density.
An alternative possibility is that NFkB is activated by the laminin used as a culture
substratum. Laminins are a family of extracellular matrix proteins that bind to cell
surface receptors of the integrin family and which are involved in cell motility in a
range of cell types (Gu et al., 2002; Hintermann and Quaranta, 2004; Hirosaki et al.,
2002; Kariya and Miyazaki, 2004; Powell and Kleinman, 1997; Schober et al., 2000)
In neurons, laminins are implicated particularly in neurite outgrowth (DeFreitas et
al., 1995; Schmidt et al., 1995; Tomaselli et al., 1993; Yong et al., 1988; Rivas et al.,
1992; Powell and Kleinman, 1997; Luckenbill-Edds, 1997), as are other related
extracellular matrix proteins that signal through integrins, such as osteopontin
(Hikita, 2003) and fibronectin (Yong, 1988; Hikita, 2003; Gomez and LeToumeau,
1994; Kuhn, 1995). Some of these proteins, such as fibronectin either promote or
inhibit outgrowth, depending on the neuronal type (Yong, 1988; Hikita, 2003;
Gomez and LeToumeau, 1994; Kuhn, 1995). In our culture system laminin-1 is used
to attach cells to the culture dish and as a substratum that is permissive for neurite
outgrowth (Baron-Van Evercooren, 1982; Yong, 1988). Outside the nervous system
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some links have been established between laminins and related extracellular matrix
proteins, integrins and NFkB activation. In mammary tumour cell lines, laminin-5
promotes NFkB dependent cell survival (Zahir, 2003). Osteopontin, a cell adhesion
molecule related to laminin, that also promotes neurite outgrowth in retinal neurons
(Hikita, 2003), has recently been shown to mediate cell motility in breast cancer cell
lines via PI3K, NIK, ItcBa and NFkB (Philip and Kundu, 2003; Das et al, 2003;
Rangaswami, 2004). Integrins themselves have been shown to be developmentally
regulated in neurons (Bronner-Fraser, 1992) and if laminin was found to be the
source of the constitutive activation of NFkB in our culture system, developmentally
regulated changes in integrin subunit expression could potentially explain the
developmental restriction of the role of NFkB in neurite outgrowth.
To further understand the role of NFkB in promoting neurite outgrowth in nodose
neurons the p65 NFkB subunit was overexpressed in neonatal nodose neurons and
NFkB activation, neuronal survival and neurite outgrowth examined. This
experimental manipulation greatly increased the level of NFKB-induced gene
expression 24 hours after transfection, yet did not appear to promote any additional
neurite outgrowth in BDNF-treated neurons, suggesting either that at its basal level
NFkB activity is maximal for neurite outgrowth or that the observed outgrowth in
BDNF-treated neurons is already the most these neurons can grow in 24 hours.
Future experiments could investigate this by establishing a dose-response curve for
neurite outgrowth in BDNF-exposed neurons, as here we simply used a
concentration previously determined to be saturating for cell survival. A
concentration of BDNF could then be used that is suboptimal for neurite outgrowth,
perhaps in conjunction with caspase inhibitors, or in Bax knockout neurons, to
eliminate any possible effects of reducing BDNF concentrations on cell survival.
Such a manipulation may then allow us to detect an increase in neurite outgrowth in
response to overexpression of the p65 protein.
Interestingly, overexpression of NFkB in neurons in the absence of trophic support
was able to promote cell survival to an extent indistinguishable from that of BDNF,
showing that while NFkB is not involved in mediating BDNF-promoted neuronal
survival, alone it can be sufficient for cell survival. Similar to nodose neurons,
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trigeminal sensory neurons overexpressing p65 also survive without neurotrophic
factors, as well as those cultured with NGF (Hamanoue et al., 1999). In these
neurons, however, it has been shown that while there is basal activation of NFkB,
NGF induced a threefold increase in NFkB transcriptional activity via p75.
Nevertheless, this suggests that there is a high level of redundancy in the systems
capable of promoting neuronal survival, at least in nodose neurons. These results also
indicate that the threshold levels of NFkB activation for neurite outgrowth and
neuronal survival are different, with higher levels of NFkB activation being required
for NFkB to promote survival in nodose neurons, as compared to the levels required
for NFkB to have a positive influence on neurite outgrowth.
A number of intrinsic developmental programs establish certain morphological
features depending on the neuronal type. In addition to these intrinsic settings, a wide
variety of extrinsic signals regulate the growth and morphology of developing
neurites, including neurotransmitters, growth factors, extracellular matrix proteins
and neuronal guidance molecules. Each of these inputs engages a specific set of
intracellular signalling pathways to influence neurite growth. An additional
observation made in the course of our experiments was that while overexpression of
p65 in nodose neurons was sufficient to promote neuronal survival, robust activation
of NFkB is not alone capable of promoting neurite outgrowth, as no outgrowth was
seen in p65-transfected neurons in the absence of BDNF. This confirms the earlier
conclusion that for optimal neurite outgrowth in cultured nodose neurons at this age,
cooperation is required between NFkB and a BDNF-induced signalling pathway.
Signalling pathways known to be implicated in neurite outgrowth include Ras-MEK-
ERK, PI3-kinase-Akt and calcium/calmodulin kinases (see chapter 1.5.3). Of these,
BDNF can activate both Ras-MEK-ERK and PI3-kinase-Akt with Ras-MEK-ERK
being particularly associated with mediating neurite outgrowth (Atwal et al., 2000).
Additionally MAPK has been found to be implicated in co-operative promotion of
neurite outgrowth by FGF-1 and the extracellular matrix component fibronectin in
PC 12 cells (Choung et al., 2002). Activation of these pathways influences
cytoskeletal dynamics to alter axonal and dendritic growth. For example,
phosphorylation of microtubule associated proteins and regulation of the activity of
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Rho GTPases and their effectors regulate the structure and dynamics of the actin-
based cytoskeleton, and have been linked to neurotrophin activated MAP kinase
signalling (Fink and Meyer, 2002; Lundquist, 2003; Miller and Kaplan, 2003).
Regulation of transcription has also been shown to influence process growth, with
the transcription factors CREB and NeuroD being implicated in mediating the effects
of calcium/calmodulin kinases on dendritic growth, although the target genes
involved are unknown (Gaudilliere et al., 2004; Redmond et ah, 2002). Neurotrophin
regulation of p-actin mRNA localisation, and consequently protein levels in growth
cones has also been implicated in neurite outgrowth (Zhang et al., 1999; Zhang et al.,
2001).
Of the wide variety of genes induced by NFkB in various cell types, several cell
adhesion molecules and other proteins that influence cell migration can be identified
that may be relevant to process extension in neurons (Pahl, 1999). These include
NCAM, pi-integrin and Tenascin-C. NCAM is a cell adhesion molecule that is
widely expressed on dendrites and axons of a range of neurons throughout the
developing brain (Butler et al., 1998; Chung et al., 1991;Fox et al., 1995; Persohn
and Schachner, 1990). During development its expression becomes localised to
synapses (Butler et al., 1998; Persohn and Schachner, 1990) and its expression is
upregulated in response to electrical activity in cultured striatal neurons, an effect
that is mediated by NFkB (Simpson and Morris, 2000). NCAM stimulates neurite
growth from a number of neuronal types in vitro (Skaper et al., 2001) and an NCAM-
mimetic peptide has been found to promote synapse formation and remodelling and
to affect learning and memory in adult rats (Cambon et al., 2003; Cambon et al.,
2004; Dityatev et al., 2004; Flartz et al., 2003). Clustering of NCAM on cultured
cerebellar neurons leads to activation of MAP-kinase (Schmid et al., 1999), which
may then promote dendritic growth, as it does in cultured hippocampal, retinal and
sympathetic neurons (Dimitropoulou and Bixby, 2000; Vaillant et al., 2002; Wu et
al., 2001). NCAM acts principally through homophillic interactions with adjacent
cells. In our culture system, such interactions may be involved in the outgrowth seen
in the neurons cultured at high density (required for transfection using the gene gun)
as the neurons interact with one another. However, they are less likely to be
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implicated in the outgrowth seen in the low-density cultures, in which
pharmacological inhibitors were used or in cultures establish with neurons from
transgenic mice, as contact between individual neurons does not occur. Soluble
NCAMs do, however, promote neurite outgrowth in culture and can be detected in
the extracellular milieu of living cells (Ronn et ah, 1998). Thus, it is possible that
upregulation of NCAM expression in cells plated at low density could be acting in
this manner. Alternatively it has recently been proposed that polysialated NCAM
may sensitise neurons to BDNF. It has been proposed that this may be through
inducing pre-clustering of receptor dimers, modifying the turnover and inactivation
of the receptor, or by directly affecting the ability of the receptor to bind BDNF, thus
amplifying the response of the cell to BDNF (Kiss et ah, 2001). While such an effect
may be important in vivo, where neurons are competing for a limited quantity of
growth factor, it is less likely that such an effect is important in our culture system,
where BDNF is present in excess, particularly as exogenous BDNF can restore
normal function in neurons deficient in PSA-NCAM.
(31-integrin is another NFtcB-upregulated cell adhesion molecule (Wang et ah, 2003).
Unlike NCAM, pi-integrin is involved in mediating the interaction of neurons with
the extracellular matrix, rather than adjacent cells, where heterodimer of a and p
integrins together act as the cell surface receptors for extracellular matrix proteins
such as collagen, laminin and fibronectin (Hikita et ah, 2003; Previtali et ah, 2001).
Interaction between laminin and aipi and a3pi integrins expressed on the growth
cone of developing neurites promotes the growth of sensory and sympathetic neurites
in culture (DeFreitas et ah, 1995; Schmidt et ah, 1995; Tomaselli et ah, 1993) and
anti-integrin pi antibody in combination with anti LI and anti-N-cadherin can reduce
the growth of ciliary ganglion neurons on a monolayer of cultured Schwann cells
(Bixby et ah, 1988). I described earlier the potential for such an interaction itself to
promote NFkB activation. An additional signalling pathway that may be activated to
promote neurite outgrowth through integrin signalling is the Ras-MEK-Erk pathway
(Perron and Bixby, 1999). A final possibility is for an NFKB-regulated protein that
could mediate the promotion of neurite outgrowth is Tenascin-C (Mettouchi et ah,
1997), a protein expressed principally by glial cells in both the peripheral and central
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nervous system. It is also transiently expressed by subsets of neurons in the
embryonic hippocampus and postnatal spinal cord (Ferhat et al., 1996; Zhang et al.,
1995b) and is an extracellular matrix component important in regulating neurite
outgrowth and guidance (Joester and Faissner, 2001).
Cooperation between NFkB and BDNF-activated signalling could also be possible
prior to their ultimate effects on the cytoskeleton. It has been shown that NFkB
requires phosphorylation after it has been released from the IkBcx complex to be at its
most effective in activation gene transcription. This phosphorlyation appears to act
through affecting the ability of NFkB to recruit modulatory proteins that cooperate to
more efficiently activate transcription. MAP kinase has been shown to regulate
NFkB activity in neurons, independently of PI3 kinase and the typical path of NFkB
release from the IkB complex. (Cassarino et al., 2000; Zhou et al., 2004a), and might
thus be involved in post-release modifications of NFkB. However as NFkB alone is
not capable of promoting neurite outgrowth and the 81% drop in NFkB dependent
gene transcription induced in the experiments did not elicit a decrease in neurite
outgrowth as robust as might be expected if NFkB were the principal player, it seems
more likely that it is the consequences of NFkB activated gene transcription that is
cooperating with the downstream effects of an alternative pathway, such as MAPK,
that is concomitantly promoting neurite outgrowth.
In summary, a novel role for NFkB signalling has been characterised. The
experimental findings show that NFkB transcriptional activity promotes the growth
and branching of neuritic processes in the developing peripheral nervous system.
This finding extends improving our understanding of the molecular mechanisms
involved in establishing and refining neuronal connections during development.
Additionally this knowledge has potentially important implications for understanding





The roles of NFkB in neuronal survival and neurite
outgrowth are not mutually exclusive
3.1. Introduction
Nuclear factor kB (NFkB) is a ubiquitously expressed transcription factor involved in
a variety of cellular processes throughout the body. These processes include innate
and adaptive immune responses, stress responses, cell survival, proliferation and
differentiation (Baldwin, Jr., 1996; Karin, 1999; Li et al., 2002). In the previous
chapter I described a novel role for NFkB in regulating neurite outgrowth in
peripheral sensory neurons of the nodose ganglia. Nodose neurons are a well-defined
population of peripheral neurons that can be easily established and maintained in
vitro in the presence of BDNF (Davies et al., 1993). Unlike other populations of
peripheral neurons, no link had been described between BDNF-induced neuronal
survival and NFkB, making this an ideal system in which to investigate the role
NFkB in neurite outgrowth without having to deal with confounding effects of NFkB
on neuronal viability (Hamanoue et al., 1999; Maggirwar et al., 1998). In nodose
neurons cultured in the presence of BDNF, several methods of inhibiting NFkB
signalling caused significant decreases in neurite length and branching, and revealed
the importance of NFkB for neurite outgrowth in vitro. These results raised the
question of whether NFkB has different effects on neurite growth and cell survival in
different types of neurons.
The superior cervical ganglion (SCG), part of the sympathetic nervous system, is
derived from a different precursor cell population than nodose neurons, and responds
to a different set of neurotrophic factors (Le Douarin et al., 2004; Wyatt and Davies,
1995; Zhou and Rush, 1995) reviewed in chapter 1). The survival of these neurons
with NGF is dependent in part on phoshotidylinositol-3 kinase (PI3K) and protein
kinase C (PKC) and, at the transcriptional level, NFkB (Maggirwar et al., 1998;
Pierchala et al., 2004; Tsui-Pierchala et al., 2000). In this chapter I investigate the
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separation between NFrcB-induced neurite outgrowth and survival and whether in
specific cell types NFkB induces exclusively neurite outgrowth or survival, or
whether these effects can occur side by side. I do this by examining the consequences
of inhibiting NFkB signalling in neonatal SCG neurons. Caspases are able to rescue
SCG neurons from NGF deprivation without any observable changes in process
morphology (Werth et al., 2000), and were used to prevent cell death as a
consequence of inhibiting NFkB signalling. I also investigated whether NFkB is
involved in neurite outgrowth in neonatal nodose neurons maintained in vitro by
neuropoietic cytokines. These proteins are as effective as BDNF at promoting
neuronal survival (Chapter 4; (Middleton et al., 2000). Unlike BDNF, however, the
survival response of nodose neurons to these cytokines has been reported to be
dependent on NFkB signalling (Middleton et al., 2000). In this chapter I report that
NFkB regulates neurite length and branching in sympathetic neurons maintained in
culture by NGF and caspase inhibitors. It also plays a role in the neurite outgrowth
from nodose neurons treated with neuropoietic cytokines. However, this effect varies
according to the effectiveness of the individual cytokines at promoting neurite
growth. Additionally, in the experimental paradigm used here, the survival of nodose
neurons in the presence of cytokines does not appear to be NFKB-dependent. My
results suggest that in nodose neurons, NFkB is only involved in promoting neurite




3.2. Material and Methods
Cultures of nodose neurons were established, transfected and analysed in the manner
described in chapter 2. Briefly, PO mice were killed by carbon dioxide asphyxiation
followed by decapitation, and the nodose ganglia dissected. Ganglia were then
dissociated by trypsinisation followed by trituration and plated in defined serum-free
medium (see appendix) on a polyornithine/laminin substratum in 35mm tissue
culture dishes. Transfection was performed using ballistic transfection of gold
microcarriers coated with plasmids coding for pYFP and either pSR-IxB-a or a
pCDNA control plasmid, and the cultures supplemented with 50ng/ml CNTF or LIF
(Chemicon, CA). Neuronal survival was estimated by counting the number of
neurons labelled with YFP surviving 48 hours after transfection and expressing this
as a percentage of the number of labelled neurons counted 12 hours after
transfection. Each cell was also examined using phase-contrast conditions to
corroborate cell survival. At 24 and 48 hours after transfection, neurons were
digitally imaged using confocal microscopy and neurite outgrowth quantified using
Sholl analysis (Sholl, 1953), and for total neurite length and number of branch
points.
SCG neurons were cultured in a similar manner to that of nodose neurons. The SCG
is located adjacent to the nodose ganglia in embryonic and early postnatal mice
therefore the dissection is identical until the last step when the SCG, rather than the
nodose ganglia, is removed. The location of the SCG can be seen in figure 2.1.
Trypsinisation and trituration was identical to that of the nodose ganglia. For the
cultures where the pharmacological inhibitor BAY 11-7082 was used the neurons
were plated on the same polyornithine/laminin substratum in 35mm dishes, however
cultures of neurons that were to be treated with the NFkB inhibitory peptide SN50
were established in dishes 35mm dishes containing four 11mm wells, in a total
volume of 80pl, to minimise the quantity of the peptide required. All SCG cultures
were performed at low cell densities and supplemented with lOng/ml NGF.
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Investigating the potential role of NFkB signalling in regulating the growth of
sympathetic neurons was complicated by the fact that NFkB is involved in mediating
the survival-promoting effects of NGF (Maggirwar et al., 1998). This would mean
that if neurons were cultured with NGF and NFkB inhibitor alone any effect on
neurite outgrowth could be attributed to the loss of a specific subpopulation of NFkB
dependent neurons. To circumvent this effect, cultures were treated with the caspase
inhibitor Boc-D-FMK (Caspase inhibitor III, Calbiochem, UK) at a concentration of
250pm. Neurotrophic factors (NGF, lOng/ml) were added after an initial cell count
and a 45min pre-incubation with the caspase inhibitor plus either BAY 11-7082
(lOpM) or SN50 (25pg/ml). Survival and neurite outgrowth were quantified as
described in chapter 2. All statistical comparisons are performed using ANOVA




The results in the previous chapter showed that NFkB is important in regulating the
growth and morphology of nodose neurons cultured in the presence of BDNF. In this
chapter I performed further studies to investigate whether this role was maintained in
neurons in which NFkB is also required for cell survival.
3.3.1. NFkB signalling is important to the neurite outgrowth of
neonatal sympathetic neurons
The aim of this first investigation was to study whether NFkB is involved in neurite
outgrowth in the sympathetic neurons of the superior cervical ganglion (SCG), a
population of peripheral neurons in which NFkB has previously been shown to
mediate neurotrophin-induced neuronal survival (Maggirwar et al., 1998). Neonatal
SCG neurons were cultured in the presence of NGF and treated with either BAY 11-
7082, an inhibitor of IkB-cx phosphorylation, or SN50. SN50 is synthetic peptide that
contains the nuclear localisation sequence of p50, thus inhibiting the translocation of
active NFkB dimers to the nucleus. SN50 has previously been shown to be effective
in preventing NFKB-induced gene transcription in sympathetic neurons, and
consequently to decrease the survival response of SCG neurons to NGF (Maggirwar
et al., 1998). Neurons were imaged using a confocal microscope after a 24h
incubation and neurite outgrowth assessed by Sholl analysis and measurement of
total neurite length and branching. The potential confounding effect of NFkB on
neuronal survival was controlled by also treating cultures with caspase inhibitor III,
an irreversible broad-spectrum caspase inhibitor, which is capable of rescuing
neurons from death induced by neurotrophin withdrawal (Werth et al., 2000).
3.3.1.1. BAY 11-7082 reduces the NGF-induced neurite
outgrowth of SCG neurons maintained in vitro in the
presence of caspase inhibitors
P0 SCG neurons were grown in low-density dissociated cultures in defined medium
supplemented with NGF (lOng/ml) and caspase inhibitor III (250pM), and half the
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culture dishes were treated with BAY 11-7082 (lOpM). Figure 3.1 A shows the
survival of these neurons after 24 hours in culture. Sixty percent of SCG neurons
cultured in medium supplemented with NGF alone were surviving after 24 hours,
while in unsupplemented medium less that 5% of the neurons remained. Caspase
inhibitor III, in the absence of any trophic support, rescued the same proportion of
SCG neurons that were supported by the presence of NGF alone, as there is no
significant difference between the survival between these two groups (p>0.5) and no
additive effect of treating SCG neurons with both NGF and caspase inhibitor III. The
addition of BAY 11-7082 to neurons cultured in the presence of NGF killed 81% of
neurons and these were also effectively rescued by the addition of caspase inhibitor
III to the culture medium. These results confirm that NGF-induced neuronal survival
is NFkB dependent, as treating NGF-supported neurons with the MB-a
phosphorylation inhibitor BAY 11-7082 resulted in a significant amount of cell
death. As caspase inhibitor rescued all neurons in the BAY 11-7082 treated cultures,
neurite outgrowth in BAY 11-7082-treated neurons was studied independently of the
effect of this compound on neuronal survival.
Neurite outgrowth was quantified in images of neurons captured after 24 hours in
culture. The resultant Sholl analysis can be seen in Figure 3. IB. Neurons cultured in
medium supplemented with NGF alone extended large neurite arbours, which
produced a Sholl analysis similar in shape to the equivalent culture of nodose
neurons, with peak of 7.7 intersections at 210pm from the cell soma. Interestingly
addition of caspase inhibitor III to these neurons produced a significant decrease in
the number of intersections at each ring between 90 and 450pm from the cell body
*
Figure 3.1 BAY 11-7082 reduces neurite outgrowth from SCG neurons
P0 SCG neurons were incubated in medium containing lOOpM caspase inhibitor III, lOng/ml NGF
and either the IkB-oi phosphorylation inhibitor BAY 11-7082 at a concentration of lOnM or vehicle
control. Vehicle treated neurons were also grown without NGF. A) Percent survival after 48h in
culture. B) Sholl analysis of neurite arbor morphology after 24h in culture. C) Total neurite length
after 24h in culture. D) Number of branch points in neurite arbors after 24h in culture. E)
Photomicrographs of a typical p-III tubulin stained, vehicle or BAY 11-7082 treated neurons grown
for 24 hours with NGF and caspase inhibitor III (Scale bar = 50 gm). The means and standard errors
of data obtained from 60-90 neurons in each experimental condition shown. Statistical comparisons
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(p<0.05 for rings 90-180; p<0.001 for rings 210-450). This effect could represent a
direct involvement of caspases in neurite outgrowth or could be due to the neurons,
whilst surviving, not being as healthy as neurons grown in the presence of NGF
alone. Most important, however, is the observation that neurons grown with NGF
plus caspase inhibitor and treated with BAY 11-7082 exhibited a highly significant
decrease in neurite outgrowth compared to neurons grown with NGF plus caspase
inhibitor alone. The number of intersections per ring, in the vehicle-treated group,
increased from 3.7 intersections at 30pm to 5.8 intersections at 150pm from the cell
body, subsequently decreasing slowly towards 450pm. In neurons treated with BAY
11-7082, the initial number of intersections was very similar, starting at 3.8
intersections at 30pm, but there was no following peak, with the mean number of
intersections tailing off rapidly until 150pm, where there was less than 1 intersection
per ring (p<0.001 from the 60pm ring onwards). The only distinction between this
BAY 11-7082-treated group of neurons and those grown with caspase inhibitors
alone appears to be that they extended more initial neurites. Typical neurons from the
NGF + caspase inhibitor III and the NGF + caspase inhibitor + BAY 11-7082 groups
can be seen in figure 3. IE. The effects of treatment with caspase inhibitors and BAY
11-7082 seen in the Sholl analysis are also reflected in the quantification of total
neurite length, where addition of caspase inhibitors to NGF-treated neurons caused a
28% decrease in total neurite length and a further addition of BAY 11-7082 resulted
in an additional decrease in length of 56%. Interestingly, while addition of caspase
inhibitors to NGF-treated neurons also resulted in a 39% decrease in neurite
branching, the further addition of BAY 11-7082 produced only an additional 18%
decrease in neurite outgrowth, an effect that was not significantly different from that
of adding only the caspase inhibitor to NGF-treated neurons (p>0.1), suggesting that
in SCG neurons NFkB may only be involved in signalling neurite growth, and not in
neurite branching. Nevertheless, these results suggest that the phosphorylation of
IkB-oi is important for NGF-promoted neurite outgrowth in neonatal SCG neurons.
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3.3.1.2. SN50 reduces the NGF-promoted outgrowth of SCG
neurons grown in the presence of caspase inhibitors
The role of NFkB in the neurite outgrowth of SCG neurons was confirmed using the
inhibitory peptide SN50, previously used by (Maggirwar et ah, 1998) to interfere
with NFicB-dependent neuronal survival. Neurons were cultured in the same manner
as in the previous study, with different combinations of NGF (lOng/ml), caspase
inhibitor III (250pM) and SN50 (25pg/ml) or its inactive control peptide, SN50M, at
the same concentration. SN50 has been reported to completely block NGF induced
neuronal survival in SCG neurons at lOOpg/ml, with this effect disappearing by the
time this concentration is reduced to 50pg/ml (Maggirwar et ah, 1998). In our hands
SCG neurons proved more sensitive to SN50, with maximal cell death being
observed at a concentration of 50pg/ml (data not shown) and significant cell death
(50.3%, p<0.001) still being detected at dose of 25pg/ml (figure 3.2A). It was this
lower concentration that was used in the analysis of neurite outgrowth, as 250pM
caspase inhibitor III was unable to completely reverse the cell death induced by
50pg/ml SN50 (data not shown).
Neurite outgrowth was analysed in images of SCG neurons taken 24 hours after the
addition of trophic support. Sholl analysis revealed that neurons cultured in the
presence of NGF, caspase inhibitor III and SN50 had less intersections with each
ring between 60pm and 450pm from the cell body, as compared to neurons treated
with NGF, caspase inhibitor III and the control peptide. This difference reached
significance at 180pm from the cell soma (p<0.05) and between 240 and 450pm
from the cell soma (figure 3.2B). This effect could also be seen in the analysis of
Figure 3.2 SN50 reduces neurite outgrowth from SCG neurons
P0 nodose neurons were incubated in medium containing lOOpM caspase inhibitor III, lOng/ml NGF
and either the NFkB inhibitory peptide SN50 at a concentration of 25pg/ml or a peptide control
(SN50M). Control treated neurons were also grown without NGF. A) Percent survival after 48h in
culture. B) Sholl analysis of neurite arbor morphology after 24h in culture. C) Total neurite length
after 24h in culture. D) Number of branch points in neurite arbors after 24h in culture. E)
Photomicrographs of a typical P-III tubulin stained, control or SN50 treated neurons grown for 24h
with NGF (Scale bar = 50 pm). The means and standard errors of data obtained from 60-90 neurons in
each experimental condition shown. Statistical comparisons shown are with respect to the control
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total neurite length, where SN50 induced a 19% larger decrease in total neurite
length than that observed in neurons grown with NGF, caspase inhibitor III and
treated with the control peptide SN50M (p<0.05) (figure 3.2C). As with BAY 11-
7082, there was not a significant difference between the decrease in number of
branch points seen with neurons supported by NGF and caspase inhibitor III and
treated with SN50 (46%) and neurons grown in the same conditions but treated with
SN50M (37%) (Figure 3.2D). Typical neurons from the NGF + caspase inhibitor III
+ SN50M and the NGF + caspase inhibitor + SN50 groups are shown in figure 3.2E.
Taken together with the data shown in figure 3.1, these results suggest NFkB-
activated gene transcription is important in promoting extension, but not branching
of neurites in SCG neurons.
3.3.2. CNTF, but not LIF, promotes the outgrowth of neonatal
nodose neurons through NFKB-activated gene transcription
The second group of investigations addressed the question of whether NFkB is
involved in the outgrowth of neonatal nodose neurons maintained in vitro by
neuropoietic cytokines. This was done by transfecting neonatal nodose neurons with
the super-repressor IkB-cc construct, culturing them in the presence of either CNTF
or LIF and analysing outgrowth and survival.
3.3.2.1. Super-repressor IkB-o reduces CNTF-induced
neurite outgrowth in nodose neurons
Dissociated cultures of P0 nodose neurons were established and cultured for three
hours in the absence of neurotrophic factors until they had attached to the culture
dish. Using the Helios gene gun, neurons were transfected with pYFP in combination
with either the super-repressor MB-a construct or an empty control plasmid. At this
point CNTF (50ng/ml) was added and the cultures were incubated at 37°C for 24
hours before the neurons were imaged for analysis of neuronal morphology. A
further set of images was also taken at 48 hours to assess the morphology of the
neurons at this later time point. Neuronal survival was assessed by comparing the
number of YFP-positive neurons surviving at 48 hours to the number of neurons













30 90 150 210 270 330 390 450

















30 90 150 210 270 330 390 450






























h24 h48 h24 h48
Figure 3.3
113
Figure 3.3 Super-repressor IkB-o. reduces neurite growth from neonatal nodose neurons cultured in
the presence ofCNTF, but does not affect survival
PO nodose neurons were transfected with a YFP expression plasmid together with either a super-
repressor IkB-u plasmid or an empty control plasmid and incubated in medium containing 50 ng/ml
CNTF. Control transfected neurons were also grown without CNTF. A) Percent survival 48 hours
after transfection. B) Sholl analysis of neurite arbor morphology 24 hours after transfection. C)
Sholl analysis of neurite arbor morphology 48 hours after transfection. D) Total neurite length 24
and 48 hours after transfection. E) Number of branch points in neurite arbors 24 and 48 hours after
transfection. F) Photomicrographs of a typical control and super-repressor IkB-o transfected
neurons grown for 24 and 48 hours with CNTF (Scale bar = 50 pm). The means and standard errors
of data obtained from 60-90 neurons in each experimental condition are shown. Statistical
comparisons shown are with respect to the control transfected neurons, * p<0.05, ** pO.OOl.
114
Chapter 3
neurons transfected with IxB-a and cultured for 48 hours in the presence of CNTF
survived, which was as good as the survival of control transfected neurons (61%),
and this survival was significantly above that of control-transfected neurons cultured
in the absence of neurotrophic support (29%; pcO.OOl). This suggests that, in this
culture system, blocking NFkB activation by using super-repressor IkB-oi has no
effect on neuronal survival.
Neuronal morphology was analysed by Sholl analysis and by measuring total neurite
length and the number of branch points for each neuron. Figures 3.3B and C show
the Sholl analysis of neuronal morphology at 24 and 48 hours respectively. An
additional analysis of neurite length was performed at 48 hours as the overall neurite
arbours in these cultures appeared smaller at 24 hours than those of the cultures
shown in chapter 2, where neurons were grown in the presence of BDNF. PO control-
transfected neurons cultured for 24 hours in the presence of BDNF had a maximum
no of intersections of 14.2 at a mean distance of 150pm from the cell body, whereas
in neurons cultured for 24 hours in the presence of CNTF the maximum number of
intersections in control-transfected neurons was only 5.5 and this occurred at 60pm.
At 48 hours this had increased to 6.6 intersections at the ring 120pm from the cell
soma. However this still did not approach the outgrowth seen in BDNF-treated
neurons at 24 hours, suggesting that CNTF is less effective than BDNF at promoting
neurite outgrowth, despite promoting similar effects on neuronal survival. At both 24
and 48 hours after transfection, the neurite outgrowth seen in neurons transfected
with super-repressor IkB-cx was significantly decreased compared to control
transfected neurons. At 24 hours the number of intersections per ring barely
increased after the first ring, and was half that seen in control neurons (2.6
intersections at 60pm; p<0.001). At 48 hours a peak could be seen, but this is at 90
rather than 120pm from the cell body and only 4.6 intersections were counted at the
maximum, compared to 6.6 in control neurons. These differences are reflected in the
analysis of total neurite length, where 57% and 33% decreases were seen at 24 and
48h respectively (p<0.001; figure 3.3D). Likewise, there were 40% and 37%
decreases in branches detected at 24 and 48h respectively (p<0.05 and p<0.001;
figure 3.3E). At both time points, however, the length and branching seen in IkB-cx
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transfected neurons was higher than that seen in control-transfected neurons cultured
in the absence of trophic support. Typical control and IidB-a transfected neurons
cultured in the presence of CNTF are shown in figures 3.3F and G (24 and 48h
respectively). Overall these results suggest that while CNTF is less effective than
BDNF at promoting neurite outgrowth in neonatal nodose neurons, there is a similar
requirement for NFkB signalling to promote neurite outgrowth when nodose neurons
are cultured in the presence of CNTF.
3.3.2.2. Super-repressor IkB-o does not effect the neurite
outgrowth of nodose neurons cultured in the presence
of UF
To assess whether NFkB is also necessary to promote neurite outgrowth in neurons
cultured in the presence of LIF, dissociated cultures of PO nodose neurons were
established and transfected in the same manner as that described for CNTF. Neuronal
survival was assessed after 48 hours in culture with LIF, where transfection with
IkB-o. had no effect of neuronal survival compared to control-transfected neurons
(figure 3.4A). Neuronal morphology was assessed at 24, 48 and 72 hours after
transfection and it was found that LIF is a poor promoter of neurite outgrowth, even
when compared to the growth promoting ability of CNTF. Analysis of total neurite
length and number of branch points showed that by 48 hours in vitro, neurites of
Figure 3.4 Super-repressor IxB-does not affect the survival or neurite growth from neonatal nodose
neurons cultured in the presence ofLIF
PO nodose neurons were transfected with a YFP expression plasmid together with either a super-
repressor IkB-ci plasmid or an empty control plasmid and incubated in medium containing 50 ng/ml
LIF. Control transfected neurons were also grown without LIF. A) Percent survival 48 hours after
transfection. B) Total neurite length up to 72 hours after transfection. C) Number of branch points in
neurite arbors up to 72 hours after transfection. D) Sholl analysis of neurite arbor morphology 24
hours after transfection. E) Sholl analysis of neurite arbor morphology 48 hours after transfection. F)
Sholl analysis of neurite arbor morphology 72 hours after transfection. G) Photomicrographs of a
typical control and super-repressor IkB-cx transfected neurons grown for 24, 48 and 72 hours with LIF
(Scale bar = 50 pm). The means and standard errors of data obtained from 60-90 neurons in each
experimental condition are shown. Statistical comparisons shown are with respect to the control
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neurons cultured in the presence of CNTF were 30% longer and possessed 187%
more branch points than neurons cultured with LIF (compare figures 3.3D and E
with 3.4B and C). By Sholl analysis, control neurons cultured in the presence of LIF
showed a peak number of intersections (3.0) at 90pm from the cell body at 24 hours
(fig 3.4D), which increased to only 3.9 intersections at 150pm 48 hours after
transfection (figure 3.4E). By 72 hours after transfection the maximal number of
intersections had decreased, to 2.6 intersections, although this peak was further from
the nucleus, at 180pm, and a significant difference in number of intersections
between the control transfected neurons cultured in the presence of LIF and the
control-transfected neurons cultured in the absence of neurotrophic support was only
achieved at 330, 390, 420 and 450pm from the cell body (p<0.05; figure 3.4F). In
neurons transfected with IkB-cx there was a tendency towards a decrease in the
number of intersections, however this only reached significance at two distances
(210 and 330, p<0.05) at 24 hours after transfection and two distances (210 and
330pm, p<0.05) 72 hours after transfection. Transfection of LIF-treated neurons with
the super-repressor IkB-cx plasmid caused a significant decrease in total neurite
length only at 72 hours after transfection (46%; p<0.05) and has no significant effect
on the number of branch points at any time point (Figure 3.4B and C). Overall these
results suggest that LIF is ineffective at promoting neurite outgrowth in neonatal
nodose neurons, as compared to either CNTF or LIF, and that transfection with




This study investigated whether the two roles of NFkB previously identified in
neurons, survival (Maggirwar et al., 1998; Middleton et ah, 2000) and neurite
outgrowth (chapter 2), are mutually exclusive or whether, in some circumstances,
NFkB is capable of influencing both neuronal survival and neurite outgrowth
simultaneously. This was done by investigating the consequences of inhibiting NFkB
activation in nodose neurons cultured in the presence of neuropoietic cytokines and
in SCG neurons sustained in vitro by NGF.
In neonatal nodose neurons, both CNTF and LIF effectively promoted neuronal
survival, but that LIF was a much poorer promoter of neurite outgrowth, as compared
to CNTF. After 48 hours in vitro, neurites of neurons cultured in the presence of
CNTF were 30% longer and possessed a massive 187% more branch points than
neurons cultured with LIF, with this decreased branching meaning that in the Sholl
analysis the growth of LIF-treated neurons was barely above that of neurons cultured
without neurotrophic support. Generally, in the nervous system, there are few
reported differences between either the in vitro or in vivo effects of CNTF and LIF
(Turnley and Bartlett, 2000), an impression substantiated by the considerable
redundancy between neuropoietic cytokines revealed by comparison of ligand and
receptor knockout animals (DeChiara et al., 1995; Li et al., 1995; Masu et al., 1993;
Ware et al., 1995). One interesting difference that is observed concerns
differentiation. Some cell types release CNTF in combination with soluble CNTFRa,
allowing CNTF to act on cells that do not themselves express CNTFRa (Elson et al.,
2000; Marz et al., 1999). Marz et al. (2002), have produced a CNTF-sCNTFRa
fusion protein (hyper-CNTF) and compared its effects to those of LIF in several cells
lines, finding that in PC 12 cells hyper-CNTF, but not LIF, induced differentiation
into a neuronal phenotype. They also observed that while both LIF and hyper-CNTF
induced STAT-3 activation in this cell line, only hyper-CNTF was capable of
activating MAP kinase. This agrees with earlier studies that have shown the ability of
neuropoietic cytokines to induce neuronal differentiation or gliogenesis in neural
precursors depends upon a balance between the activation of the MAP kinase and
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JAK-STAT signalling pathways, both of which are initiated by activation of the LIF
receptor(3/gpl30 receptor complex (Bonni et al., 1997; Ihara et ah, 1997). The
presence of other neurotrophic factors, including NGF, can alter the final phenotype
of neural precursor cells in vitro. This effect can be brought about by activation of
MAP kinase pathways or by inducing the activation of SOCS (Suppressor of
Cytokine Signalling) proteins that are capable of inhibiting JAK-STAT signalling
(Ihara et ah, 1997; Turnley and Bartlett, 2000) (Li and Stark, 2002). If the balance
swings towards more MAP kinase activation a neuronal phenotype, and consequently
neurite outgrowth, is observed (Ihara et ah, 1997; Turnley and Bartlett, 2000).
Both CNTF and LIF are capable of promoting neurite outgrowth. However, the
presence of other factors or cells can influence the ability of these factors to promote
neurite outgrowth and survival, and can even cause neuropoetic cytokines of have an
inhibitory effect on the growth of some processes (Burnham et ah, 1994; Edoff and
Jerregard, 2002; Gillespie et ah, 2001; Goldberg et ah, 2002; Guo et ah, 1997; Guo et
ah, 1999; Kessler et ah, 1993; Ng et ah, 2003; Richards et ah, 1992). Such retractory
effects can be important in establishing neuronal morphology (Guo et ah, 1999). Guo
et al (1999) found that LIF and CNTF inhibited dendritic formation and caused
dendritic retraction in sympathetic neurons cultured with BMP-7 and NGF. Ng et al
(2003) found that LIF and CNTF, when used in combination with NGF, in either
PC 12 cells or sympathetic neurons decreases NGF-induced neurite outgrowth
through inhibition of Racl activation (Ng et ah, 2003). Thus a similar change in the
balance between the JAK-STAT and MAP kinase signalling to that which alters the
effect of cytokines on differentiation may explain the switch between neuropoietic
cytokines promoting or inhibiting neurite outgrowth in different circumstances. A
difference in the abilities of CNTF and LIF to activate MAP kinase signalling in
neonatal nodose neurons, similar to that described by (Marz et ah, 2002) in PC12
cells, could explain the different outgrowth responses seen in my experiments.
In neonatal nodose neurons supported in vitro by CNTF I found that transfection
with the super-repressor IkBcx plasmid had no effect on survival, but caused a
significant decrease in neurite outgrowth. In neurons maintained by the presence of
LIF, transfection with super-repressor IicBa had no effect on survival, but unlike
120
Chapter 3
neurons sustained with CNTF, no effect on neurite outgrowth was not found. It is
possible that an effect on neurite growth was undetectable in LIF-supplemented
cultures because the low level of neurite growth promoted by this factor.
Alternatively, the additional neurite outgrowth seen in CNTF-stimulated neurons
could be via an NFicB-dependent pathway not activated by LIF.
While BDNF does not activate NFicB-induced gene transcription, it has been shown
that cytokines can activate NFkB (Middleton et ah, 2000; Nishimune et al., 2000).
Nishimune et al. (2000) found that overexpression of IkBo. abrogated the CNTF-
induced survival response in motoneurons, while Middleton et al. (2000) found that
microinjection of a construct coding for super-repressor IkBcx into El8 nodose
neurons prevented both CNTF- and LIF-induced neuronal survival. Using particle-
mediated gene transfection in neonatal neurons, we could not confirm the effect of
transfecting nodose neurons with pSR-ItcBa, reported in Middleton et al. (2000), on
neuronal survival in the presence of CNTF, although the observed effect on neurite
outgrowth confirms that our plasmid was functional. The culture systems used were
very similar, however there are a few possibilities to explain this difference. One
possibility is that the sensitivity of CNTF-supported nodose neurons to inhibition of
NFkB activation is lost between E18 and P0. Alternatively, the high density cultures,
used for ballistic transfection could potentially have affected the need for functional
NFkB signalling to promote neuronal survival. If this were true, however, one might
expect culturing neurons at high density alone might be sufficient to promote
significant neuronal survival, which is not the case.
In agreement with Maggirwar et al. (1998), I found that NFkB is important for NGF-
induced neuronal survival of SCG neurons. Furthermore, the ikb-phosphorylation
inhibitor BAY 11-7082 and the inhibitory peptide SN50 also caused significant
decreases neurite outgrowth in SCG neurons whose survival was sustained by
caspase inhibitors. This suggests that whereas NFkB regulated the survival and
neurite growth of SCG neurons, it appears only to be important for regulation of
neurite growth in sensory neurons of the nodose ganglia.
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Although NFkB plays a role in regulating neurite outgrowth in both sympathetic and
sensory neurons, the effects of inhibiting NFkB in these two types of neurons are
qualitatively and quantitatively different. While interfering with NFkB signalling
caused decreases in both total neurite length and the number of branch points in
nodose neurons, interfering with NFkB signalling in SCG neurons affected neurite
extension to a greater extent but had no effect on branching. This difference may be
due to the manner of NFkB activation in the different neuronal types. While NFkB
activation in nodose neurons is independent of BDNF, NGF has previously been
shown to activate NFkB to promote neuronal survival (Maggirwar et al., 1998). It is
likely that this activation route also occurs in the cultures described in this chapter as
a comparable role for NFkB in the survival of SCG neurons is observed. Thus NGF-
activated NFkB could be mediating some neurite outgrowth in SCG neurons.
In PC 12 cells, more than one pathway leading from NGF exposure to NFkB
activation has been described. Mamidipudi et al. describe the formation of a complex
including both p75 and TrkA linked through IRAK, p62 and traf6, leading to
activation of an atypical PKC, which phosphorylates IKK(3 to cause NFkB release
through IkB degradation (Mamidipudi et al., 2002; Mamidipudi and Wooten, 2002).
An atypical pathway for the activation of NFkB by NGF has also been described
(Bui et al., 2001). Rather than serine phosphorylation causing targeted degradation of
IkBcx, they showed that NGF-induced tyrosine phosphorylation of IkBcx led to
activation of NFkB without significant MBa degradation. It is not known if NFkB is
constitutively active in SCG neurons, as is the case nodose neurons. In future
experiments it would be interesting to investigate whether NFkB is constitutively
active in neonatal sympathetic neurons in vitro, and determine whether NGF causes
additional activation of NFkB in these neurons. Also, it will be important to ascertain
whether constitutive and induced NFkB activation in these neurons occurs via
tyrosine or serine phosphorylation of IkBol
The roles of NFkB in development are different in different neuronal populations. In
nodose neurons NFkB is involved exclusively in neurite outgrowth, while in neurons
of the SCG NFkB is involved in both survival and outgrowth. Additionally, the
change in outgrowth induced by interfering with NFKB-activated gene transcription
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in the two different populations appears different in character. For neurite outgrowth,
however, the role of NFkB is restricted to a similar time window in both populations.
In chapter 2,1 showed that NFkB is only involved in promoting neurite outgrowth
between E18 and PI, while in SCG neurons the effect of NFkB is also
developmentally restricted, with no effect being detected at E17, but with a small
effect still being detectable by P5 (D Gallager; personal communication). Although
further clarification of this time window is necessary, a slightly later time window is
consistent with NFkB being important for neurite outgrowth at the same stage of
development of SCG neurons as occurs in nodose neurons, as neurons of the SCG
develop slightly later than those of the nodose ganglia.
An interesting additional observation made from my studies of sympathetic neurons
was that the broad-spectrum caspase inhibitor induced a decrease in total neurite
length of between 19% and 28%, and a decrease in neurite branching of just under
40% in SCG neurons grown with NGF. While caspases play a key role in bringing
about apoptosis, they have recently been implicated in neuronal growth and
plasticity, as well as differentiation and cell cycle progression in a number of cell
types (Fadeel et al., 2000; Fernando et al., 2002; Gilman and Mattson, 2002;
Gulyaeva, 2004; Los et al., 2001). Specific caspases are localised in developing
neurites and adult synapses (Shimohama et al., 2001a; Shimohama et al., 2001b; Yan
et al., 2001) and caspase-3 has been found to be necessary for normal long-term
potentiation in hippocampal neurons (Gulyaeva et al., 2003). Caspases have also
been found to be important in long-term, but not short-term, spatial memory (Dash et
al., 2000). Gilman and Mattson (2002) found that the use of a broad-spectrum
caspase inhibitor in embryonic hippocampal neurons resulted in an increase in the
rate of neurite extension and suggest that this is a consequence of caspase cleavage
of proteins involved in neurite outgrowth including actin and members of the Ras
and Rho families of GTPases. Therefore, while it is possible that the decrease in
neurite outgrowth seen in our experiments could be due to a sub-toxic, but
nevertheless deleterious, effects of the caspase inhibitor on neuronal health, it could
also be that this effect reflects an involvement of caspases in neurite outgrowth. In
other studies of SCG neurons, caspase inhibitors have been used to maintain neurons
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during NGF deprivation without any observable changes in process morphology,
although small reversible changes in the electrical properties of these neurons were
detected (Werth et ah, 2000). These studies, using different caspase inhibitors, have
suggested that the involvement of caspases in neurite outgrowth vary. It will be
interesting in future to see whether caspases are physiological regulators of neurite
growth.
In summary, the data reported in this chapter shows that NFkB is involved in the
regulation of neurite outgrowth, but not survival, in nodose neurons, while in
sympathetic neurons, inhibition of NFkB signalling results in both decreased survival
and neurite outgrowth. These findings indicate that NFkB may regulate one or more




Reg-2 is involved in the regulation of neuronal survival in
the developing mouse peripheral nervous system.
4.1. Introduction
Reg-2 is a 65kDa protein, also called Reg-IIlp in mice, or pancreatitis associated
protein (PAP), peptide-23 or HIP (gene induced in hepatocellular carcinoma,
intestine and pancreas) in rats and humans. It is expressed in developing sensory and
motor neurons and its expression in the rat small intestine is developmentally
regulated, corresponding principally with the period of high cell stress during
weaning (Chakraborty et al., 1995; Livesey et al., 1997). Adult mice also express
Reg-2 at lower levels in the small intestine, pancreas and colon (Narushima et al.,
1997). In many cells its expression can be regulated by cytokines, particularly TNF-
a, IL-6 and CNTF via MEK1 or STAT3 (TNF-a and IL-6/CNTF respectively
(Chakraborty et al., 1995; Dusetti et al., 1995; Nishimune et al., 2000). Reg-2 has
several physiological effects, with its predominant role being the promotion of
growth and survival in a range of cell types. Reg-2 is anti-apoptotic for
gastrointestinal epithelial and pancreatic acinar cells and in the nervous system it acts
on both neuronal and non-neuronal cells, promoting Schwann cell mitogenesis and
motor neuron survival (Christa et al., 1996; Livesey et al., 1997; Nishimune et al.,
2000; Ortiz et al., 1998). Indeed, in cultured motor neurons Reg-2 has been found to
be an obligatory signalling intermediate for CNTF-induced neuronal survival
(Nishimune et al., 2000). As yet, no receptor for Reg-2 has been discovered. Reg-2 is
detected in sera from patients suffering from hepatocellular carcinoma and is
secreted by proliferating ductules, rat uterine and pituitary cells and during
pancreatitis (Chakraborty et al., 1995; Christa et al., 1999; Iovanna et al., 1994;
Katsumata et al., 1995). In the nervous system, application of the exogenous protein
to cultured cells elicits survival effects, and in vivo anti-Reg-2 antibodies block
regenerative effects after nerve injury (Livesey et al., 1997; Nishimune et al., 2000).
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In both the developing and adult nervous system, neuropoietic cytokines have several
roles, including proliferation, survival, differentiation, regeneration, maintenance of
neurotransmitter phenotype and plasticity (reviewed in (English, 2003; Profyris et ah,
2004; Stankoff et ah, 2002; Turnley and Bartlett, 2000). In chapter 3 I demonstrated
that NF-kB regulates the growth, but not survival, of newborn nodose neurons in
response to CNTF. This suggests that at some point following the activation of the
CNTF receptor complex, the pathways transducing survival- or neurite outgrowth-
promoting effects in these neurons diverge. Current knowledge of CNTF-induced
signalling pathways in other neuronal populations suggests that CNTF binding to the
gpl30-FIFRP-CNTFRa complex induces janus kinases (JAK) to phosphorylate
several tyrosine residues on the cytoplasmic tail of the gpl30 protein. This creates
docking sites for a range of proteins containing SH2 domains and subsequent
activation of kinases such as PI3- kinase and MAP kinases, and transcription factors
such as STAT-3 (Ffeinrich et ah, 2003; Turnley and Bartlett, 2000). One point of
divergence in the signalling of survival and outgrowth is potentially Reg-2. In motor
neurons, exposure to CNTF leads to STAT-3 activation and Reg-2 production, with
Reg-2 then promoting neuronal survival via PI3K and NFkB (Nishimune et ah,
2000). In this population, Reg-2 expression occurs at a late stage in development,
after target innervation is established, thus excluding Reg-2 from a major role in
neurite outgrowth (Nishimune et ah, 2000). Activation of other pathways, such as the
MAP kinase cascade, could support neurite outgrowth. The results presented in
chapter 3 already suggest that there are differences in the outgrowth- and survival-
promoting signalling pathways induced by CNTF between central motor neurons and
peripheral sensory neurons, as super-repressor IxBa does not affect sensory neuron
survival. I therefore chose to investigate the relationship between Reg-2 and CNTF
in nodose neurons and trigeminal neurons, which also respond to CNTF.
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4.2. Materials and Methods
4.2.1. Neuronal culture
Dissociated cultures of nodose and trigeminal ganglia neurons were set up from
embryos and early postnatal mice obtained from overnight matings of CD1 mice, and
cultured in the manner described in chapter 2. All the cultures were established in
35mm culture dishes except for those used in the initial dose-response experiment.
This experiment was performed in 35mm dishes containing four 11mm wells in
order to conserve Reg-2 protein, as limited quantities were available. This protein
was a gift from C. Henderson (INSERM U382, IBDM, Marseille, France) and had
been purified from adult rat pancreatic juice (Nishimune et al., 2000). The use of 4-
well dishes is described for the SCG cultures in chapter 3.
The murine trigeminal ganglia are located in the base of the skull. The dissections
were performed differently depending on the age of the embryo. Up to E14, the
trigeminal ganglia were isolated by using tungsten needles (E12) or fine scissors
(E14) by making two coronal incisions, one just above the eye, and the other
between the maxillary and mandibular processes of the first brachial arch (figure
4.1). The trigeminal ganglia are thus revealed as two opaque structures in the this
tissue slice which can be freed from the tissue slice and cleaned of any remaining
connective tissue using tungsten needles. Ganglia from mice of E16 or over were
dissected by using fine scissors to remove the top of the skull, after which the brain
was removed. This revealed the trigeminal ganglia, resting in two niches in the base
of the skull. These ganglia were removed using forceps and cleaned of all connective
tissue using tungsten needles.
Dissected ganglia were trypsinized and triturated as described in chapter 2.
Trypsinisation time varied from 8 to 30 minutes depending on the age of the mice.
All trigeminal ganglia of E18 and over and nodose ganglia at PI and older destined
for RT-PCR were purified using differential sedimentation techniques. For this
purification, trypsinized ganglia were washed in F12 plus 10% HIHS to inactivate
the trypsin, then in CMF-HBSS and trituration performed in 1ml CMF-HBSS. This
127
A B
Figure 4.1 Dissection of the trigeminal ganglia
A) The lateral aspect of an El 1 head showing the location of the transverse incisions made in order
to obtain a tissue slice containing the trigeminal ganglia. B) The rostral aspect of the tissue slice
containg the trigeminal ganglia (TG). Mx, Maxillary process; Mn Mandibular process; IV fourth
ventricle. Taken from Davies, 1995
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cell suspension-was layered on top of 50-60ml F14 + 10% HIHS which had been
placed in a 100ml glass dropping funnel on a vibration free platform at 4°C the
previous evening. After one hour, the medium was carefully run off the column in
5ml aliquots, and the fractions containing neurons or non-neuronal cells identified.
The neuronal fractions were then pooled and the cells plated or immediately
collected for RNA extraction as required.
4.2.2. Genotyping transgenic mice
IKK-a and p65 knockout embryos were generated by mating mice heterozygous for
null mutations in the relevant gene. Deletion of STAT-3 causes embryonic lethality
at E6.5 (Takeda et ah, 1997), therefore to study the effects of STAT-3 deletion at a
later age I used a strain of STAT-3 conditional mutant mice used by (Alonzi et ah,
2001) where STAT-3 expression was eliminated after gastrulation, but before El2.5
by the use of balancer strain of cre-transgenic mice. Mice were generated by matings
crossing ball+/STAT3wt/n males with ball /STAT3fl/n females. Embryos inheriting
the ball+ and STAT311 allele, which would have been deleted in the male, in
combination with STAT3fl allele from the female, showed a significant reduction in
STAT-3 expression. Mice of the Ball", STAT3wt/fl genotype were used as a positive
control. Pregnant females were killed by carbon dioxide asphyxiation, followed by
cervical dislocation, after 18 days of gestation for IKK-a and STAT-3 mice, or 14
days gestation for p65 mice. Tissue samples were collected for each embryo and
DNA extraction performed using the Nucleospin Tissue DNA extraction kit
(Macherey-Nagel, Germany) following the manufacturers instructions. Briefly, cell
were lysed by incubation of the tissue sample overnight in an SDS / proteinase K.
DNA was then extracted by incubating the lysate with a silica membrane supplied as
part of a spin column, and contaminants removed by washing with an ethanol-based
solution. Finally DNA was eluted from the column using the low-ionic strength
buffer supplied.
PCR was again used to identify the genotype of each embryo. The IKK-a genotyping
was performed as described in chapter 2. Genotyping of the p65 knockout mice was
performed in a similar manner, with altered annealing temperatures and cycle
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numbers (see appendix). This genotyping used 3 primers (5'-
CCTATAGAGGAGCAGCGCGGG-3'; 5'-
AAATGTGTCAGTTTCATAGCCTGAAGAACG-3'; 5' -
AATCGGATGTGAGAGGACAGG-3') producing two distinct products, that were
separated on a 3% agarose gel, a 390bp product corresponding to the wildtype
genotype and a 550bp product corresponding to the knockout product. Genotyping
the STAT-3 mice required three different reactions. Reaction one detected the bal
status of the mice, reaction two detected the presence of wildtype or fl alleles, and
reaction three detected the presence of the deleted allele
4.2.3. RNA isolation and purification
RNA isolation and purification was performed according to the extraction method
described by (Chomczynski and Sacchi, 1987). Ganglia or cells were lysed in 500pl
of solution D (4M guanidinium thiocyanate, 25mM tri-sodium citrate pH 7.0, 0.5%
N-laurylsarcosine, 0.1M 2-mercaptoethanol). Ganglia from older ages were also
passed through a 25-gauge needle fitted with a 1ml syringe to ensure complete
homogenisation. The following solution were added sequentially: 2pl of 5pg/ml E.
coli tRNA; 50pl of 2M sodium acetate (pH4.4); 500pl of water saturated acidic
phenol and 150pl of 25:1 chloroforrmisoamyl alcohol. This mixture was shaken
vigorously and incubated on ice for 5 minutes, then centrifuged at 15,000 rpm for 10
minutes. The upper aqueous phase, containing the total RNA, was transferred to a
fresh microfuge tube and the RNA precipitated by the addition of two volumes of
ethanol and incubated at -20°C overnight. The ethanol mixture was centrifuged at
15,000rpm for 30 minutes, to recover the total RNA from the mixture. The
supernatant was discarded and the RNA pellet washed in 70% ethanol and air-dried.
In order to remove all contamination with genomic DNA, the pellet was resuspended
in a 50pl volume of 40mM Tris pH7.5, 6mM MgCl2 20mM vanadyl-ribonucleoside
complex (VRC, an RNase inhibitor) and 37.5 units of RNase-free DNase I
(Pharmacia) and incubated at 37°C for 90-120 minutes. The RNA was then purified
using the RNaid kit (Bio 101), as per manufacturers instructions. Briefly, 3 volumes
of 3M NaC103 were added to the RNA solution followed by 30pl of RNA binding
matrix for whole ganglia, or 20pl for cultured cells. This was mixed thoroughly and
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incubated at room temperature for 15 minutes to allow the RNA to bind to the
matrix. The matrix was sedimented by centrifugation and washed twice using the
supplied washing solution. The solution was discarded and the RNA eluted from the
matrix by the addition of 30pl of DEPC-treated water for cultured cells, or lOOpl for
whole ganglia and incubation at 60°C for 2-3 minutes. Following centrifugation, the
supernatant, containing the total RNA, was transferred to a fresh tube and stored at -
80°C until required.
4.2.4. Quantification of Reg-2 mRNA levels using competitive RT-
PCR
RT-PCR is a sensitive technique for the detection of rare mRNA species in a total
RNA extract from a small amount of tissue. The technique used for this study uses a
cRNA internal control (competitor) to control for variations in amplification from
reaction to reaction. The competitor is synthesised from the mRNA of interest, so
that the sequence of the competitor differs by only 3-4% in the area to be amplified
in the PCR reaction. This ensures that the kinetics of the amplification reactions for
the two species are as similar as possible (previously described in (Wyatt et ah, 1997;
Wyatt and Davies, 1993). The reverse transcription mix is spiked with known
quantities of the cRNA competitors for the gene of interest and a constitutively
expressed housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) before reverse transcription is carried out. Two separate PCR reactions are
then performed, one for the gene of interest, and the other for GAPDH. The products
of the RT-PCR reactions are separated using acrylamide gel electrophoresis and the
quantity of the natural species determined as a ratio of that of the competitor species.
Before the final reaction is performed, the amount of the competitor species to be
added must be titrated against that of the natural species, as the response of the
imaging system is only linear over a small range. The aim is to have no more than a
5x difference between the intensity of the two amplified products. The amount of
product for the mRNA of interest is expressed relative to the levels of GAPDH in the





The mouse Reg-2 mRNA was cloned into pBluescript SK+ and kindly donated by
the lab of C. Henderson (INSERM U.382, Marseilles). To obtain a sequence 3-4%
longer than the natural species for the RT-PCR assay 3-4 base pairs had to be added
to the middle of the cloned sequence. This was done by digesting the plasmid with
Ncol (Promega), a restriction enzyme with a single site of restriction located 237bp
into the 486bp insert, to produce a 4bp 5' overhang. The resultant DNA was purified
using the MIDAS Cleanlt kit (Biogene), the overhang was the filled in using Klenow
polymerase, repurified and the blunt ends religated using reagents from the pGEM-T
vector kit (Promega). The resulting plasmids were then used to transform JM109
competent cells (Promega). First, however, a digestion was again performed using
Ncol, this linearised unfilled plasmids, but did not affect filled plasmids, thus
decreasing the chances of producing transformed colonies containing the unfilled
plasmid. After overnight incubation at 37°C, single ampicillin-resistant colonies
were picked and used to inoculate 5ml of LB broth containing ampicillin (50pg/ml).
These were incubated overnight at 37°C and the plasmid DNA extracted using the
MIDAS Plasmidspin kit (Biogene) as per manufacturers instructions. To verify that
the plasmid contained the fill-in, a digestion was again performed using Ncol and the
digest analysed using gel electrophoresis. The plasmid was then sent for sequencing
(MWG-Biotech) to determine the size of the insert, which was 4bp for the Reg-2
competitor.
The last step of competitor synthesis was to perform an in vitro transcription to
synthesise the cRNA. To produce run-off transcripts of a defined length, the plasmid
was linearised at the 3' end of the inserted DNA using EcoRI (Promega), the digest
analysed using gel electrophoresis and the plasmid band cut out of the gel and
purified using the MIDAS Cleanlt kit (Biogene). In vitro transcription was
performed using T7 RNA polymerase (Promega), in a reaction mix also containing
RNAguard (Pharmacia). The in vitro transcription was carried out for 2 hours at
37°C, after which VRC and DNasel were added and a further 2 hour incubation at
37°C was performed in order to degrade the plasmid DNA. The RNA transcripts
were purified using the RNaid kit (BiolOl) as described earlier, and the purified
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RNA recovered in lOOpl of DEPC-treated water. lOjil of the transcript were run on a
1% RNase free agarose gel to check the integrity of the transcript and a further lOpl
were used to determine the RNA concentration spectrophotometrically. The
remaining RNA was diluted with water and precipitated at a concentration of lng/pl
by the addition of an appropriate volume of water, 0.1 volumes of 3M sodium acetate
(pH 5.5), 3 volumes of ethanol and 20ng E. coli tRNA for every lng of transcript.
The ethanol-precipitated transcripts were then kept at -20°C until use. The GAPDH
competitor had been synthesised previously and is described in (Wyatt et al., 1997).
4.2.4.2. The competitive RT/PCR assay
The first part of the RT/PCR assay is to reverse transcribe total RNA from the
experimental samples in combination with the cRNA for the genes of interest. A
reaction mix was prepared containing total RNA (between 1 and lOpl depending on
the concentration of the sample), a known amount of cRNA competitor, 500pM
dNTPs (MBI Fermentas), lOpM random hexanucleotides (Pharmacia), lOmM DTT
and 5xBuffer (supplied with the superscript reverse transcriptase, Gibco BRL) and
made up to a total volume of 40pl per reaction. The reverse transcription was
performed by incubating the reaction mix for 2 minutes at 90°C, in order to break
down any secondary structure within the RNA, before the addition of lpl of
Superscript reverse transcriptase per tube, except for those tubes that were to serve as
negative controls. These tubes contained everything except the enzyme, in order to
check for the presence of contaminating genomic DNA, which would be amplified in
the PCR reaction even in the absence of reverse transcriptase. Addition of the
enzyme was immediately followed by a 90 minute incubation at 37°C, after which
the reaction was halted by denaturation of the enzyme by a 6 minute incubation at
95 °C.
The second part of the RT-PCR assay was to amplify the cDNAs for Reg-2 and
GAPDH, using a separate PCR reaction for each product. Two primers were used for
each reaction, designed to span the region of the insert in the competitor. Each
reaction therefore produced two different species, the competitor producing a species
that was 4bp longer than the natural product. The products of the Reg-2 reaction
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were 84 and 88 bp in length, whereas those of the GAPDH reaction were 97 and 101
bp long. The GAPDH primers and reaction conditions have been described
previously (Wyatt and Davies, 1993). The details of the Reg-2 reaction can be found
in appendix 1. After amplification the two species in each reaction were separated by
electrophoresis on an 8% non-denaturing polyacrylamide gel and visualised, after a
15 minute incubation with the non-isotopic UV-sensitive dye SyberGold. UV
illumination and a computer-controlled video-imaging system were used in
conjunction with the Phoretix ID quantifier software to assess individual band
intensity.
4.2.5. mRNA expression studies using semi-quantitative RT-PCR
Semi-quantitative RT-PCR was used to investigate the expression of other Reg
family genes in the nodose and trigeminal ganglia. Unlike competitive RT-PCR, this
does not use an external competitor to determine the absolute concentration of
mRNA in a sample, rather it expresses the levels of the mRNA of interest in terms of
the levels of expression of a control mRNA, in this case GAPDH, whose expression
has been found to be constant. The amplification of both products is carried out in
the same reaction mix, thus controlling for both different levels of DNA in differing
samples and the different efficiency of amplication between separate reactions. The
products amplified were designed to be approximately lOObp different in size so that
they could be distinguished by agarose gel electrophoresis. Agarose gels were
stained using ethidium bromide, imaged using a computer controlled UV imaging
system and quantified using the Phoretix ID Quantifier software. The reverse
transcription and PCR reactions were performed using the same basic protocols
described earlier and details of reaction mixtures and cycling times can be found in
the appendix.
4.2.6. Western blotting
Polyacrylamide gel electrophoresis (PAGE) followed by immunolabelling was used
to analyze the phosphorylation, and therefore activation state, of Akt and Erkl/2 in
cultured neurons stimulated with Reg-2 for 5, 15 and 30 minutes.
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PI nodose neurons and purified PI trigeminal neurons were established in
dissociated culture on a polyornithine/laminin substratum on 24-well plates in 1ml
defined medium. The neurons were cultured in the absence of trophic support for 3
hours to permit attachment, then stimulated for 5, 15 or 30 minutes with 1 ng/ml
Reg-2, before finally being washed in PBS and lysed in 25pl lysis buffer. Each
sample was collected in lysis buffer and prepared for electrophoresis by sonication
for 1 minute followed by the addition of loading buffer. The samples, as well as a
protein standard, were then loaded onto a pre-prepared 8 by 6cm running gel (8%)
with a 3% loading gel above and electrophoresis performed at 25mA until the
bromophenol blue dye front in the loading buffer reached the bottom of the gel.
Protein was then transferred to a polyvinylidene difluoride (PVDF) membrane (BDH
Poole, UK) using electrophoretic elution and any non-specific binding sites blocked
by a 1 hour incubation at room temperature in 0.01% tween-tris buffered saline (T-
TBS) containing 5% non-fat dried milk powder. The membrane was washed three
times in T-TBS and incubated over two nights with a 1:1000 dilution of rabbit anti-
phospho-Akt antibody (Cell Signalling Technology, UK) in T-TBS. After another set
of washes the membrane was then incubated with a 1:5000 dilution of a horseradish-
peroxidase-linked donkey anti-rabbit IgG secondary antibody (Amersham
Biosciences, UK) diluted in T-TBS containing 5% non-fat dried milk powder for
three hours. Binding was then detected using the ECL+ kit (Amersham Pharmacia
Biotech, UK) as per manufacturers instructions and an autoradiography film exposed
to the membrane for between 5 and 15 minutes, before the film was developed. The
membrane was then stripped by incubating the membrane in lOOmM 2-
mercaptoethanol, 2% SDS and 62.5 mM Tris-ElCl (ph6.7) for 30 minutes at 70°C
before reblocking, reprobing with first rabbit anti-phosho-Erkl/2, followed by a
rabbit pan-Akt antibody (Cell Signalling Technology, UK) as a loading control.
4.2.7. Quantification of neurite outgrowth.
PI trigeminal neurons were established in low density cultures and after 24, 48 and
72 hours the neurons were fixed and immunocytochemistry performed as described
in chapter 2.2.6, to label the neurons for pill-tubulin. The neurons were then imaged
using the Zeiss 510 laser-scanning microscope and neurite outgrowth quantified
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using the Sholl analysis, for the total neurite length and the number of branch points.
In this study the rings used for the Sholl analysis are 50pm apart, rather than the




4.3.1. Reg-2 expression is regulated by IL-6 type cytokines in
peripheral sensory neurons
My investigation into the role of Reg-2 in the peripheral nervous system began by
studying the expression of Reg-2 in two sensory neuron populations, those of the
nodose and trigeminal ganglia. I also investigated the expression of Reg-2 in three
signalling knockouts, p65, IKKa and STAT-3 and whether its expression was
regulated by cytokines, as has been suggested for motoneurons (Nishimune et ah,
2000). These studies used competitive RT-PCR to assess the levels of Reg-2 mRNA
expressed in either whole ganglia or dissociated neuronal cultures.
4.3.1.1. Reg-2 mRNA is expressed in both the nodose and
trigeminal ganglia during a restricted developmental
period
The first step in this investigation was to look at the expression of Reg-2 mRNA in
nodose neurons throughout development. Nodose and trigeminal ganglia were
dissected from embryos between E12 and El8 and pups at PI and P5, and the total
RNA extracted. Competitive RT-PCR was then used to quantify the levels of mRNA
for Reg-2 and the housekeeping gene, GAPDH. Figure 4.2 shows that Reg-2 mRNA
was expressed in both nodose and trigeminal ganglia. In nodose ganglia Reg-2
mRNA was barely detectable at E12 and E14, after which its expression increased to
a peak of 5 fg/pg GAPDH at El8 (p<0.05), with levels decreasing to barely above
the baseline by P5. In trigeminal ganglia, reg-2 expression had increased
significantly by E14 (p<0.05), although the level at this age was small compared to
later ages. By E16 the level of reg-2 mRNA expression had increased to 18 fg/pg
GAPDH, over 3 times the peak expression levels seen in nodose ganglia. Reg-2
mRNA expression in trigeminal ganglia then stayed at a plateau until PI after which
levels fell rapidly, so that by P5 the levels of expression were similar to those at E14.
These results show that reg-2 mRNA is expressed in peripheral sensory neurons
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Figure 4.2 Reg-2 mRNA is expressed in both the nodose and trigeminal ganglia during a restricted
developmentalperiod.
Nodose and trigeminal ganglia were dissected from mice between E12 and P5 and their expression of
Reg-2 mRNA assessed using competitive RT-PCR. The means and standard deviations of data
obtained from 3-5 individuals at each age are shown. Statistical comparisons shown are with respect
to E12 ganglia, * p<0.05, ** p<0.001
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4.3.1.2. Reg-2 expression in sensory ganglia is dependent
on STATS, but not IKK-a or p65 expression.
The next investigation examined whether several intracellular signalling proteins
downstream of CNTF receptor activation are involved in the regulation of Reg-2
expression in vivo. The JAK/STAT and NFkB intracellular signalling pathways were
studied by assessing the Reg-2 mRNA levels in ganglia isolated from transgenic
embryos lacking STAT-3, IKK-a or p65. Figure 4.3A shows the levels of Reg-2
mRNA expression in El8 ganglia dissected from embryos from conditionally deleted
STAT-3 mice possessing 2 (Bal-, wt/fl), 1 (Bal-, fl/A) or 0 (Bal+, fl/A) active copies
of the STAT-3 gene. Here, the results are expressed as a percentage of the Bal-, wt/fl
group for each ganglion, to allow comparison between ganglia. This was necessary
because the absolute levels of Reg-2 mRNA were again substantially higher in the
trigeminal than in the nodose ganglia. In trigeminal ganglia a 45% decrease in Reg-2
mRNA expression was found in embryos carrying only one active copy of the gene
(p<0.05) and a 80% decrease was seen in mice carrying two inactivated STAT-3
genes (p<0.001). Similar mean decreases can be seen in nodose ganglia (30% and
75% respectively), however these decreases did not reach significance. This is most
likely to be because the very low quantities of Reg-2 mRNA in these ganglia makes
detection difficult and increases the effects of variation between samples. In neither
ganglion was Reg-2 expression completely abolished in the STAT-3 conditional
knockout mice. Conditional inactivation can, however, be incomplete, and the extent
of the inactivation can vary from cell to cell, therefore some residual Reg-2
expression might be expected due to incomplete activation in some cells.
Nodose and trigeminal ganglia were also dissected from IKK-a mice at E18 and
from p65 mice at E14, and the levels of Reg-2 mRNA expression quantified (figure
4.3B and 4.3C, respectively). No significant differences in Reg-2 mRNA levels could
be detected between wildtype and knockout nodose and trigeminal ganglia from
IKK-a embryos or p65 wildtype and knockout trigeminal ganglia. Reg-2 expression
in nodose ganglia at E14 is virtually nonexistent, therefore the levels of Reg-2
mRNA expression could not be assessed in the p65 knockout mice and these mice














































Figure 4.3 Reg-2 expression in sensory ganglia is dependent on STAT-3, but not IKK-a orp65,
expression.
Nodose and trigeminal ganglia were dissected from STAT-3, IKK-a or p65 knockout mice at either
E18 (STAT-3, IKK-a) or E14 (p65) and Reg-2 mRNA expression assessed using competitive RT-
PCR. A) Reg-2 expression in STAT-3 conditionally deleted mice. B) Reg-2 expression in IKK-a
knockout mice. C) Reg-2 expression in p65 knockout mice. The levels of Reg-2 expressed are shown
relative to the wildtype mice for each ganglion to allow for comparison and the means and standard
deviations of data obtained from 3-6 individuals per group shown. Statistical comparisons shown are
with respect to wild-type ganglia, * p<0.05, **p<0.001
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peripheral sensory neurons is regulated via the JAK/STAT, but not the NFkB
signalling pathway.
4.3.1.3. Reg-2 expression in sensory neurons is maintained
by cytokine, not neurotrophin stimulation
To investigate whether CNTF was capable of directly regulating neuronal Reg-2
expression in vitro, purified sensory neurons were cultured in the presence of
combinations of neurotrophins and cytokines and their expression of Reg-2 mRNA
quantified. Purified PI nodose and trigeminal neurons were cultured for 3 hours in
the absence of trophic factors, an initial sample of neurons collected and the
remaining culture dishes supplemented with CNTF or LIF (50ng/ml), BDNF or NGF
(10 ng/ml) respectively, or a combination of a cytokine and the relevant
neurotrophin. After 24 hours in culture the neurons were lysed, the lysate collected,
and the levels of Reg-2 mRNA quantified and compared to the level of Reg-2 mRNA
expression in the initial samples. In Figure 4.4A the levels of reg-2 mRNA in nodose
and trigeminal neurons cultured with combinations of CNTF and the relevant
neurotrophin are shown. The levels of reg-2mRNA levels are expressed as a
percentage of the mean level of expression after 3 hours in culture. This is to allow
comparison between nodose and trigeminal neurons because the absolute levels of
expression in the trigeminal neurons after 3 hours were 7 times greater than in the
nodose neurons. In both the nodose and trigeminal neurons cultured for 24 hours in
the presence of CNTF, the same level of reg-2 mRNA expression was detected as at
the initial time point. In contrast, when these neurons were cultured in the presence
of neurotrophins, decreased levels of Reg-2 expression were seen. In nodose neurons
there was a 50% decrease in Reg-2 expression (p<0.05) and in trigeminal neurons
this decrease was 55% (p<0.001). Interestingly, when each type of neuron was
subject to a 24 hour incubation in the presence of both CNTF and either BDNF
(nodose) or NGF (trigeminal), there was a difference in the response seen in the two
neuronal populations. For nodose neurons cultured in the presence of CNTF and
BDNF the level of reg-2 expression seen after 24 hours was decreased to 50% of that
seen in the initial sample (p<0.05), similar to the level seen in neurons cultured in
media supplemented with BDNF alone. In contrast, trigeminal neurons cultured for
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24 hours in the presence of CNTF and NGF showed levels of Reg-2 expression that
were not significantly different from those of the initial sample, or of neurons
cultured with CNTF alone. The neuronal survival in these cultures was also
monitored and there were no significant differences in survival between any of these
conditions in either ganglion (Fig 4.4 C).
The same set of experiments was repeated replacing CNTF with LIF, to see if a
similar expression pattern could be detected with another member of the cytokine
family. These results are seen in figure 4.4B. In nodose neurons there was a tendency
towards decreased Reg-2 expression in neurons cultured in the presence of LIF
alone, as compared to the initial time point (40%), although this decrease is not
significant. Significant decreases in Reg-2 mRNA expression, however, were seen in
nodose neurons incubated in defined medium supplemented with BDNF or BDNF
plus LIF (70 and 60% decrease respectively, p<0.05). Trigeminal neurons showed a
tendency towards increased Reg-2 mRNA expression when cultured in the presence
of either LIF or LIF + NGF (20 and 15% respectively), although these increases were
not significant. When cultured in the presence of NGF alone trigeminal neurons
again showed a 52% decrease in Reg-2 mRNA expression (p<0.05). Again there
were no significant differences in the survival of neurons of different groups from
either ganglion (fig 4.4D). Broadly speaking, these results show the same trends as
those seen in neurons cultured with combinations of CNTF and neurotrophins.
Together the results from the CNTF and LIF cultures suggest that Reg-2 expression
is maintained in nodose and trigeminal neurons cultured in the presence of cytokines,
*
Figure 4.4 Reg-2 expression in sensory ganglia is maintained by cytokine, but not neurotrophin
stimulation.
Purified PI nodose and trigeminal ganglia were cultured in the presence of cytokines or
neurotrophins, or both, for 24 hours and their level of Reg-2 mRNA expression quantified using
competitive RT-PCR. A) Reg-2 expression in neurons cultured with CNTF (50 ng/ml), BDNF or NGF
(10 ng/ml, nodose and trigeminal ganglia respectively) or both. B) Reg-2 expression in neurons
cultured with LIF (50 ng/ml), BDNF or NGF (10 ng/ml, nodose and trigeminal ganglia respectively)
or both. C) and D) Percent survival after 24h in culture for the cultures in (A) and (B). The levels of
Reg-2 are expressed relative to the Oh control group to allow for comparison and the means and
standard deviations of data obtained from 3 duplicate cultures are shown. Statistical comparisons




































































but decreased in neurons cultured with neurotrophins. The results seen when the two
populations are cultured with both types of factors together suggest that the
signalling events in each type of neuron vary. In trigeminal neurons the results
suggest that cytokines actively promote the maintenance of reg-2 expression, and
that neurotrophins are not involved in reg-2 expression, whereas those in the nodose
neurons might suggest that BDNF is actively suppressing reg-2 expression, which
may be maintained either by default or through CNTF-induced gene expression.
To further investigate the above question, cultures of purified PI nodose and
trigeminal neurons were established in the same manner. However in these
experiments, all dishes were incubated for 24 hours in the presence of 10 ng/ml
BDNF or NGF respectively. After 24 hours, the neurons were washed twice in
unsupplemented media and cultured for a further 24 hours with either CNTF,
neurotrophin or both. Reg-2 expression was quantified in neurons after 3 hours in
defined media without additional trophic support, at 24 hours, and at 48 hours. The
results of this experiment can be seen in figure 4.5. After 24 hours in culture with
BDNF or NGF, the expression of Reg-2 had decreased to less than 20% of the level
of expression at the initial time point. After a further 24 hours in culture with CNTF,
neurotrophin or both there were no further changes from this low level of expression
in any group. These results, when compared to the earlier 24h results, are ambiguous
and further experiments, such as starting with a 24 hour incubation with CNTF then
switching to neurotrophin would be needed before the roles of neurotrophins and
cytokines in regulating reg-2 expression in vitro can be further defined.
Figure 4.5 Reg-2 expression is not rescued by CNTF stimulation after 24h cultured with
neurotrophins.
Purified PI nodose and trigeminal neurons were cultured for 24 hours in the presence of BDNF (10
ng/ml, nodose neurons) or NGF (10 ng/ml, trigeminal neurons), washed and supplemented with
CNTF (50 ng/ml), neurotrophin, or both for a further 48 hours. Reg-2 mRNA expression was
quantified using competitive RT-PCR. A) Reg-2 mRNA expression. B) Percent survival. The levels of
Reg-2 are expressed relative to the Oh control group to allow for comparison and the means and
standard deviations of data obtained from 3 duplicate cultures are shown. Statistical comparisons











































4.3.2. Stimulation of cultured neonatal neurons with Reg-2
results in Akt and Erk1/2 activation in nodose neurons, but
only Erk1/2 activation in trigeminal neurons.
The receptor for Reg-2 has yet to be identified, therefore I could not address whether
either nodose or trigeminal neurons have the potential to respond to Reg-2.1 thus
decided to look at whether Reg-2 was capable of inducing the phosphorylation of
two intracellular kinases commonly involved in survival and neurite outgrowth,
known biological effects of CNTF in nodose and trigeminal neurons. This was done
by using immunoblotting techniques. PI nodose and purified PI trigeminal neurons
were established in culture for three hours in the absence of trophic support, before
being stimulated for 5, 15 or 30 minutes with 1 ng/ml Reg-2. These cultures were
lysed immediately after stimulation and the lysate collected. The proteins in the
sample were then electrophoretically separated on a non-denaturing polyacrylamide
gel and transferred to a PVDF membrane. This was probed sequentially using
phospho-Akt, phospho-Erkl/2 and pan-Akt antibodies. Figure 4.6 shows images of a
single gel that has been probed with all three antibodies, and is representative of the
results seen in three separate experiments. It shows that stimulation of nodose
neurons with Reg-2 induces an increase in Akt phosphorylation that is detectable
after 5 minutes stimulation, and which is maximal at 15 minutes after stimulation. An
increase in Erkl/2 phosphorylation was also detected in nodose neurons as early as 5
minutes after Reg-2 stimulation, and which was still detectable after a 30 minutes
exposure. In contrast Erkl/2 activation in trigeminal neurons was seen after 5
minutes stimulation with Reg-2, reaching a maximum after 15 minutes exposure, but
no phosphorylation of Akt was detected at any time point. These results suggest that
Reg-2 is capable of activating intracellular signalling pathways in both nodose and
trigeminal neurons, and that the intracellular consequences of Reg-2 exposure in
nodose and trigeminal neurons are overlapping but not identical.
4.3.3. Reg-2 promotes the survival of selected populations of
sensory neurons during development
The observation that exposure of nodose or trigeminal neurons to Reg-2 resulted in
the phosphorylation of Akt, a kinase commonly implicated in survival-related
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Figure 4.6 Stimulation ofcultured neonatal neurons with Reg-2 results in Akt and Erkl/2
phosphorylation in nodose neurons, but only Erkl/2 phosphorylation in trigeminal neurons.
PI nodose and trigeminal neurons were cultured in the absence of trophic factors then stimulated for
5, 15 or 30 minutes with Reg-2. Here western blots were performed with the same membrane being
probed for phosphorylated Akt and Erkl/2, as well as a control blot with a pan Akt antibody. These
images are representative of three independent experiments.
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signalling cascades (Alonzi et al., 2001; Crowder and Freeman, 1998; Downward,
1998; Klesse and Parada, 1998; Thompson et al., 2004; Virdee et al., 1999; Xue et
al., 2000; Zhang et al., 2000)), in only one of two populations of sensory neurons
known to survive in response to CNTF led me to investigate whether either neuronal
population could survive when cultured in the presence of Reg-2. Low-density
dissociated cultures of nodose and trigeminal neurons were established from mice at
postnatal day 1 and supplemented with a range of doses of Reg-2. This age is
equivalent to the age at which Reg-2 promoted CNTF-induced neuronal survival in
developing motor neurons, as it is an age at which the later phases of neuronal death
are occurring in these ganglia (Nishimune et al., 2000) The survival of these neurons
was assessed after 48 hours in culture by counting the number of surviving neurons
and expressing this as a percentage of the number of neurons attached to the dish
three hours after plating. Figure 4.7 shows that in defined medium alone only 22% of
nodose neurons and less than 3% of trigeminal neurons survive after 48 hours in
culture. In nodose neurons concentrations of 0.01 ng/ml Reg-2 and over promote
significant increases in neuronal survival, with concentrations above 0.1 ng/ml
producing a maximal effect. Reg-2 did not promote the survival of neurons of the
trigeminal ganglia at any concentration. This effect is consistent with my previous
observation that Reg-2 induced Akt phosphorylation in nodose but not trigeminal
neurons.
I also chose to compare Reg-2 induced neuronal survival to that promoted by other
neurotrophic factors in both nodose and trigeminal neurons. Again dissociated
cultures of these neurons from PI mice were established and supplemented with a
range of neurotrophic factors at saturating concentrations and survival assessed after
a 48 hour incubation period. BDNF is a well characterised neurotrophic factor for
nodose neurons, and in my cultures it aided 86% of the initially plated neurons to
survive to 48 hours (lOng/ml), while only 31% survived without trophic support.
(Figure 4.8A). The percentage of neurons surviving in the absence of trophic support
is slightly improved in this culture compared to that in figure 4.7 because neurons
generally survive better when cultured in the larger volume of media present in

















Figure 4.7 Reg-2 promotes the survival ofneonatal nodose, but not trigeminal, neurons.
PI nodose neurons were cultured in the presence of increasing concentrations of Reg-2 and their
survival quantified 48 hours after plating. The means and standard errors of data obtained from three
separate triplicate cultures for each experimental condition are shown. Statistical comparisons shown
are with respect to untreated control neurons, * p<0.05, ** pO.001
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survival of 85% of nodose neurons after 48 hours in culture, and CNTF (50ng/ml)
promoted the survival of a similar proportion of neurons (72%, no significant
difference). Supplementing nodose neurons with Reg-2 and CNTF together produced
no additional increase in survival, suggesting that Reg-2 and CNTF act on the same
population of nodose neurons. Figure 4.8B presents a similar experiment performed
in PI trigeminal neurons. NGF, the neurotrophin known to promote the survival of
trigeminal neurons, supported the survival of 61% of neurons after 48 hours in
culture, and in the absence of trophic support just 16% survived. In trigeminal
neurons both CNTF (50 ng/ml) and GDNF (lOng/ml) have been reported to support
sub-populations of trigeminal neurons and in this experiment produced 42% and 26%
survival, respectively (p<0.001 and p<0.05 w.r.t No Factor controls). Reg-2, as
expected, did not promote the survival of PI trigeminal neurons and, at a dose that
promotes survival in nodose neurons, was unable to facilitate the neuronal survival
induced by either CNTF or GDNF. Together these results show that Reg-2
effectively promotes the survival of neonatal nodose neurons, while having no
survival promoting effects in trigeminal neurons at the same age.
4.3.4. Reg-2 does not promote neurite outgrowth in trigeminal
neurons
TheMAP kinase intracellular signalling pathway has been reported to be the principal
pathway involved in signalling the promotion of neurite outgrowth, rather than
neuronal survival, particularly in neonatal peripheral neurons (Aletsee et ah, 2001;
Aletsee et ah, 2002; Alonzi et ah, 2001; Choung et ah, 2002; Creedon et ah, 1996;
Klesse and Parada, 1998; Sjogreen et ah, 2000; Thompson et ah, 2004;
Figure 4.8 Reg-2 is as effective as neurotrophins or cytokines at promoting the survival ofneonatal
nodose neurons.
PI nodose and trigeminal neurons were cultured in the presence of Reg-2, neurotrophins, cytokines, or
combinations thereof and their survival quantified 48 hours after plating. A) Survival of nodose
neurons cultured in the presence of either BDNF (10 ng/ml). Reg-2 (0.1 ng/ml), CNTF (50ng/ml) or
Reg-2 and CNTF together. B) Survival of trigeminal neurons cultured in the presence of NGF (10
ng/ml), Reg-2 (0.1 ng/ml), CNTF (50ng/ml), GDNF (10 ng/ml) or Reg-2 in combination with CNTF
or GDNF. The means and standard errors of data obtained from three separate triplicate cultures for
each experimental condition are shown.
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Virdee and Tolkovsky, 1996; Xue et ah, 2000; Zhang et ah, 2000). The activation of
Erkl/2 in trigeminal neurons after Reg-2 stimulation therefore indicates that while
Reg-2 is unable to promote the survival of these neurons it may regulate neurite
outgrowth. To investigate this, I established low density cultures of PI trigeminal
neurons and incubated them in defined media containing either NGF alone
(lOng/ml), NGF plus Reg-2 (lng/ml) or NGF plus CNTF (50ng/ml). Trigeminal
neurons could not be cultured with Reg-2 alone, due to the lack of survival effect.
The outgrowth of these neurons was then studied after 24, 48 and 72 hours in culture.
Figures 4.9A, B and C show the Sholl analyses of neurite outgrowth after 24, 48 and
72 hours respectively. Trigeminal neurons cultured in NGF alone elaborated
significant neurite arbours in the first 24 hours in culture. A mean of over 8
intersections are found at 50pm from the cell body, increasing to a peak of 13.2
intersections at 100pm from the cell body. At this time point addition of either Reg-2
or CNTF to the culture medium has no effect on the arbours elaborated by these
neurons. After a further 24 hours in culture the neurite arbours of PI trigeminal
neurons cultured in the presence of NGF alone have increased in both size and
complexity, and in the Sholl analysis the maximal number of intersections has
increased to 26.2, occurring 150pm from the cell soma. The addition of Reg-2 to the
culture medium had no effect on the pattern of neurite outgrowth, however
supplementing the cultures with CNTF resulted in a significant change in
morphology with a lower peak number of intersections (14.4) occurring further from
the centre (250pm). By 72 hours after the addition of trophic factors this difference
has disappeared and the neurons cultured under each condition assume a mean
morphology closer to that of the neurons cultured with NGF plus CNTF at 48 hours,
with a peak number of between 15.1 and 20.0 intersections occurring between 200
Figure 4.9 Reg-2 does not promote neurite outgrowth in neonatal trigeminal neurons
PI trigeminal neurons were cultured for 72 hours in medium supplemented with NGF (lOng/ml), NGF
+ Reg-2 (0.1 ng/ml) or NGF + CNTF (50 ng/ml) and the neurite arbour morphology assessed at 24, 48
and 72hours using the Sholl analysis and analysis of total neurite length and number of branch points.
The means and standard errors of data obtained from 20 neurons in each experimental condition are
shown, * P<0.05.
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and 250 pm from the cell soma, suggesting that while CNTF may have promoted the
rate at which the neurons assume a more mature neurite arbour, it had no long-term
effect on the morphology of trigeminal neurons in culture. Analysis of total neurite
length and branching reveals that while there is no difference in the total length of
neurites between any factor combination at and time point, CNTF causes a
significant decrease in the number of branch points after 48 hours in culture (figures
4.9D and E respectively). This suggests that the difference in the shape of the Sholl
analysis is because the neurites are branching less, but growing further between each
branch point. Together these results suggest that Reg-2 has no effect on neurite
outgrowth in trigeminal neurons, however it should be noted that these results are
only preliminary. Any repetition of these results was prevented by deterioration in
the Reg-2 protein and our inability to obtain any additional protein that promoted the
survival of nodose neurons.
4.3.5. Other Reg-family members are expressed in sensory
ganglia during development
Reg-2 belongs to a family containing 6 different murine proteins, therefore one
possibility is that another family member might play the role of the necessary
signalling intermediate for cytokine-induced neuronal survival in trigeminal neurons
that Reg-2 plays in motoneurons and possibly neurons of the nodose ganglia. To this
end I studied the expression of the mRNAs coding for each of the family member in
nodose and trigeminal neurons throughout development. Figures 4.10A and B show
representative semi-quantitative RT-PCR gels for each family member in nodose and
trigeminal ganglia respectively. In each gel two bands are seen, the upper band
representing GAPDH mRNA expression and the lower band representing the
relevant family member in all cases except for that of Reg-III□ (Reg-2) where the
bands are reversed and the upper band represents Reg-2 and the lower GAPDH. Reg-
2 mRNA expression was included to validate this method of detection as compared
to the competitive RT-PCR used earlier, and to calibrate the levels of primers used in
the reaction. This is necessary as the levels of GAPDH mRNA expressed is
approximately 250 times higher that those of reg-2. Increasing the excess of reg-2
primers relative to the levels of GAPDH primers increases the amplification rate of
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Figure 4.10 Reg-IIIa and Reg-IIIy mRNAs are expressed in sensory ganglia during development.
Nodose and trigeminal ganglia were dissected from mice between E12 and P5 and their expression of
Reg family mRNAs assessed using semi-quantitative RT-PCR. A) Semi-quantitative RT-PCR gels of
the expression of all Reg family genes in nodose ganglia. B) Semi-quantitative RT-PCR gels of the
expression of all Reg-2 family genes in trigeminal ganglia. C) Quantification of the level of Reg Ilia
expression in the nodose ganglia D) Quantification of the levels ofReg Ilia and Reg Illy expression
in the trigeminal ganglia. The means and standard deviations of data obtained from 3 individuals at




























































the Reg-2 reaction relative to the GAPDH reaction thus allowing both species to be
detected in the same gel without one being overwhelmed by the other, and while still
allowing the GAPDH levels to be used as a control for variation in the amount of
between samples. In these reactions the reg family primer concentrations used are 5
times those of GAPDH. Reg-2 expression in this experiment followed a similar
pattern observed in the quantitative experiments, with mRNA detected between E16
and P5 in the nodose ganglia and between E14 and P5 in trigeminal ganglia. In both
ganglia the intensity of the reg-2 band is greater than or equal to that of the GAPDH
band and reg-2 expression can also be detected in the pancreas, a tissue that has
previously been reported to express all reg-family genes, and is undetectable in the
heart, which was used as a negative control (Abe et al., 2000; Narushima et al.,
1997). In the nodose ganglia (figure 4.10A) very little expression of mRNAs for
other reg-family proteins could be detected, the only occurrence being the presence
of a Reg-III band at PI. In trigeminal ganglia the situation appears a little different,
with bands representing Reg-III□ being detectable between E16 and PI and Reg-IIO
bands being observed at EI4 and PI. In all cases the integrity of the reaction was
confirmed by the presence of a band of the predicted size in the positive control
reaction (pancreas) and its absence in the negative control (heart).
The semi-quantitative RT-PCR for the genes where any positive identification of
expression occurred was repeated using three samples at each age and the results
quantified by expressing the intensity of the mRNA band for the gene of interest as a
percentage of the intensity of the GAPDH band, as quantified using the Phoretix ID
analysis software. The results of these experiments can be seen in figures 4.10C and
D for the nodose and trigeminal ganglia, respectively. In the nodose ganglia, apart
from Reg-2, only the expression of Reg-IIITwas detected in the initial experiments.
Quantification of this expression throughout development shows that low levels of
reg-III 11 expression could be detected from E16 onwards, but this expression was
variable, particularly in the samples studied at PI where one sample had high levels
of reg-III□ and the others had very low levels. These levels appear to be much lower
than the levels of Reg-2 expression would be if quantified, as in figure 4.10A the
intensity of the Reg-2 bands in mice at E16 or older are either the same as or greater
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than those of GAPDH, whereas when reg-IIIUexpression was quantified, the
intensity of the bands appeared to be around 10% of that of GAPDH. In the
trigeminal ganglia, expression of reg-III□ and reg-IIICwere initially detected and
selected for further analysis. Significant increases in reg-IIIGexpression could be
detected in trigeminal neurons between E16 and E18 (p<0.001 and p<0.05
respectively, relative to E12 and E14), with levels decreasing to nothing by P5. As
with the nodose ganglia, these levels of expression were very low compared to those
of Reg-2, where in the trigeminal ganglia the intensity of the Reg-2 band appeared
much greater than that of GAPDH between E14 and P5. Quantification of the levels
of reg-III□expression in the trigeminal ganglia revealed a very low level of
expression with no significant increase in expression at any age. Together these
results suggest that there might be some developmental pattern in the expression of




This study has investigated the relationship between Reg-2 and CNTF in promoting
the survival and outgrowth of sensory neurons from the developing peripheral
nervous system. Reg-2 mRNA expression was detected in both nodose and
trigeminal ganglia in vivo during a defined developmental window, from E16 to PI.
Reg-2 has previously been shown to be developmentally regulated, both in the
nervous system and elsewhere, with its expression occurring during periods when
cells are subject to stress, such as when neuronal number is adjusted to the size of
target during the development of the nervous system (Livesey et al., 1997;
Nishimune et al., 2000) or during weaning in the gastrointestinal epithelia
(Chakraborty et al., 1995). Detection of Reg-2 in purified neonatal nodose and
trigeminal neurons confirmed that it is expressed at least in part by the neurons of
these sensory ganglia. Reg-2 expression occurred in both populations of sensory
neurons during the later stages of establishment of innervation and programmed cell
death, starting soon after the peak levels of neuronal apoptosis are seen (Davies and
Lumsden, 1984a; Pinon et al., 1996). It is likely that the exposure of neurons to novel
target-derived trophic factors, such as cytokines, induces Reg-2 expression in these
neurons. However, the cause of the subsequent fall in Reg-2 expression soon after
birth may not be a result of decreased cytokine expression at this time. Murphy et al
(1993) found increased LIF mRNA expression in a range of DRG neuron target
fields, including skin and muscle, at E12, just prior to when these neurons start
responding to LIF in vitro. In some tissues LIF appears to be transiently expressed,
while in others expression is over a much longer term, well into the postnatal period
(Murphy et al., 1993; Yamamori, 1991). No information about cytokine expression is
available for the target fields of nodose and trigeminal neurons, however, if they
were continuing to have contact with LIF postnatally, an alternative mechanism must
be present to suppress Reg-2 expression. In the liver, normal cells have been shown
to express a transacting factor that binds to a silencing element in the Reg-2 promoter
and which is absent in hepatoma cells that can express Reg-2 protein (Dusetti et ah,
1996). Such an intrinsic regulatory mechanism could limit the duration of Reg-2
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expression after initial exposure to cytokines, alternatively another external factor
could block Reg-2 mRNA expression after a certain time period.
There is currently no direct evidence of a link between neurotrophins and Reg-2
expression. However crosstalk between neurotrophin and cytokine signalling
pathways in neuronal systems has been reported. In neuroblastoma cell lines NGF
modulates CNTF-induced neuropeptide expression (Symes et ah, 1993), which, like
Reg-2 expression, requires STAT activation (Symes et ah, 1994). Also, culturing
adult SCG explants for several days in the presence of either NGF or BDNF results
in decreased STAT activation after 5 days, compared to untreated ganglia where
STAT activation continues for up to 8 days in vitro. This suggests that these
neurotrophins limit long-term STAT activation (Rajan et ah, 1998). The serine
phosphorylation inhibitor H7 blocked this effect. In some cases serine
phosphorylation has been shown to be necessary for maximal STAT activation (Chen
et ah, 2004; Ng and Cantrell, 1997; Wen et ah, 1995; Zhang et ah, 1995a). However
Jain et ah (1998) and Chung et ah (1997) have shown that in different circumstances
serine phosphorylation by ERK2 was enough to decrease STAT-3 activation. This
suggests that neurotrophins could block STAT activation by activating an inhibitory
serine kinase upstream of STAT. Several protein groups negatively regulate STAT-
activation in a variety of manners. These include protein phosphatases, such as SHP1
and 2, PIAS (Protein Inhibitors of Activated STAT) proteins and SOCS (Suppressor
of Cytokine Signalling; (Chen et ah, 2004; Wu et ah, 2002). SHP-2 regulates the
dephosphorylation of STAT-1 in A431 cells and is also activated by neurotrophin
signalling, when it mediates survival and neurite growth (Araki et ah, 2000b; Araki
et ah, 2000a; Chen et ah, 2002; Ohnishi et ah, 1999; Okada et ah, 1996; Takai et ah,
2002; Wu et ah, 2002). SOCS protein expression is regulated by STAT activation
itself therefore SOCS proteins act as part of a negative feedback loop controlling
JAK/STAT signalling. These proteins act by inhibiting JAK kinase and thus STAT
phosphorylation (Endo et ah, 1997; Hilton, 1999; Nicholson et ah, 1999; Starr et ah,
1997). SOCS expression can be regulated by the growth factor FGF-2 during
development, suggesting its expression can be regulated by other signalling pathways
such as MAPK or PI3K (Turnley and Bartlett, 2000). SOCS-3 expression has also
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been found to be regulated by NF1B in fibroblasts (Li et al., 2002). Additionally, as I
discussed in chapter three, not all cytokine signalling is dependent on a STAT related
pathway. One or more of these proteins are potential mediators of crosstalk between
neurotrophin and cytokine signalling pathways. In chapter 3,1 also discussed that the
physiological outcomes of cytokine exposure is dependent upon a balance between
STAT and MAPK signalling (Bonni et al., 1997; Ihara et al., 1997; Marz et al., 2002;
Tumley and Bartlett, 2000). The presence of neurotrophins in a culture system,
which can themselves activate MAPK signalling, can therefore affect the outcome of
cytokine exposure and could potentially affect Reg-2 expression through alterations
in this balance (Ihara et al., 1997; Turnley and Bartlett, 2000).
Since neuronal expression of Reg-2 mRNA is largely dependent on functional
STAT-3 in both sensory neurons during development (this chapter) and in motor
neurons after axotomy (Schweizer et al., 2002), it is likely that any effect of
neurotrophins on cytokine-induced STAT-3 activation also impact on Reg-2
expression. The similarities in the duration of expression of Reg-2 during
development and the delay before neurotrophins suppress STAT-3 activation in
organotypic cultures (Rajan et ah, 1998) provides a clue, suggesting that this might
be the case, although how such a delay occurs is unknown. In dissociated culture, the
expression of Reg-2 mRNA by peripheral sensory neurons was maintained for at
least 24 hours by the presence of IL-6 type cytokines in the culture medium, but not
by the presence of neurotrophins. Unexpectedly, when neurons were cultured with a
combination of both cytokine and neurotrophin together, differences between the
responses of the two populations were detected. Culturing trigeminal neurons in the
presence of cytokine and NGF maintained Reg-2 mRNA expression at 24 hours,
while in nodose neurons exposed to cytokine and BDNF there was a large drop in the
level of Reg-2 expression after 24 hours. This raises several questions, the principal
of which is whether CNTF is indeed promoting the expression of Reg-2 mRNA in
either population of neurons. Exposure of both types of neurons to concentrations of
cytokines that have been established in our lab as eliciting a maximal survival
response (Horton et al., 1998) did not promote increased expression of Reg-2
mRNA, although the levels of expression seen in the presence of cytokines were
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significantly greater than that seen with neurotrophins at the same time point. One
explanation is that Reg-2 mRNA expression in these neurons is already maximal at
the time of dissection, although this might imply that saturating levels of CNTF are
present in vivo, a situation which would contradict the prevailing theory that it is
limited quantities of neurotrophic factors that select cells for survival or death at this
period of development. Alternatively Reg-2 mRNA expression in these neurons
could be entirely "constitutive", controlled by an as yet uncharacterised mechanism.
If this is the case, the decreased Reg-2 mRNA expression seen in the presence of
neurotrophins may well be an active process, a conclusion that would be supported
by the effect seen in the presence of cytokine plus neurotrophin in nodose but not
trigeminal neurons. The results seen in trigeminal neurons suggest that NGF does not
affect Reg-2 mRNA expression since this remains high when neurons are cultured in
the presence of both factors. Currently the weight of published evidence in both
neuronal and non-neuronal cells, particularly the abolition of Reg-2 expression in
LIF receptor and STAT-3 knockout mice (Livesey et ah, 1997; Schweizer et ah,
2002), suggests that it is most likely that cytokines actively maintain neuronal
expression of Reg-2 mRNA in both populations. As for neurotrophins, my results
suggest that BDNF, at least, is in some way implicated in regulating reg-2 mRNA
expression. As I described earlier, despite no direct evidence relating neurotrophins
to Reg-2, a mechanism can be postulated involving the crosstalk between
neurotrophin and cytokine signalling pathways regulating levels of STAT-3
activation and subsequent gene expression. Alternatively neurotrophins could act to
influence Reg-2 expression at a point less directly dependent on cytokine signalling.
TNF-flhas been shown to induce PAPI/Reg-2 expression via MEK1 (Malka et ah,
2000). As both Reg-2 and BDNF have been show to activate the MAPK pathway, it
is possible that there is an alternative pathway through which neurotrophins, or even
Reg-2 itself, could influence Reg-2 levels, although in both cases a positive feedback
loop, supporting Reg-2 expression, might be expected.
Additional experiments were performed to investigate whether re-exposure to
cytokines could rescue Reg-2 mRNA expression after a 24h incubation in the
presence of neurotrophins. No recovery of Reg-2 mRNA expression at 48 hours
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occurred in any condition, however this may have been a consequence of inadequate
experimental design. After 48h in culture these neurons are approaching the time at
which Reg-2 expression is down-regulated in vivo. While in culture many external
developmental influences are removed, neurons in my culture system may still
execute an intrinsic program that terminates Reg-2 expression. Further experiments
could clarify the roles of both neurotrophins and cytokines in the regulation of Reg-2
expression in peripheral sensory neurons. Evaluation of whether the levels of Reg-2
mRNA expression are maintained after continuous exposure to cytokines for 48
hours could be informative, as would evaluation of expression levels when neurons
are maintained in culture not through neurotrophic support, but by inhibition of the
apoptotic machinery. Following these studies the effect of switching between
cytokines and neurotrophins could be re-examined. I would also like to have studied
whether Reg-2 itself is capable of regulating its own expression in light of the fact
that I have found that Reg-2 is capable of activating the MAP kinase pathway, a
pathway implicated in TNFH-induced PAPl/Reg-2 expression in pancreatic acinar
cell lines (Malka et al., 2000). This, however, was not possible because I was unable
to obtain further supplies of functional Reg-2 protein.
Having detected the presence of Reg-2 in the peripheral sensory nervous system
during a developmentally restricted period corresponding to the period during which
Reg-2 promotes neuronal survival in other neuronal populations, I investigated
whether Reg-2 could directly promote the survival of peripheral sensory neurons. In
nodose neurons this was the case, however in PI trigeminal neurons Reg-2 had no
survival effects. This difference in the effect of Reg-2 on the survival of these
neurons was surprising since CNTF promotes the survival of both nodose neurons
and a substantial sub-population of trigeminal neurons at this age (Horton et al.,
1998). Akt is a protein kinase that is widely reported as being involved in signalling
neuronal survival in response to a variety of neurotrophic factors including cytokines
(Brunet et al., 2001; Middleton et al., 2000; Nishimune et al., 2000). It is activated by
phosphorylation therefore I investigated whether Reg-2 stimulation was capable of
inducing Akt phosphorylation. In line with the survival experiments I found that in
nodose, but not trigeminal neurons, a 15 minute exposure to Reg-2 induced robust
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Akt phosphorylation. Reg-2 expression in nodose neurons is dependent on STAT-3
signalling, which in turn can be activated by cytokines, and in culture Reg-2
promotes neuronal survival to a similar extent as CNTF. Thus, while it is possible
that cytokines exert their survival effect via the Reg-2 secreted signalling
intermediate in nodose neurons this does not seem to be the case for trigeminal
neurons. It should also be noted that while Reg-2 expression in nodose neurons first
occurs at significant levels at El8, both CNTF and LIF have previously been found
to promote the survival of a proportion of nodose neurons as early as El 1. This
suggests that at this early stage a Reg-2 independent mechanism mediates cytokine-
induced survival. Likewise, there appears to be an alternative Reg-2 independent
mechanism mediating cytokine-induced neuronal survival in trigeminal neurons.
During the same developmental window, trigeminal neurons express Reg-2 more
robustly that nodose neurons, yet Reg-2 does not promote survival in these neurons,
despite their response to CNTF.
While Reg-2 does not promote the survival of trigeminal neurons, it stimulates
ERK1/2 phosphorylation. ERK1/2 forms part of the MAP kinase cascade, a
signalling pathway known to be important in the promotion of neurite outgrowth by a
range of neurotrophic factors, including cytokines, in many neuronal types (Aletsee
et al., 2001; Choung et al., 2002; Ihara et al., 1997; Marz et ah, 2002; Sjogreen et ah,
2000; Thompson et ah, 2004; Wiklund et ah, 2002; Wiklund and Ekstrom, 2000).
Reg-1 Hand Reg IV have, to date, been reported to activate p38 MAPK signalling
pathways (Hartupee et ah, 2002), but no links have been described between any Reg
protein and Erkl/2. I detected increased levels of phosphorylated Erkl/2 in both
nodose and trigeminal neurons and, although not documented, saw robust neurite
outgrowth in nodose neurons cultured in the presence of Reg-2. An effect of Reg-2
on neurite outgrowth in trigeminal neurons cannot be easily observed, as trigeminal
neurons cultured in the presence of Reg-2 do not survive. A preliminary study was
performed to investigate whether Reg-2 was capable of increasing neurite outgrowth
in NGF-supplemented cultures of trigeminal neurons. In this study, Reg-2 appeared
to have no ability to alter NGF-induced neuronal morphology, despite CNTF
increasing the rate at which these neurons achieved a more mature neuritic arbour.
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This observation does not completely exclude Reg-2 having a neurite outgrowth-
promoting effect. NGF already promotes a significant amount of neurite outgrowth
in trigeminal neurons and in other peripheral ganglia this activity has been reported
to be through a MAP kinase-dependent mechanism (Liu and Snider, 2001; Pang et
ah, 1995a; Pang et ah, 1995b; Xiao and Liu, 2003). It may therefore be that the
effects of NGF on neurite outgrowth was masking a possible effect of Reg-2 on
growth or that NGF was promoting maximal neurite outgrowth via the MAP kinase
pathway. An alternative pathway could then mediate the effect of CNTF on neurite
branching. If further Reg-2 protein was available for experimentation, culturing
trigeminal neurons with a sub-saturating concentration of NGF, in combination with
Reg-2, might reveal an effect of Reg-2. Another possibility would be to used caspase
inhibitors or over-expression of an anti-apoptotic Bcl-2 family protein to maintain
the neurons in culture with Reg-2 alone (Doxakis et al., 2004; Middleton and Davies,
2001; Werth et ah, 2000).
The production of Reg-2 by developing trigeminal neurons might have a role in
stimulating the proliferation of Schwann cell precursors, as it has been shown that
Reg-2 promotes the division of dedifferentiated adult Schwann cells after nerve
injury (Livesey et ah, 1997). There are, for example, many more non-neuronal cells
present in the trigeminal ganglia at this stage of development than in the nodose
ganglia. The expression of Reg-2 between E16 and PI also coincides with the period
during which immature Schwann cells emerge, starting between E12 and E16 and
continuing until the first postnatal days, after which they withdraw from the cell
cycle and establish their mature phenotype (Dong et ah, 1999; Syroid et ah, 1996).
The difference in the effect of Reg-2 on the survival of newborn nodose and
trigeminal neurons, both of which survive in response to CNTF suggests that Reg-2
is not a universal intermediate in CNTF-induced neuronal survival. There are two
possibilities to explain this observation. Firstly, CNTF could activate pathways
promoting neuronal survival and neurite outgrowth that are entirely independent of
reg family proteins. This could include activation of MAPK pathways, as discussed
in this chapter and in chapter 3 or through the expression of other STAT-induced
genes. Genes containing STAT-binding elements and which are expressed in
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response to STAT activation include other growth factors, such as HGF and OSM, as
well as Bax, Bcl-2 and Bcl-xL (Catlett-Falcone et ah, 1999; Dumon et ah, 1999;
Fukada et ah, 1996; Kirito et ah, 2002; Seto et ah, 1988; Silva et ah, 1999;
Socolovsky et ah, 1999; Tomida and Saito, 2004). Alternatively STAT activation by
neuropoietic cytokines could promote the expression of a different member of the
Reg family. All Reg family members carry IL-6 response elements in their promoter
regions, meaning that activation of STAT transcription by neuropoietic cytokines
could subsequently promote their expression. There is, as yet no information
concerning whether any of these proteins have biological effects in neurons, although
several are known to promote survival in other systems (see 1.4.3). To this end I
examined the developmental expression of the other Reg family proteins in both
nodose and trigeminal neurons. Most other Reg family mRNAs were not expressed
in either nodose or trigeminal neurons, with only group III mRNAs present in either
ganglion. Some expression of Reg-IIIHwas detected in nodose ganglia, and both
Reg-Ill Hand reg-IIIQmRNAs were found in the trigeminal ganglia. In all cases,
however, the levels detected in each ganglion were very low compared to those of
Reg-2 and for Reg-IIIDin the nodose ganglia and Reg-IIIGin the trigeminal ganglia
expression was not detected in all samples at a particular age. Reg-III I], in the
trigeminal ganglia, was the only gene expressed robustly enough to suggest it might
be physiologically relevant. Reg-IIIIlexpression was also developmentally restricted
in a similar manner to Reg-2, between E16 and PI. The levels, compared to those of
Reg-2 in the same ganglia, were low, however the levels of Reg-2 expression
detected through competitive RT-PCR in the nodose ganglia, where Reg-2 appears to
be biologically active, were also much lower than those expressed in the trigeminal
ganglia. Only quantification of the absolute amounts of Reg-III limRNA present in
the trigeminal ganglia could allow better comparison. It might be of future interest to
investigate whether Reg-III has any physiological effect on trigeminal neurons.
The results presented in this chapter suggest that the relationship between Reg-2 and
CNTF in sensory neurons is more complex than that described in motor neurons. In
both the nodose and trigeminal ganglia CNTF appears to support Reg-2 expression in
a STAT-3 dependent manner, consistent with published literature. My expression
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studies suggest, however, that neurotrophins may also play a role in modulating Reg-
2 expression. Additional evidence also suggested that Reg-2 is not an essential
intermediate in all the physiological effects mediated by neuropoietic cytokines.
There is also a possibility that Reg-2 may act to promote neurite outgrowth in
trigeminal neurons, as it does in nodose neurons, but despite seeing phosphorylation
of Erkl/2 in these neurons, I found no further evidence for such an effect. Due to the
lack of functional Reg-2 protein I was not able to investigate any direct link between
Reg-2 and NFZB in this system. Reg-2 has been reported to activate NFZB in motor
neurons, and it was predicted that this would be through the classical pathway for
NFZB activation, that is via Akt and PI3K leading to phosphorylation and
degradation of the NF B inhibitory complex. In nodose, but not trigeminal neurons,
Reg-2 induced Akt phosphorylation. This is consistent with the survival studies and
indicates that a signalling pathway through Akt could well be a responsible for Reg-
2-induced neuronal survival. In the previous chapter, however, I found that
overexpression of superrepressor IIBUdid not affect CNTF-induced survival of
nodose neurons suggesting that either Reg-2 does not induce neuronal survival via
NFN3, or that if it does that Reg-2 may not be an intermediate in CNTF-induced
neuronal survival. The observation that Reg-2 also promotes neurite outgrowth in
nodose neurons suggests that Reg-2 is unlikely to be a point at which CNTF
signalling for survival and neurite outgrowth diverges. Interestingly, the range of
ages over which Reg-2 is potentially produced by both nodose and trigeminal
neurons, as deduced from express studies of Reg-2 mRNA is the same period during





In this thesis I have investigated the role of NFIB-dependent gene expression in the
development of the murine peripheral nervous system. In sensory neurons of the
nodose ganglia I found that interfering with the NF1B signalling pathway, using a
variety of chemical and genetic methods caused a substantial decrease in the size and
complexity of the neurite arbors of neurons cultured in the presence of BDNF,
without affecting neuronal survival. This effect was seen during a restricted
developmental window, between E18 and PI, a period during which, in vivo,
developing neurons are modifying and refining their process morphology and
interconnectivity. In the same type of neurons, NFIB was also implicated in the
neurite outgrowth of neurons cultured in the presence of CNTF, but not LIF.
I also investigated the role of NFIB-dependent gene expression in the elaboration of
neurites from sympathetic neurons of the superior cervical ganglion. In this neuronal
population, the study of neurite outgrowth is complicated by the role of NF B in
mediating neuronal survival. This was overcome through the use of caspase
inhibitors to prevent cell death, and revealed that NF B also plays a role in
regulating the growth and complexity of neurite arbors in SCG neurons cultured in
the presence of NGF. Together the studies in the nodose ganglia and SCG revealed a
novel role for NFIB-dependant gene expression in the growth and elaboration of
neurite arbors in the peripheral nervous system.
The final set of investigations that I performed for this thesis was investigating the
role of Reg-2 in CNTF-induced survival of sensory neurons. Many of these studies
were inconclusive, however my studies showed that Reg-2 is capable of promoting
the survival of nodose, but not trigeminal neurons and that Reg-2 expression in both
ganglia is dependent on the transcription factor STAT-3. Theses results suggest that
Reg-2 is unlikely to be a universal intermediate in cytokine-induced neuronal
survival, as had previously been suggested.
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BDNF Brain derived neurotrophic factor
BMP Bone morphogenetic protein
CAMK Ca2+/calmodulin-dependent protein kinase
cIAP cellular inhibitor of apoptosis-1
CLC Cardiotrophin-like compound
CNS Central nervous system
CNTF Ciliary neurotrophic factor
CNTFRa CNTF receptor a
COX Cyclooxygenase
CREB cAMP-responsive element-binding protein
CT-1 Cardiotrophin-1
DRG Dorsal root ganglion
EGF epidermal growth factor
ERK extracellular signal-regulated kinase
FGF fibroblast growth factor
GDNF Ghal-cell line derived neurotrophic factor
GFAP glial fibrillary acidic protein
GFR (a3) GDNF family receptor (a3)
GM-CSF Granulocyte Macrophage Colony Stimulating Factor
GPA Growth-promoting activity
GSK Glycogen synthase kinase
HGF Hepatocyte growth factor
HIP gene expressed in hepatocellular carcinoma-intestine-pancreas




INGAP Islet neogenesis-associated protein




JNK c-Jun N-terminal kinase
LIF Leukaemia inhibitory factor
LIFRJ3 LIF receptor p
MAGE melanoma antigen
MAP Microtubule associated protein
MAPK Mitogen-activated protein kinase
MEK mitogen-activated protein kinase kinase
MSK mitogen- and stress-activated protein kinases
MSP Macrophage-stimulating protein
NADE P75 NTR-associated cell death executor
NAK NFicB-activating kinase
NEMO NFkB essential modifier
NFkB Nuclear factor kB
NGF Nerve growth factor
NIK NFicB-inducing kinase
NP Neuropoietin
NRAGE Neurotrophin receptor-interacting MAGE





PI3K Phosphotidylinositol 3 kinase
PKA or PKC Protein kinase A or C
PLC Phosholipase C
PNS Peripheral nervous system
PSP Pancreatic stone protein
PTP Pancreatic thread protein
RSK ribosomal S6 kinase
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SCG Superior cervical ganglion
SH2 Src homology 2
SHP SH2-containing tyrosine phosphatase
SOCS Suppressor of cytokine signalling
STAT Signal transducer and activator of transcription
TAK TGF(3-activating kinase
TNFa Tumour necrosis factor a
TRAF TNF receptor associated factor a
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Appendix II: Supplementary Methods
Solutions and media used in tissue culture
0.1% Trypsin: 50mg of trypsin was added to 5ml of CMF-HBSS (Hanks' Balanced
Salt Solution without calcium and magnesium, GibcoBRL) and sterilised with a
0.22pm filter (Nalgene). lOOpl aliquots were stored at -20°C.
Poly-DL-ornithine: 0.5 mg/ml poly-DL-omithine (Sigma) was prepared in 0.15M
borate buffer (4.6g boric acid (BDH) in 500ml de-ionised, distilled water, pH 8.4)
and filter sterilised using a 0.22pm bell filter (Gelman Sc).
Laminin: Murine laminin (Sigma) was thawed at 4°C and diluted in CMF-HBSS to
give a final concentration of 20pg/ml.
L-15: A 11 unit of L-15 powder (GibcoBRL) was dissolved in 11 of de-ionised,
distilled water containing lOOmg streptomycin (Sigma) and 60mg penicillin (Sigma).
The pH was adjusted to 7.3 and the solution sterilised with a 0.22pm bell filter.
Hams' F-12: All unit of F-12 powder (GibcoBRL) was dissolved in 11 of de-
ionised, distilled water containing lOOmg streptomycin (Sigma) and 60 mg penicillin
(Sigma). The pH was adjusted to 7.3 and the solution sterilised with a 0.22pm bell
filter. To prepare serum-supplemented medium 50ml of heat-inactivated horse serum
(GibcoBRL) was added to 450ml lx F-12.
Hams' F-14: lOx stock: A 51 unit of F-14 powder (Imperial labatories) was
dissolved in 500ml of de-ionised, distilled water containing 500mg streptomycin
(Sigma) and 300mg penicillin (Sigma). The lOx stock was stored in 50ml aliquots at
-20°C.
lx solution: a 50ml aliquot of lOx F-14 was diluted to 500ml with de-ionised,
distilled water containing Ig NaHC03 (BDH). The pH was adjusted to pH7 by
bubbling through CO2, after which the solution was sterilised with a 0.22pm bell
filter.
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SATO supplement: A stock solution was prepared containing the following
reagents: 100ml Albumax-1 (GibcoBRL), 100ml ddH20, 160mg putrescine, 1ml
progesterone (0.625mg/ml in ethanol, Sigma), 10ml L-thyroxine (0.4mg/ml in
ethanol, Sigma). This stock solution was stored in 5.55ml aliquots at -20°C. To
prepare the culture medium 5.55ml of SATO stock was diluted with 2.5ml 200mM
L-glutamine (GibcoBRL) and 250ml lx F-14.
Neurotrophic Factors: All neurotrophic factors were kept in stock aliquots of
lOpg/ml in phophate-buffered saline (PBS, GibcoBRL) plus 10% HIHS, at 4°C, -
20°C or -70°C as per manufacturers instructions. BDNF and NGF originated from...,
while CNTF and LIF were from Chemicon.
Genotyping: Reaction mixes and cycling parameters
All genotyping reactions were performed using Hotstart Taq DNA polymerase and
supplied buffers (Biogene, UK)
IKKA p65
1Ox buffer 2pl 2pl
MgCh 5pi lpl
Mr solution 3.8pl -
5mM dNTP lpl lpl
Primers Ipl or each primer lpl or each primer
Tciq DNA polymerase 0.15pl 0.15 pi
dH20 6.5 14.25
Genomic DNA lpl lpl
Annealing temperature 55 57
Number ofcycles 35 32
254
Competitive RT-PCR
All reactions were carried out using Superscript reverse transcriptase (Sigma) and






1 pi reverse transcriptase
5pl total RNA or sample
lpl Reg-2 competitor RNA (concentration calibrated for each set of samples)
lpl GAPDH competitor RNA (concentration calibrated for each set of samples)
12pl dH.O
PCR: The sequences of the Reg-2 primers were
5' -GGACACCTCGTATCTGTGCTC-3' and
5'-TCCAAGTGTATTGGTAGCTGTTTC-3' and the reaction was carried out at an
annealing temperature of 60°C for 35 cycles.
4pl lOx buffer
4pl primers (stock contains lpg/pl of each primer)
1 pi dNTP




Semi-quantitative RT-PCR: Reaction mix and cycling
parameters
All reactions were carried out using Superscript reverse transcriptase (Sigma) and











lpl specific primers (stock contains lpg/pl of each primer)
lpl GAPDH primers (stock contains 0.lpg/pl of each primer)
1 pi dNTP
0.2pl Taq DNA polymerase
5pi RT reaction
14.3pl dH.O
An annealing temperature of 56°C and 35 cycles were used.














Reg-1115 5' -AACTGTCTTCTCCACGCATC' -3'
5' -CTCCACTTCCATCCATTTTC-3'
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